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Abstract
Human papillomavirus (HPV) is the most common sexually transmitted virus, and is
causally related to several cancers. HPV vaccination rates are far below HealthyPeople
2020 targets and vary across geographic, socioeconomic, and demographic populations.
The purpose of this research was to test the relationships among socioeconomic and
demographic variables, HPV vaccination, social vulnerability, and physician
recommendation within select local areas in the United States. Fundamental cause theory
and behavioral economics informed this quantitative secondary analysis of National
Immunization Survey-Teen and Social Vulnerability Index data (n = 43,271). Statistical
analyses included chi-square and binomial logistic regression. Teens whose mothers had
less than a college degree were more likely to initiate the HPV vaccine series (p < .01),
while teens living in Hidalgo County and Houston were less likely to initiate the series (p
< .001). Younger teens (p < .001), males (p < .001) and teens whose mothers had some
college (p < .01) were less likely to complete the series, while older teens (p < .001) and
teens living in Philadelphia and Houston (p < .01) were more likely to complete the
series. Fewer teens in Bexar County received a physician recommendation (p < .01);
there was no difference between vaccine initiation and select local area. These findings
highlight the need to consider local sociodemographic influences on underlying
disparities in health and physician behavior. Informed interventions may produce positive
social change by reducing variance in health care quality, tailoring public health efforts to
local needs, and moving persons experiencing disparities in health outcomes toward a
healthy future.
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Section 1: Foundation of the Study and Literature Review
Introduction
Human papillomavirus (HPV) is the most common sexually transmitted virus in
the world; every sexually active person will likely be infected with HPV at least once in
his or her lifetime (Centers for Disease Control and Prevention [CDC], 2017a). While
90% of infections will clear on their own, the remaining 10%–known as high risk
infections–are causally related to cervical, oropharyngeal, and anogenital cancers, genital
warts, and recurrent respiratory papillomatosis (CDC, 2017a; Galbraith et al., 2016;
Kulczycki, Qu, & Shewchuk, 2016; Palmer, Carrico, & Costanzo, 2015). To date, HPV
infection cannot be treated, but in the past 10 years three vaccines were approved by the
Food and Drug Administration (FDA) covering males and females ages 9 to 26 years to
protect against HPV infection (FDA, 2016).
A number of factors contribute to rates of HPV infection as well as receipt of
HPV vaccination: age, sexual onset at a young age, socioeconomic status, racial or ethnic
background, physician awareness and recommendation, and parental knowledge and
attitudes (Burger et al., 2016; Small, Sampselle, Martyn, & Dempsey, 2014).
The narrative around HPV vaccination is unique among other adolescent
vaccines, as the focus has been on the behavior leading to infection (e.g., adolescent
sexual activity) rather than the diseases prevented (e.g., cervical cancer) (Bailey et al.,
2016). In addition, the lack of a clear, strong physician recommendation for the vaccine
contributes to parental misperceptions of the importance of the vaccine (Bailey et al.,
2016). The Advisory Committee on Immunization Practices (ACIP) recommends HPV

2
vaccination for boys and girls at age 11 to 12 years, as the vaccine is most effective when
given prior to sexual activity, has greater immunoreactivity in adolescence, and can be
bundled with other adolescent vaccines for efficient delivery (ACIP, 2016; Bailey et al.,
2016). In October 2016, ACIP, CDC, and FDA recommended a two-dose series for
adolescents ages 9 to 14 years; three doses of the vaccination is still recommended for
teens and young adults ages 15 to 26 years (ACIP, 2016; FDA, 2016; Kim, Riley,
Harriman, Hunter, & Bridges, 2017).
Although the prevalence of certain HPV types has decreased and vaccination rates
have increased since the first HPV vaccine was introduced, initiation and completion of
the vaccine series continues to be below the 80% target to achieve herd immunity and
protect adolescents, teenagers, and young adults against infection (Berenson, Laz, &
Rahman, 2016; Moss, Reiter, Rimer, & Brewer, 2016; Rahman, Laz, McGrath, &
Berenson, 2015). As of 2015, only 41.9% of female and 28.1% of male ages 13 to 17
years had completed the HPV vaccine series (Reagan-Steiner et al., 2016). Of primary
concern for public health, vaccine initiation and completion vary across geographical
region, gender, socioeconomic status, and with different race and ethnic background; low
socio-economic status and minority populations are at higher risk for HPV infection and
related morbidity and mortality (Bruno, Wilson, Gany, & Aragones, 2014; Collins,
Holcomb, Chapman-Davis, Khabele, & Farley, 2014; Daniel-Ulloa, Gilbert, & Parker,
2016; Henry, Stroup, Warner, & Kepka, 2016; Jeudin et al., 2014).
Considering cervical cancer only for today’s cohort of female adolescents ages 12
years and younger, CDC estimates the low rates of vaccination will contribute to over
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50,000 cases of cervical cancer; for every year below the 80% target, an additional 4,400
girls will develop cervical cancer (Hswen, Gilkey, Rimer, & Brewer, 2017). Given that
African-American and Native American populations are expected to increase in the
United States at a modest rate between today and 2050, and Hispanic and Asian
populations are expected to grow more than double in that same time period, narrowing
the gap in HPV-related disparities is a critical public health need (Colby & Ortman, 2015;
Jeudin et al., 2014;). In addition, these minority population increases will require
culturally sensitive and relevant interventions and policies to allow for appropriate
allocation of resources and program planning, as each population may face unique
barriers to HPV vaccination (Galbraith et al., 2016; Reiter et al., 2014).
Researchers have identified lack of awareness of HPV, the cost of the vaccine and
office visits, cultural norms, and lack of physician recommendation to be associated with
disparities in HPV vaccination (Perkins, Brogly, Adams, & Freund, 2012; Rahman et al.,
2015). The strongest predictors of vaccine initiation and completion continue to be low
socioeconomic and racial and ethnic minority status, physician recommendation, and
provaccine policy (Choi, Eworuke, & Segal, 2016; Galbraith et al., 2016; Henry et al.,
2016; Jeudin et al., 2014; Palmer et al., 2015; Rahman et al., 2015; Rahman, Hirth, &
Berenson, 2017). However, no researchers to date have examined all of these predictors
together at the regional or county levels; while state-wide analyses offer larger sample
sizes for greater statistical accuracy, many public health decisions are made at the local
level (Waldrop, Moss, Liu, & Zhu, 2017). In addition, physician recommendations vary
across geography, minority status, age, socioeconomic status, and gender; policies are
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patchwork and often ineffectual; and guidelines lack the rigor of legislative mandate
(Galbraith et al., 2016; Jeudin et al., 2014; Moss et al., 2016; National Conference of
State Legislatures [NCSL], 2017; Perkins et al., 2012; Rahman, Islam, & Berenson,
2015).
Vaccination rates against other diseases near or above 80% needed for herd
immunity, in large part due to childcare and school-entry requirements (see Table 1). Of
note, Hepatitis B, a viral infection transmitted by sexual activity or sharing drug
paraphernalia, has the highest immunization rates (National Center for Health Statistics
[NCHS], 2016). National HPV rates are less than half those for other diseases (NCHS,
2016).
Table 1
Immunization Rates for Select Recommended Adolescent Vaccines, 2014-2015
Disease

Immunization Rate
(%), 2014

Immunization Rate
(%), 2015

Measles, mumps, rubella (≥ 2 doses)
Hepatitis B (≥ 3 doses)
Varicella (≥ 2 doses, or a history of
varicella)
Tetanus, diphtheria, pertussis (≥ 1
dose)
HPV (≥ 1 dose, females)
HPV (≥ 3 doses, females)
HPV (≥ 1 dose, males)
HPV (≥ 3 doses, males)

90.7
91.4
85.0

90.7
91.1
86.1

87.6

86.4

60.0
39.7
41.7
21.6

62.8
41.9
49.8
28.1

Note. From Table 67 in the National Center for Health Statistics report (2016).
Many interventions focus on increasing awareness and education of vaccination
(including HPV); these efforts may be necessary but insufficient when making a decision

5
to accept vaccination (Brandt, Pierce, & Crary, 2016). Policy-level interventions for HPV
vaccination are underutilized, if used at all, despite the use of public health policy in
many of the great achievements in public and population health (Brandt et al., 2016). In
particular, public health departments make little use of the public health authority as an
alternate to legislative action (Abiola, Colgrove, & Mello, 2013; Brandt et al., 2016;
Colgrove, Abiola, & Mello, 2010).
Clinics and physicians are not consistently implementing recommended practices
for HPV vaccination, especially among low socioeconomic and racial and ethnic minority
patients (Askelson, Edmonds, Momany, & Tegegne, 2016). Evidence-based guidelines
and recommendations published by ACIP, American Academy of Pediatrics, CDC,
Community Preventive Services Task Force, and others include:
•

immunization information systems,

•

alerts and reminders for physicians and parents,

•

standing orders for non-physicians to administer vaccines,

•

participation in Vaccines For Children program,

•

strategies to discuss the vaccine with parents who request delays or refuse,

•

scheduling wellness visits for children 11 and 12 years old,

•

allowing walk-in vaccination visits,

•

vaccinating during sick visits,

•

scheduling visits for subsequent doses at the time of vaccination, and

•

individual physician feedback on vaccination rates (Askelson et al., 2016;
Bailey et al., 2016).
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These recommendations and guidelines reflect the importance of the social
determinants of health and the context in which people make decisions and behave
(Ferrer, Audrey, Trotter, & Hickman, 2015). A large number of HPV vaccination studies
are grounded in individual or interpersonal health behavioral theories, which tend to view
people as rational, logical actors wanting to maximize the benefit of health (Ferrer et al.,
2015). Yet physicians and patients often make decisions that do not align with evidencebased science to maximize health, and behavior is influenced not only by individual
psychology but also structural, economic, social, and political factors (Askelson et al.,
2016; Ferrer et al., 2015). As stated by Vanderpool, Crosby, and Stradtman (2014), “The
annual death rate from HPV-related cancers demands much more than minor alterations
to our current patchwork approach to prevention” (p. 2560). Such comprehensive,
evidence-based programs are needed to make progress toward the Healthy People 2020
goals of HPV vaccination coverage and reduction of HPV infection and associated
cancers, as well as reduce the nearly $8 billion in annual costs for HPV-associated
management (Palmer et al., 2015).
After a decade of research supporting the conclusion that HPV vaccines are safe
and effective, vaccine initiation and completion continue to be low; additional research is
needed to better understand how to reach those who are eligible for vaccination to protect
against multiple HPV-related cancers (Maness, Reitzel, Watkins, & McNeill, 2016;
Perkins, 2016). In addition, researchers recently have begun to explore potential
relationships among health, local geographic areas, and social vulnerability – a composite
of socioeconomic status, household composition and disability, minority status and
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language, and housing and transportation (Boscoe et al., 2014; Henry et al., 2016; Henry,
Swiecki-Sikora, Stroup, Warner, & Kepka, 2017; Rutten et al., 2017). While researchers
have published recent analyses on HPV vaccination data and policy, I am not aware of
any to date that have tested the influence of the socioeconomic, demographic, cultural,
geographical, and health history variables on HPV vaccine initiation and completion
alongside the social vulnerability context in which these relationships exist. This will also
be the first test of a potential relationship between social vulnerability and HPV
vaccination in the literature, to my knowledge.
These implications, such as the identification of the factors most strongly
associated with HPV vaccination and common error decision points in physician
recommendation, can advance social change by highlighting the need to consider local
social and demographic influences on physician behavior. Informed interventions may be
able to reduce variance in quality, increase culturally competent health care, and move
those persons experiencing disparities in health outcomes toward a positive and healthy
future. As noted in Andre et al. (2008), “a comprehensive vaccination programme is a
cornerstone of good public health and will reduce inequities” (p. 144).
The remainder of this chapter contains a review of the research problem, the
purpose of the study, the research questions and hypotheses, the theoretical foundation
and relation to the research questions, and the nature of the study.
Problem Statement
The Chicago Department of Health reported in July of 2015 that a recent inperson training and public education campaign increased rates of HPV vaccination by
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nearly 20%, as indicated in the 2014 National Immunization Survey-Teen data (City of
Chicago, 2015). However, no discussion of data based on key determinants of
vaccination, including socioeconomic and racial and ethnic minority status or physician
recommendation, has occurred (City of Chicago, 2015).
The hypotheses of minority poverty and diminishing returns suggest that minority
populations start life with poorer health and any gains in socioeconomic status result in
smaller health improvements than non-minority populations with equivalent gains
(Farmer & Ferraro, 2005; Kish et al., 2014; Lu et al., 2015). However, the higher burden
of HPV infection, morbidity, and mortality and lower vaccination rates in vulnerable
populations have the potential to exacerbate disparities in health outcomes (Braveman,
Cubbin, Egerter, Williams, & Pamuk, 2010; Galbraith et al., 2016).
Researchers have focused on individual-level efforts targeting patients, but these
programs have yielded little progress in vaccination completion (Ferrer et al., 2015). In
addition, despite recommendations and policies set by federal bodies and national
associations, physicians continue to recommend the HPV vaccine at lower rates than for
other adolescent vaccines (Galbraith et al., 2016; Henry et al., 2016; Osazuwa-Peters et
al., 2015; Teplow-Phipps et al., 2016; Vadaparampil et al., 2014).
The relationship between population- and structural-level factors influencing the
predictors of HPV vaccination has not yet been clarified, so there is no consensus on
which variables may be most appropriate to target in interventions (Ferrer et al., 2015;
Oliver, Frawley, & Garland, 2016; Small et al., 2014). While overall HPV vaccination in
the United States is rising slowly, incidence and prevalence of HPV-associated cancer in
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the United States are growing quickly, and disparities in vaccination rates and cancer
mortality persist. Without knowledge of factors that influence vaccination in each
population, public health practitioners may have difficulty designing effective methods to
reduce these disparities. The newly released 2015 NIS-Teen data will provide the
opportunity to update relationship and distribution patterns of socioeconomic and
demographic variables across the nation. Understanding these patterns and their
relationship with persistently low HPV vaccination initiation and completion can inform
more cost-effective, culturally-grounded efforts in policy development and other changes
to the environment in which vaccine decisions are made (Burger et al., 2016; Ferrer et al.,
2015; Small et al., 2014; Zimet, Rosberger, Fisher, Perez, & Stupiansky, 2013).
Purpose of the Study
The purpose of this retrospective quantitative study is to test the relationship
between HPV vaccine initiation and completion, socioeconomic status, and demographic
variables in eight select local areas in the United States. In addition, I will test the
relationship between HPV vaccine initiation, physician recommendation, and social
vulnerability in four select local areas.
Research Questions and Hypotheses
I will attempt to answer four research questions:
Research Question 1: Is there a relationship between HPV vaccination initiation
(1 dose) and socioeconomic status and demographic variables in selected local areas,
using data from the 2015 NIS-Teen?
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H01: There is no relationship between HPV vaccination initiation and
socioeconomic and demographic variables in selected local areas.
Ha1: There is a relationship between HPV vaccination initiation and at least one
socioeconomic or demographic in selected local areas.
Research Question 2: Is there a relationship between HPV vaccination completion
(3 doses) and socioeconomic status and demographic variables in selected local areas
using data from the 2015 NIS-Teen?
H02: There is no relationship between HPV vaccination completion and
socioeconomic and demographic variables in selected local areas.
Ha2: There is a relationship between HPV vaccination completion and at least one
socioeconomic or demographic variable in selected local areas.
Research Question 3: Is there a relationship between HPV vaccination initiation
(1 dose) and social vulnerability by select local area county in the United States using
data from the 2014 NIS-Teen and 2014 Social Vulnerability Index?
H03: There is no relationship between HPV vaccination initiation and social
vulnerability by select local area county in the United States.
Ha3: There is a relationship between HPV vaccination initiation and social
vulnerability by select local area county in the United States.
Research Question 4: Is there a relationship between physician recommendation
(yes/no) and social vulnerability by select local area county in the United States using
data from the 2014 NIS-Teen and 2014 Social Vulnerability Index?
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H04: There is no relationship between physician recommendation and social
vulnerability by select local area county in the United States.
Ha4: There is a relationship between physician recommendation and social
vulnerability by select local area county in the United States.
Theoretical Foundation for the Study
Two theories provide useful constructs with which to interpret the study results:
fundamental cause theory, addressing the presence and persistence of socioeconomic and
minority disparities in health, and behavioral economics, establishing a need to consider
the context and key influences of an environment on physician decision making.
Fundamental cause theory. Fundamental cause theory (FCT), developed by
Link and Phelan (1995), is built on the idea that disparities develop alongside
improvements in health care access and innovations due to the unequal distribution of
health-promoting resources (Phelan, Link, & Tehranifar, 2010; Polonijo & Carpiano,
2013). The associations between disparities in health and health outcomes for preventable
diseases by socioeconomic status and racial and ethnic backgrounds are well established,
with poor and minority populations often experiencing poorer health and shortened
lifespans (Howlader et al., 2017; Polonijo & Carpiano, 2013; Tehranifar et al., 2009).
Those with access to flexible resources are able to take advantage of health-promoting
assets in their environment and adapt to future health challenges, while those without
access may experience some overall health improvement but at a lower level (Phelan et
al., 2010; Polonijo & Carpiano, 2013).
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For example, with the advent of cervical cancer screening, overall deaths
declined, yet incidence and mortality continues to be highest in Hispanics, African
Americans, and Native Americans (Howlader et al., 2017). According to FCT, these
populations have fewer resources for learning about and attaining benefits of health
innovations such as screening (Phelan et al., 2010). The HPV vaccine is another
innovation in knowledge and technology, yet a gradient has emerged in which low
socioeconomic status and racial and ethnic minority populations are less likely to be
vaccinated (Phelan et al., 2010). The implication of FCT is that interventions must
minimize the degree to which flexible resources engender better health (Polonijo &
Carpiano, 2013). HPV vaccination is thus an important test of theory; if specific causes
are not identified and addressed in interventions and resources are distributed unequally,
disparities in HPV-related cancers will persist (Polonijo & Carpiano, 2013).
Behavioral economics theory. Traditional economic models assume people are
rational actors who make decisions independent of social or environmental contexts;
however, there is consensus among researchers that behavior is strongly influenced by
social determinants, and people are consistently irrational in making decisions (Getzen,
2013; Hoff & Stiglitz, 2016; Volpp, Loewenstein, & Asch, 2015). Researchers use the
theory of behavioral economics, credited to Kahneman and Tversky (1979), to augment
traditional economic models with social influence on human decisions. This theory
advocates for the inclusion of common decision errors in interventions with a goal of
improving health beyond a quantitative increase or decrease in behavior change in a costeffective way (Bickel, Moody & Higgins, 2016; Getzen, 2013; Volpp et al., 2015). Of all
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health economic models, Frank (2004) and Glanz, Rimer, and Viswanath (2015)
suggested that physician behavior is most associated with behavioral economics, which
can be used to help explain why physicians often deviate from evidence-based medicine;
these findings can subsequently be used to inform more appropriate measures of behavior
change.
Physicians make decisions about the intensity of treatment within the context of
an asymmetrical power relationship with the patient, rigid time constraints, and risk
aversion with patient outcomes. In this setting, physicians are influenced by constructs of
stereotype and availability heuristics, time discounting, loss aversion, and choice
architectures–all suggesting that physicians understandably use shortcuts in assessing
patients, stick with treatments that have worked in the past, and select intensity of
treatment based on local rather than national norms and evidence-based data (Frank,
2004; Hoff & Stiglitz, 2016). In behavioral economics, framing or choice architecture
matters and many common decision error points can be redirected toward making healthpromoting, evidence-based decisions. Understanding the internal barriers (such as
heuristics) and external factors (such as physician prompts in electronic medical records)
that motivate physicians to recommend the HPV vaccine may help guide individual,
community, and population-level changes to facilitate physician recommendation for all
patients (Dovidio & Fiske, 2012; Emanuel et al., 2016; Gesser-Edelsburg, Walter, ShirRaz, & Green, 2015; Kao, 2015).
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Nature of the Study
The nature of this study is a quantitative retrospective secondary analysis of
national, publicly available data. Secondary analysis of large, reliable data sets such as
NIS-Teen is less time-consuming and expensive than conducting primary quantitative
research, and provides a sufficiently large sample size to make generalizations to the
whole population, analyze data with a high level of statistical accuracy, and allow
analysis among subgroups (Dale, 2004). Retrospective analysis is similarly a timely and
cost-effective way to gather data, rather than waiting for events to occur, and can be
reliable when data are objective events and can be verified by other sources (de Vaus,
2006). Gathering and analyzing generalizable data in a timely fashion can help identify
potential factors, modifiable or not, that can be used to develop policies and programs
aiming to increase U.S. HPV vaccination rates in the near future.
CDC conducts the annual NIS-Teen to monitor vaccination initiation and
completion of adolescents aged 13 to 17 years among a stratified probability sample of all
50 states, the District of Columbia, and territories (Henry et al., 2016; Rahman et al.,
2015). In addition, selected local areas that receive federal Section 317 funds to purchase
vaccines, particularly for priority populations, are sampled and analyzed separately
(Reagan-Steiner et al., 2016). The NIS-Teen gathers data in two phases, a telephone
survey (both landline and cellular as of 2011) of parents or guardians of the target
adolescents to obtain socioeconomic and demographic data, and a mailed survey to
parent or guardian-identified providers to verify immunization records (CDC, 2016a;
Henry et al., 2016; Rahman et al., 2015).
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All analyses will include appropriate sampling weights when determining
estimates to account for survey design. As the dependent variables are considered to be
nominal (yes / no), statistical tests will include Chi-square and binomial logistic
regression. This approach will be used to assess the relationship among a number of
independent variables hypothesized to influence the dependent variables: HPV
vaccination initiation and completion and physician recommendation of the HPV vaccine
(Rahman et al., 2015; Perkins, 2016). Key variables as described in the 2014 and 2015
Data User’s Guide (CDC, National Center for Immunization and Respiratory Diseases, &
National Center for Health Statistics, 2015, 2016) are defined as follows.
Ethnic and racial minority status. A categorical independent variable describing
the race/ethnicity of the adolescent or teen. Options are Hispanic, Non-Hispanic White
Only, Non-Hispanic Black Only, Non-Hispanic Other + Multiple Races, and Other +
Multiple Race (a recode of NHO + Multiple Races) (CDC et al., 2015, 2016).
HPV vaccination completion. A nominal dependent variable indicating the
adolescent or teen has received three or more doses of the HPV vaccine. Some teens may
have received more than three recommended doses; a secondary calculation by the CDC
refers to a teen who, among those who received one or more HPV dose and over a
minimum of 24 weeks between the first dose and the interview date, received a total of
three or more doses (Reagan-Steiner et al., 2015).
HPV vaccination initiation. A nominal dependent variable indicating the
adolescent or teen has received one or more doses of the HPV vaccine (Reagan-Steiner et
al., 2015).
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Physician recommendation. A categorical dependent variable (research question
4) indicating whether the person participating in the survey recalls receiving a
recommendation from a physician or health care professional for the adolescent or teen to
receive the HPV vaccination (CDC et al., 2015; 2016).
Selected local areas. Seven specific estimation areas highlighted in the 2015
NIS-Teen dataset (Bexar County, TX; Chicago, IL; El Paso County, TX; Hidalgo
County, TX; Houston, TX; New York City; and Philadelphia County, PA) (CDC et al.,
2015; 2016). As Washington, D.C. is sampled separately, I have included it as one of the
select local areas. These local areas receive federal Section 317 funds to purchase
vaccines, particularly for priority populations, and are sampled and analyzed separately;
El Paso County and Hidalgo County were oversampled (Reagan-Steiner et al., 2016).
Given the demonstrated differences in HPV vaccination by geography, as well as the
hypothesized relationship between social vulnerability and HPV vaccination, inclusion of
local areas will add significant value to the research. In order to compare county-level
data from the Social Vulnerability Index (described below) and the NIS-Teen database, I
will include only four selected local areas that are stand-alone counties from the 2014
NIS-Teen in the SVI portion of my analysis: Bexar County, District of Columbia, El Paso
County, and Philadelphia (Hidalgo County was added in 2015).
Social vulnerability. As defined by the CDC and Agency for Toxic Substances
and Disease Registry [ATSDR], social vulnerability refers to the extent to which the
health of communities is likely to be affected by socioeconomic and demographic factors
(CDC & ATSDR, 2017). Vulnerable populations are those who are disproportionately
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burdened by a combination of factors, are less likely to be able to cope with stressors, and
whose needs are inadequately accounted for in resource allocation plans (Flanagan,
Gregory, Hallisey, Heitgerd, & Lewis, 2011). The CDC and ATSDR’s Social
Vulnerability Index ranks each census tract or county on overall vulnerability, comprised
of four themes and 15 social factors affecting health: socioeconomic status (below
poverty, unemployed, income, no high school diploma); household composition and
disability (aged 65 and older, aged 17 or younger, civilian with a disability, single-parent
households); minority status and language (minority, speak English less than well); and
housing and transportation (multi-unit structures, mobile homes, crowding, no vehicle,
group quarters) (CDC & ATSDR, 2017). As the most recent data set was published in
2014, I will compare the 2014 NIS-Teen dataset with the 2014 SVI.
Socioeconomic status. Categorical independent variables including income
(poverty status, family income), health insurance and education (the current level of
education of the adolescent or teen and the mother) (CDC et al., 2015; 2016).
Literature Review
In the decade since the first HPV vaccine was approved for use, researchers have
proposed many theories and arguments to explain the low levels of HPV vaccine uptake.
In this chapter, I present the literature on the themes relevant to my study: health
disparities and social determinants of health including racial and ethnic minority status,
socioeconomic status, and geography; policy and guidelines relating to vaccination; and
physician recommendation of the HPV vaccine. In addition, I will present the literature
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on epidemiology of HPV for context, as well as propose two theories that may be useful
for guiding future interventions in HPV vaccination research.
Literature Search Strategy
The literature search was conducted using search engines and databases in the
Walden University Library, specifically CINAHL & MEDLINE Simultaneous Search,
Expanded Academic ASAP, Google, Google Scholar, PsycINFO, PubMed, SAGE
Premier, and ScienceDirect. In addition, a small number of journals featuring issues
dedicated to HPV research (including Human Vaccines & Immunotherapeutics in June
2016 and Vaccines in November 2012) and an annually published journal
(Papillomavirus Research) were reviewed for relevant publications.
Search terms within these databases and search engines included behavioral
economics theory (with or without health or health behavior), fundamental cause of
health, fundamental cause theory (with or without health), HPV or human
papillomavirus (with or without vaccin*), papillomavirus history, and social
determinants of health (with or without policy). In addition, HPV or human
papillomavirus with or without vaccin* was combined with behavioral economics,
cancer, disparities, fundamental cause theory, minority, physician recommendation,
policy, and socioeconomic. The scope of the literature review in terms of years included
(a) 1935-2017 for seminal literature regarding the history of HPV research, fundamental
cause theory, and behavioral economics, (b) 2010-2017 for statistics on the most current
data available on applicable variables, and (c) 2011-2017 for current peer-reviewed
articles; peer-reviewed articles published 2015 through 2017 were prioritized.
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Selection criteria for peer-reviewed articles included (a) publication in English,
(b) original research or review articles, commentary, and editorials, (c) discussion or
description of the aforementioned variables and their relationships to health and health
outcomes in the United States, (d) HPV vaccination research with a primary focus on
adolescents and teenagers ages 11 to 17, and (e) discussion or description of the
theoretical foundations of this proposal and their application to health, policy, and
economics. Literature on the application of the selected theoretical foundations to HPV
vaccination was scarce; therefore, articles discussing these theories and their application
to health in general were reviewed. In addition, literature regarding global trends in the
aforementioned variables was reviewed if information was directly relevant to, or
including a data collection component within, the United States.
Epidemiology of Human Papillomavirus and HPV-Associated Disease
Over 200 types of human papillomaviruses have been isolated and characterized
and classified as one of two types: (a) low-risk, causing benign or low-grade tissue
abnormalities, anogenital warts, and recurrent respiratory papillomatosis; and (b) highrisk, causing cervical, vaginal, vulvar, penile, anal, and oropharyngeal cancers (Hutter &
Decker, 2016).
Global infection and cancer. HPV is the only cancer-causing virus to be
endemic worldwide and is one of the most important infectious carcinogens in humans
(Chan, Wong, Qin, & Chan, 2016; zur Hausen, 2009). HPV infects an estimated 12% of
women of all ages worldwide, with a peak infection rate of 24% for those under 25 years
old (Handler, Handler, Majewski, & Schwartz, 2015). Over half a billion cancers
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annually are associated with HPV infection annually worldwide; the populationattributable fraction (PAF), or the proportional reduction in disease that would occur if
HPV were not present, is nearly 90% (Forman et al., 2012; World Health Organization,
2016).
U.S. incidence. Both HPV and genital wart figures are estimates; testing for HPV
in cancer diagnoses does not happen routinely, nor do registries collect data on HPV
status (with the exception of New Mexico for cervical cancer), so HPV infection rates are
calculated based on the estimated infection rate within tissue known to be associated with
HPV (CDC, 2016b; Katzel, Merchant, Chaturvedi, & Silverberg, 2015). Genital wart
incidence is estimated based on persons who seek treatment, so true incidence is likely
underrepresented (CDC, 2016b). However, previous studies support 70-80% concordance
between estimates and direct measurement of HPV infection, and therefore national
estimates are considered reliable (Katzel et al., 2015).
In the United States, annual incidence of HPV infection is 14 to 20 million
people, while prevalence is 79 to 110 million (CDC, 2017b; Handler et al., 2015). An
estimated $8 billion are spent annually managing HPV-related morbidity and mortality,
second only to HIV (Chesson, Markowitz, Hariri, Ekwueme, & Saraiya, 2016). Initial
visits to physician’s offices for genital warts has increased over 730% in the past 50
years, with over 465,000 initial visits in 2014 (CDC, 2017c). Finally, annual incidence of
HPV-associated cancers has increased over time, with an estimated 40,000 cases annually
(8 per 100,000), although estimates vary by cancer site, ethnicity, study methodology,
and geographic location (Handler et al., 2015; Viens et al., 2016). The incidence of HPV-
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associated cancers differs by geography, from 7.5 per 100,000 in Utah to 14.7 per
100,000 in Kentucky (Saraiya et al., 2015; Viens et al., 2016).
U.S. HPV infection by cancer site. The estimated detection of HPV in the
United States is (a) 99% in cervical cancer and cervical cancer in situ, (b) 91% in anal
cancer, (c) 75% in vaginal cancer, (d) 70% to 90% in oropharyngeal cancer, (e) 70% in
vulvar cancer, (f) 63% in penile cancer, and (g) 53% in oral cavity and laryngeal cancer
(Bailey et al., 2016; Garland et al., 2016; Saraiya et al., 2015). Cervical, anal, and
oropharyngeal cancers are of particular interest to researchers given their incidence and
risk factors.
Cervical cancer. Knowing patterns of preventable, evidence-based population
risk factors contributing to incidence of HPV infection and associated cancers are key for
creating benchmarks in public health policy and planning efforts (Franco, Shinder, Tota,
& Isidean, 2015). For example, mortality for cancers for which early detection,
prevention, and/or treatment exist and were adequately implemented was reduced by 50%
between 1990 and 2015 (Byers, Wender, Jemal, Baskies, Ward, & Brawley, 2016). Of
the HPV-associated cancers, only cervical cancer has an established early detection
program and treatment algorithm; cervical cancer efforts are a model for programs that
can reliably detect precancerous lesions and effectively remove the tissue, and have
reduced cervical cancer mortality by 60% since 1955 (Dizon et al., 2016; Ferlay et al.,
2015; Franco et al., 2015; Hutter & Decker, 2016). However, screening is not 100%
effective: many women infected with high-risk HPV may have normal Papanicolaou
(Pap) test results; screening is less effective in preventing cervical adenocarcinoma than

22
squamous cell carcinoma; and only 81% of women get up to date regular pap smears
(Castanon, Landy, & Sasieni, 2016; Hutter & Decker, 2016; Viens et al., 2016).
Cervical screening compliance is even lower among women who are of minority
descent, uninsured or publicly insured, and low socioeconomic status (Reiter et al., 2013;
Viens et al., 2016). This is particularly troubling, as Blacks clear HPV more slowly than
White women, and cervical cancer incidence is highest among Blacks and Hispanics,
women in poverty, and women with low educational attainment (Reiter et al., 2013;
Viens et al., 2016). It is therefore crucial to understand HPV prevalence and vaccination
coverage among populations to more effectively address existing and potential future
cervical cancer disparities (Reiter et al., 2013).
Anal cancer. Anal cancer is one of only five cancers whose incidence has
increased in the past 40 years (another HPV-associated cancer, HPV-positive
oropharyngeal squamous cell carcinoma, is among the five) (Amini et al., 2016; Jemal et
al., 2013). Incidence and mortality rates of anal cancer in the United States are highest in
White females and Black males; overall, anal cancer is slightly more common in females
(Viens et al., 2016). Receptive anal sex is strongly associated with HPV infection and
anal cancer in males; men who have sex with men (MSM) have higher rates of anal
cancer than men who have sex with women (Handler et al., 2015). Rates of anal cancer in
U.S. HIV-positive MSM are on par with rates of cervical cancer sub-Saharan African
women, which are the highest in the world (Forman et al., 2012). However, even
individuals who do not participate in anal sex are still at risk given the proximity of the
anal canal and genitals (Hutter & Decker, 2016).
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Oropharyngeal cancer. Head and neck squamous cell carcinoma incidence
overall is declining in the United States., including a 50% reduction in HPV-negative
oropharyngeal cancer in less than 20 years, as tobacco and alcohol use have declined in
recent birth cohorts (Allison & Maleki, 2016; Amini et al., 2016; Chaturvedi, Engels,
Anderson, & Gillison, 2008; Chaturvedi et al., 2011; Gillison, 2016). Conversely, HPVpositive oropharyngeal cancer (HPV OSCC) has risen steeply, jumping 225% during the
same time period (Allison & Maleki, 2016; Chaturvedi et al., 2011). Given that smoking
tobacco is an established risk factor for HNSCC but smoking rates have decreased,
another causal agent–HPV–must be driving the rise in HPV OSCC in younger individuals
(Allison & Maleki, 2016; Chaturvedi et al., 2011). Researchers estimate incidence of
HPV OSCC will surpass incidence of HPV-positive cervical cancer by 2020, if not
sooner; the dramatic increase of HPV OSCC as smoking has decreased has been
described as virus-related epidemic (Allison & Maleki, 2016; Marur, D’Souza, Westra, &
Forastiere, 2010).
HPV OSCC is distinctive from HPV-negative OSCC not only in incidence, but in
molecular pathophysiology, presentation, and prognosis (Mallen-St Clair et al., 2016).
The differences are so great that survival rates for HPV OSCC patients cannot be
predicted using the current TNM staging system; to aid researchers and physicians, the
American Journal of Cancer will publish an updated staging manual including HPV
OSCC in late 2016 (Mallen-St Clair et al., 2016). If treated with radiation, HPV OSCC is
associated with improved overall survival rates (Allison & Maleki, 2016). Researchers
have yet to identify a lesion or map progression to HPV OSCC, however, and have not
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determined why HPV-positive tumors are more sensitive to radiation treatment than
HPV-negative tumors (Mallen-St. Clair et al., 2016).
Risk factors and other considerations. HPV infection and HPV-associated
cancers share a number of risk factors–sexual behavior, smoking marijuana, and other
epidemiological considerations including age, educational attainment, health care
coverage, socioeconomic status, and racial and ethnic minority background (Mullins et
al., 2016). Although these issues will be explored more fully later in the remainder of this
section, a brief discussion on their relevance to incidence is warranted.
HPV infection (and consequently development of HPV-associated cancers) is
associated with early age of first sexual encounter, high number of sexual partners, and
smoking marijuana (Chaturvedi et al., 2011; Chesson, Dunne, Hariri, & Markowitz,
2014; Mullins et al., 2016). Immunosuppressed and HIV-positive individuals are at much
higher risk of HPV infection than the general population, as their immune systems cannot
clear the infection as effectively (Forman et al., 2012).
Prevalence of male HPV infection is generally correlated with female HPV
infection, while prevention of infection in males protects both females in heterosexual
relationships and males in homosexual relationships (Allison & Maleki, 2016; Fairley,
Zou, Zhang, & Chow, 2017). Incidence of infections leading to cervical cancer tends to
peak near the age of sexual debut (teens to early 20s) while incidence of infections
leading to HPV OSCC and anal and penile cancers has a bimodal peak, one at 30 to 34
years and another at 60 to 64 years (Allison & Maleki, 2016). The age at which
individuals develop cancer influences outcomes, as younger individuals with HPV-
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associated cancers often present at higher stages and are exposed to toxic treatments that
affect long-term quality of life (Amini et al., 2016; Gillison, 2016).
Finally, incidence of HPV infections and associated cancers tends to be
disproportionately higher in persons of low socioeconomic status and racial and ethnic
minority populations; one exception is HPV OSCC, which occurs more often among
young, educated, affluent White males (Allison & Maleki, 2016, Byers et al., 2016).
In the past decade, the Food and Drug Administration approved three prophylactic
HPV vaccines (see Table 2) (Onon, 2011). Currently, clinical trials are testing efficacy in
alternate dosing schedules, efficacy and safety in pediatric and immunocompromised
patients, safety when administered in combination with other vaccines, and efficacy of
behavioral interventions to increase vaccine uptake (Onon, 2011).
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Table 2
Approved HPV Vaccines and Their Indications
Initial
Approval

Initial Indication

Subsequent
Approvals

Gardasil
(Merck & Co)

June, 2006

Girls and women ages
9 to 26 years: Cervical
cancer; genital warts;
cervical
adenocarcinoma in
situ; cervical, vulvar,
and vaginal
intraepithelial lesions

Cervarix
(GlaxoSmithKline)

October,
2009

Gardasil-9
(Merck & Co)

December,
2014

Girls and women ages
10 to 25 years:
Cervical cancer;
cervical
adenocarcinoma in
situ; cervical
intraepithelial lesions
Girls and women ages
9 to 26 years:
Cervical, vulvar,
vaginal, and anal
cancer; genital warts;
cervical, vulvar,
vaginal, and anal
intraepithelial lesions.
Boys ages 9 to 15
years: anal cancer;
genital warts, anal
intraepithelial lesions

Vulvar and vaginal HPV6, 11,
cancer (September 16, 18
2012).
Males and females
ages 9 to 26 years,
anal cancer and
anal intraepithelial
lesions (December
2010)
Girls aged 9 years HPV16, 18
(2011)

Men ages 16 to 26
(December 2015)
Two-dose regimen
for individuals
ages 9 to 14 years
(October 2016)

Covered
HPV Types

HPV6, 11,
16, 18, 31,
33, 45, 52,
58

Note. From FDA (2016). Approvals current as of July 1, 2017.
Health Disparities and Social Determinants of Health
Health is shaped by the social determinants of health, or “conditions in the
environments in which people are born, live, learn, work, play, worship, and age”
(Healthypeople.gov, 2017, “Understanding Social Determinants of Health,” para. 1).
Researchers have demonstrated strong links between a number of determinants and
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disparities in health and health outcomes, including race and ethnicity, socioeconomic
status, and geographic location (CDC, 2013). Of particular relevance to my study, these
determinants, along with physician recommendation, have been linked with HPV
vaccination (Burger et al., 2016). These determinants underpin how health-promoting
resources are distributed, as in the fundamental cause theory, and inform physician
decision-making, as in behavioral economics. Although these data on vaccination and
relationships with health determinants are useful and consistent, there continue to be gaps
in HPV vaccine research. To date, most research in the HPV vaccine space has focused
on individual-level determinants in isolation, or has been analyzed at the aggregate level,
masking inter- and intra-population differences in HPV vaccine rates (Bodson et al.,
2017; Kreuter, McQueen, Boyum, & Fu, 2016; Romaguera et al., 2016; Rutten et al.,
2017; Whittemore et al., 2016).
This leads to the questions about the relationships among a number of individual
and structural determinants known to interact with HPV vaccination, as well as whether
there are other determinants that have not yet been examined (Kreuter et al., 2016).
Testing the relationships of these determinants on multiple levels with HPV vaccine
uptake is necessary if researchers are to identify modifiable factors that contribute to
existing inequalities in HPV-related morbidity and mortality (Bodson et al., 2017). I will
address this gap and build on the body of research in this space by testing socioeconomic
and demographic variables and social vulnerability as independent variables, with HPV
vaccine initiation and completion and physician recommendation as dependent variables.
In the following discussion, I present the literature supporting the importance of
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disparities in race and ethnicity, socioeconomic status, and geography, and how I will
address gaps in the literature through this study.
Racial and ethnic minority status. Researchers have established strong
relationships among disparities in health due to cumulative, differential experience of
racial and ethnic minorities with structural and interpersonal inequities; these disparities
have been linked to HPV-related health outcomes and HPV vaccination rates (Benz et al.,
2011; Braun et al., 2015; Chang, Moonesinghe, Athar, & Truman, 2016; Gelman et al.,
2013; Jeudin et al., 2014; Reagan-Steiner et al., 2016; Williams, Priest, & Anderson,
2016). An individual’s racial and ethnic background is a non-modifiable factor, but is so
strongly linked with other social determinants and health outcomes that any examination
of disparities HPV vaccine uptake must include this variable to be valid and useful for
knowledge and practice (Burger et al., 2016).
Tehranifar et al. (2009) suggested that racial and ethnic disparities in cancer
incidence and mortality have been consistent despite the advancement of screening
techniques and treatment. This is supported by Burger et al. (2016) and others, who
presented data showing differential burden of incidence and mortality by racial and ethnic
background (see Table 3) (Bakir & Skarzynski, 2015; Gelman et al., 2013; Ramer et al.,
2016; Reagan-Steiner et al., 2016). For example, the U.S. Cancer Statistics Working
Group (2016) showed that White and Black populations tend to have higher incidence of
anal and oropharyngeal cancer. In another example, Bakir & Skarzynski (2015) reported
that while Black women are slightly less likely to develop cervical cancer than Hispanic
women, they are substantially more likely to die from the disease.
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Table 3
Age-Adjusted Cancer Incidence and Mortality by Primary Tumor Site and Race
Primary
Site

All Races
White
Black
A/PI
AI/AN
Hispanic

Anus

Cervix

Oropharynx

Incidence

Mortality

Incidence

Mortality

Incidence

Mortality

1.8
1.9
1.8
0.5
0.9
1.3

0.2
0.3
0.3
0.1

7.2
7.0
9.0
5.9
6.3
9.2

2.3
2.2
3.9
1.9
1.7
2.5

11.5
11.8
9.0
7.8
7.1
6.7

2.4
2.4
2.8
1.9
1.0
1.4

c

0.1

Note. From Adapted from 2013 data from United States Cancer Statistics (the most recent
year available). A/PI: Asian / Pacific Islander. AI/AN: American Indian / Alaska Native.
a
Female only. Anus and Oropharynx represent male and female data. b Incidence and
mortality rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard
population. c Not sufficient data
Conclusions regarding incidence and mortality by racial and ethnic background
are similar and researchers consistently show that disparities exist over time, in different
age groups, and from different population-level data sets (the National Health Interview
Survey, NIS-Teen, National Program of Cancer Registries, Surveillance, Epidemiology,
and End Results Program, and others). The number of races and ethnicities included,
however, varies by research methodology. For example, Reagan-Steiner et al. (2016) and
Burger et al. (2016) tested the relationships among non-Hispanic White, Black, Hispanic,
Asian, and American Indian / Alaska Native and HPV vaccine uptake, providing a
comprehensive snapshot of national vaccination trends (see Table 4). In contrast, Jeudin
et al. (2014) focused on subpopulations of Black, Hispanic, and Asian females and
reviewed drivers of vaccination, while Daniel-Ulloa et al. (2016) tested vaccination by
sexual orientation among Black, Hispanic, and White females. The scope of this research
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is to test the relationships among specific determinants of health and vaccination at local
and national levels, and thus inclusion of all races and ethnicities available is appropriate.
Table 4
HPV Vaccine Coverage among Females Ages 13-17 Years, by Race
≥1 dose

Race

White
Black
Hispanic
AI/AN
Asian

≥3 doses

2013

2014

2015

2013

2014

2015

53.1%
55.8%
67.5%
73.3%
57.0%

56.1%
66.4%
66.3%
71.2%
54.9%

59.2%
66.9%
68.4%
70.5%
63.8%

34.9%
34.2%
44.8%
43.2%
40.4%

37.5%
39.0%
46.9%
39.4%
35.7%

39.6%
40.8%
46.2%
38.7%
53.5%

Note. Adapted from Elam-Evans et al. (2014; 2013 data), Reagan-Steiner et al. (2015;
2014 data), and Reagan-Steiner et al. (2016; 2015 data). ≥1 dose indicates HPV vaccine
initiation, ≥3 doses indicates HPV vaccine completion. Overall in 2015, 42% of females
completed the HPV vaccine series (Hswen et al., 2017).
Khan et al. (2016) predicted that the consistently observed differences in cancer
incidence and mortality by racial and ethnic minority background will persist despite the
introduction of the HPV vaccine until the ecological factors influencing the health of
these populations have been addressed (Alligood-Percoco & Kesterson, 2015; Burdette,
Webb, Hill, & Jokinen-Gordon, 2016; DeSantis et al., 2016). However, researchers
including a comprehensive set of such variables (a) explored associations within small
subgroups in specific locations (Romaguera et al., 2016), limiting external validity; or (b)
tested relationships among the population as a whole (Galbraith et al., 2016), obscuring
differences at the local level. Given available data and other constraints, these approaches
are logical but do little to capture the diversity of resources and barriers to health in
heterogeneous populations.
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To account for external validity as well as relevance to local public health
officials, I will test the relationship of the major racial and ethnic minority categories
available in a national dataset with HPV vaccination at the national and county level. As
asserted by Burger et al. (2016), the lack of targeted interventions may result in future
differential outcomes in HPV-related incidence and mortality despite the current
availability of an efficacious vaccine. Testing the relationship between race and ethnicity
and HPV vaccine is only one piece of the puzzle, however; other local variables such as
socioeconomic status and geography influence health outcomes and must be considered
for a more comprehensive understanding of local resources and needs.
Socioeconomic status. Socioeconomic status (SES) is a multi-dimensional
variable and has a strong and significant association with health (Cutler, Lleras-Muney,
& Vogl, 2008). The socioeconomic-health gradient has been firmly established through
decades of research and observation across societies; the most commonly used proxies
for assessing SES including education, income, and occupational status.
Despite the clear links between dimensions of SES and health outcomes, one or a
few dimensions tested in isolation is insufficient to explain health outcomes, as the
dimensions are inextricably linked. As stated by Cutler et al. (2008) and Krieger et al.
(2005), the unique mix of individual-, community-, and population-level factors
influencing health poses a significant challenge in creating a unified theory to explain the
relationship between SES and health outcomes. Researchers must extend SES
considerations beyond a single or small number of SES dimensions in order to address
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heterogeneous and multidimensional fundamental needs for public health programs to
truly be effective.
The challenges and resulting health outcomes vary even among a population with
the same income, education, or occupation. For example, Kreuter et al. (2016) found that
while one family living below the poverty level may have adequate housing and a strong
social support network, another may face food insecurity and cultural isolation.
Interpreting any tested relationships between SES and vaccine uptake through the lens of
an ecological perspective, as in the FCT, Farmer and Ferraro’s (2005) minority poverty
hypothesis, or the economic principle of diminishing returns as described by Phelan et al.
(2010) may contribute to more comprehensive research designs and program planning.
An ecological perspective to SES. Farmer and Ferraro (2005) developed the
minority poverty hypothesis from the observation that the greatest disparities in health are
concentrated among low-socioeconomic, racial and ethnic minority populations as a
result of the compound stressors of poverty and racial and ethnic minority background on
these populations (Kish et al., 2014). In contrast, diminishing returns is used to predict
that the greatest disparities in health will be concentrated among high-socioeconomic
status, racial and ethnic minority populations, as these populations do not experience the
same return on health investment as non-Hispanic Whites do at the same SES level
(Getzen, 2013; Kish et al., 2014). Finally, the FCT is interpreted to suggest that lowsocioeconomic populations do not benefit from advances in health care at the same rate
or level as high-socioeconomic populations do, no matter the racial and ethnic minority
status of the population (Phelan et al., 2010). In sum, both SES and race and ethnicity are
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consistently and strongly linked with access to health-promoting resources and associated
with health outcomes. This raises the question of whether SES and race and ethnicity
contribute equally to health outcomes, and whether race and ethnicity can be considered a
component of SES (Polonijo, Carpiano, Reiter, & Brewer, 2016).
In general, SES and race and ethnicity are positively correlated. Davids, Hutchins,
Jones, and Hood (2014) and others have shown that the best health outcomes tend to be
found in high-socioeconomic communities with large Asian or native-born non-Hispanic
White populations, while the worst health outcomes are found in low-socioeconomic,
mainly Black or immigrant communities (Froment, Gomez, Roux, DeRouen, & Kidd,
2014). This is supported by Proctor, Semega, and Kollar (2016), who reported that a
higher percentage of racial and ethnic minority populations live in poverty, compared
with non-Hispanic Whites – while 9.1% of NHW lived in poverty in 2015, 21.4% of
Hispanics and 24.1% of Blacks lived below the poverty level.
The association between SES and racial and ethnic minority status extends to
HPV vaccination as well. Reagan-Steiner et al. (2016) showed that among males ages 13
to 17 years living below the poverty level, HPV vaccine initiation rates in 2015 were
higher among Hispanics (70.8%) than Blacks (60.2%). Even within the same racial and
ethnic populations, Reagan-Steiner et al. (2016) found differences in HPV vaccine
initiation rates, with lower rates in Black males living at or above the poverty level
(51.9%) than those below the poverty level. In support of these findings, Henry et al.
(2016) showed that female initiation rates followed similar trends, with the highest rates
in low-SES urban communities with predominantly Hispanic or Black populations. Thus,
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although the link between racial and ethnic minority background and SES is clear, one
can argue that it is not perfectly dependent, whether in the context of HPV vaccine uptake
or not. Consequently, I will separate racial and ethnic minority status from an SES
variable in my study.
Health insurance and SES. Researchers consistently have shown a positive
gradient between health insurance and SES components (income, occupation, and
education) (DeNavas-Walt, Proctor, & Lee, 2006). Rather than subsume health insurance
status under SES, however, I agree with Barnett and Vornovitsky (2016), Churilla et al.
(2016), and others that health insurance should be tested as a separate variable. The type
of health insurance an individual has not only differs between income levels, but within
income levels as well. For example, Barnett and Vornovitsky (2016) reported that of
Americans living below the poverty level–and therefore all considered low
socioeconomic status–in 2015, 28.6% had a private plan, 62.1% had government health
insurance, and 17.4% were uninsured. In contrast, of those at or above 400% of the
poverty level, 86.4% had a private plan, 22.6% had a government plan, and 4.5% were
uninsured (Barnett & Vornovitsky, 2016).
In addition, different types of insurance may result in different health outcomes,
Abdus and Selden (2013) and Churilla et al. (2016) observed that the type of insurance
coverage an individual has is associated with stage at diagnosis of cancer, treatment, and
mortality. The authors demonstrated that privately insured patients with cervical cancer
tend to have a usual source of care, and as such tend to present earlier in their disease
course and live longer. Medicaid-insured patients with cervical cancer tend to present at a
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later stage and die sooner than privately insured patients, while uninsured patients have
the poorest outcomes in terms of stage of diagnosis and survival than both privately
insured and Medicaid patients.
These differences by insurance type and outcomes extend to HPV vaccine uptake
as well. Agawu et al. (2015) found that adolescents who were covered by Medicaid and
lived below the poverty level were more likely to initiate the HPV vaccine than children
with non-Medicaid insurance and living at or above the poverty level; these rates were
reportedly due to the Vaccines for Children program, which provides vaccines for
Medicaid-insured children and adolescents. These data were supported by Henry et al.
(2016), and Reagan-Steiner et al. (2016), who found significant differences in HPV
vaccine initiation by racial and ethnic minority status, SES, and health insurance type.
Finally, Kish et al. (2014) and others stated that access to the same type of health
insurance does not guarantee better health outcomes. For example, Booth, Li, ZhangSalomons, and Mackillop (2010) and Du, Lin, Johnson, and Altekruse (2011) expressed
their surprise at finding disparities in cancer morbidity and mortality in Canada and the
U.K., where everyone has access to the same basic health care coverage. Based on these
findings, I will test the types of health insurance separately from SES and racial and
ethnic minority status, provided each subgroup has sufficient sample size. Understanding
the relationship between components of SES, health insurance, and racial and ethnic
minority status could advance knowledge in the field and encourage researchers to look
at variables in more detail to better target their interventions. However, given the
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importance of social determinants in health decisions, additional factors such as
geography should be included for a more comprehensive analysis.
Geography. While national estimates of disease and vaccination rates are more
readily available and may be useful metrics to measure change in population health, state
and local-level data are more relevant to the local contexts in which needs exist and
resources are allocated (Hunt, Tran, & Whitman, 2015). For example, the National
Program of Cancer Registries [NPCR] (2015) reported that the age-adjusted incidence
rate of cervical cancer in the United States fell to 7.6 per 100,000 between 2009 and
2013, yet rates ranged from 4.6 per 100,000 in New Hampshire to 10.0 per 100,000 in
West Virginia.
As reported in Kish et al. (2016), incidence among similar racial and ethnic
minorities also varied by state. For example, rates of cervical cancer in Hispanic women
ranged from 5.5 per 100,000 in Maryland to 19.5 per 100,000 in Arkansas, while rates for
Black women in those same states ranged from 8.0 per 100,000 in Maryland to 12.9 per
100,000 in Arkansas.
Even in neighboring states with significant interstate interaction and access to
health care, racial and ethnic groups may have different health outcomes. For example,
the NPCR (2015) reports that in New York, Hispanic women have lower incidence of
cervical cancer but are more likely to die from the disease than Hispanic women in New
Jersey; in New York; Black women have higher incidence of cervical cancer but are less
likely to die than Black women in New Jersey; and in New York Non-Hispanic White
women are less likely to be diagnosed with and die from cervical cancer than in New
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Jersey. The varying rates cannot be solely a product of access to state-specific preventive
measures, as Blacks and Hispanics have equal rates (and greater than rates of White
women) of Pap screenings (and greater than rates of White women) in both New York
and New Jersey (NPCR, 2015).
These data lead to the question about differences within and between states
among the same racial and ethnic populations. While state-level data are useful in
monitoring shifts in disease and disease outcomes, a single statistic does not represent the
differential burden experienced by subpopulations within the state. Therefore, as
suggested by Egen, Beatty, Blackley, Brown, and Wykoff (2017), an additional level of
detail is needed to capture intra-state differences hidden by state-level data and highlight
the areas of greatest vulnerability.
The smallest unit of analysis in national databases tends to be the county or
census tract, and although sample sizes are smaller, researchers have found significant
differences in health and health outcomes. Egen et al. (2017) showed that individuals
living in the poorest counties of a state may have similar life expectancy to populations in
developing countries, and live 7 to 10 fewer years than those in the wealthiest counties in
the same state. Lin, Schootman, and Zhan (2015) and McCarthy, Dumanovsky,
Visvanathan, Kahn, and Schymura (2010) are among the very few researchers who have
conducted studies on differences in health outcomes at the local level; they cited concerns
with external validity and small sample sizes as main barriers to this approach. However,
Lin et al. (2015) and McCarthy et al. (2010) have maintained that their results are
consistent with researchers using larger state- or national-level datasets: namely, race and
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ethnicity tend to be predictive of later-stage cervical cancer diagnosis (especially for
Black and Hispanic women), while race and ethnicity, geography, and other contextual
factors tend to predict mortality. I interpret these data as supporting the need for locallevel data to best inform resource needs and program planning, in combination with stateor national-level data to monitor changes in population health. Furthermore, these data
raise the question of how HPV vaccine uptake differs by county when broken down by
social determinant variables.
HPV vaccine uptake and geography. As reported by Galbraith et al. (2016),
Glenn et al. (2015) and others, HPV vaccination initiation and completion have been
shown to vary significantly both inter- and intra-state (see Figure 1 and Tables 5 – 6)
(Henry et al., 2016; Rahman, Islam, & Berenson, 2015). While Bharmal, Tseng, Kaplan,
and Wong (2012) and many others have examined relative differences between states,
few have examined absolute differences within states. In one such study, Reagan-Steiner
et al. (2016) showed that while rates for female adolescents in Texas were 56%, 51%, and
60% in 2013, 2014, and 2015, respectively, Bexar County rates did not match the state
during that time period (see Figure 1 and Table 5). By reporting only state-level HPV
vaccinations, researchers may unintentionally mask intrastate variation in health
determinants and thus reduce effectiveness of targeted program planning and resource
allocation.
(a)

39

(b)

40
(c)

Figure 1. Percent females, ages 13-17, receiving >1 dose HPV vaccination, 2013–2015.
(a) Percent females, ages 13–17, receiving ≥1 dose HPV vaccination, 2013. Adapted
from Elam-Evans et al. (2014). (b) Percent females, ages 13–17, receiving ≥1 dose HPV
vaccination, 2014. Adapted from Reagan-Steiner et al. (2015). (c) Percent females, ages
13–17, receiving ≥1 dose HPV vaccination, 2015. Adapted from Reagan-Steiner et al.
(2016). Charts created using mapchart.net.
Table 5
HPV Vaccine Coverage (1 dose) among Females Ages 13-17 Years by Location, 20132015
Year

United
States

Rhode
Island

Kansas

Chicago (IL)

Bexar
County (TX)

2013
2014
2015

57.3%
60.0%
62.8%

76.6%
76.0%
87.9%

39.9%
38.3%
50.9%

61.8%
78.1%
70.8%

54.8%
47.7%
56.2%

Note. From Adapted from Elam-Evans et al. (2014; 2013 data), Reagan-Steiner et al.
(2015; 2014 data), and Reagan-Steiner et al. (2016; 2015 data). ≥1 dose indicates HPV
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vaccine initiation. For all years, Rhode Island had the highest coverage nationwide, while
Kansas had the lowest in 2013-2014 (in 2015, Wyoming had the lowest, with 47.7%).
Table 6
HPV Vaccine Coverage (1 dose) among Males Ages 13-17 Years by Location, 2013-2015
Year

United
States

Rhode
Island

Kansas

Chicago (IL)

Bexar
County (TX)

2013
2014
2015

34.6%
41.7%
49.8%

69.3%
69.0%
80.6%

25.1%
32.8%
36.0%

50%
64.9%
68.1%

32.4%
35.6%
40.3%

Note. Adapted from Elam-Evans et al. (2014; 2013 data), Reagan-Steiner et al. (2015;
2014 data), and Reagan-Steiner et al. (2016; 2015 data). ≥1 dose indicates HPV vaccine
initiation. For all years, Rhode Island had the highest coverage nationwide; Kansas
provided for comparison to females (Table 5). Lowest male coverage was in Utah
(11.0%, 2013), Indiana (23.2%, 2014), and Kentucky (34.8%, 2015)
Burger et al. (2016) concluded that the intent of increasing HPV vaccination
among those who are most burdened by HPV-related morbidity and mortality is to
decrease disparities in health outcomes. However, disparities will persist and potentially
increase if the underlying structural issues contributing to these differences in HPV
infection, vaccination, and related morbidity and mortality are not addressed at the state
and local level in a culturally appropriate way. I will advance public health practice and
knowledge in the field by being the first (to my knowledge) to test the relationships
between HPV vaccine uptake and certain social determinant variables at the county level.
Expanding HPV vaccine research beyond the individual. Despite an
understanding among the public health community that multiple levels of determinants
influence HPV vaccine uptake, the bulk of intervention research for HPV vaccination has
focused on the individual level, particularly with constructs including belief, knowledge,
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and attitudes of parents and adolescents. While these constructs do play a role in parental
willingness to vaccinate, awareness of the vaccine is near saturation after a decade on the
market, and changes in knowledge and awareness are reported to be insufficient to
increase receipt of the vaccine (Joseph et al., 2016; Rahman et al., 2015; Wilson et al.,
2016). Joseph et al. (2016) suggested that even among hard-to-reach populations with
limited knowledge of the vaccine, intention to vaccinate is high. Future research efforts
will benefit from inclusion of structural and interpersonal variables alongside individual
factors (Galbraith et al., 2016; Joseph et al., 2016).
Structural and interpersonal variables influencing differences in HPV vaccine
initiation and completion are reported to include school vaccine requirements; vaccine
policy implementation; physician recommendations; physician decision-making
processes; national, regional, and local partnerships funding HPV vaccine work;
immunization information systems; technical assistance and funding by CDC; and
clinical quality improvement strategies (Elam-Evans et al., 2014; Reagan-Steiner et al.,
2015; 2016). Jeudin et al. (2014), Perkins (2016), and Rahman et al. (2015) have refined
these suggestions and focused on physician recommendation as one of the most critical
factors to influence HPV vaccine uptake. The following discussion reviews potential
causes and implications of physician recommendation.
HPV Vaccination and Physician Recommendation
In reviews of the past decade of HPV vaccine research, Gilkey and McRee (2016)
and others have suggested that a physician’s recommendation is one of the most
significant and strongest predictors of HPV vaccine uptake across sociodemographic
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categories (Hswen et al., 2017; Mohammed et al., 2016; Perkins, 2016). Despite a strong
consensus that physician recommendation significantly increases HPV vaccine uptake
across racial and ethnic minority background, socioeconomic status, and other variables,
there are few links between research, theory, and practice. Specifically, a minority of
studies comprehensively address the most documented factors influencing physician
recommendation of HPV vaccine: provider factors, audience, and message content
(Gilkey, Malo, Shah, Hall, & Brewer, 2015; Gilkey & McRee, 2016). Two additional
factors, guidelines and policy, will be discussed later. As physician recommendation is so
strongly correlated with vaccine initiation and completion, I will test this as an
independent variable in my research.
Physician recommendation rates for adolescents have increased overall in the
years since the vaccine has been available, from fewer than 50% of female adolescents
ages 13 to 17 receiving a recommendation in 2008 to nearly 66% of females in 2014.
(Burdette et al., 2017). The increase in recommendations has accompanied a concurrent
increase in HPV vaccinations, but Burdette et al. (2017), Hswen et al. (2017), and others
have challenged the idea that the increase in recommendation has been solely responsible
for vaccination rates. The authors also maintained that physicians do not consistently
recommend the vaccine across gender, racial and ethnic minorities, or age groups (Jeudin
et al., 2014; Perkins et al., 2016; Rahman et al., 2015; Ylitalo, Lee, & Mehta, 2013).
Zimet (2015) contended that years of reports from parents corroborate these claims, as
parents noted lack of physician recommendation, or a weak or ambivalent
recommendation, as among the most important reasons to delay or refuse vaccination. As
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the drivers behind this inconsistency are multifaceted, the nominal measurement of
physician recommendation in NIS-Teen survey restricts any assessment of causal
determinants in the decision-making process.
Gilkey et al. (2015) argued that physicians do not consistently adhere to or
implement evidence-based strategies to increase vaccination among patients, with
physicians citing barriers in interpersonal, clinical, and political environments to
recommendation. Gilkey and McRee (2016), Hswen et al. (2017), Mohammed et al.
(2016), and others suggested that interpretation of physician recommendation data from
NIS-Teen include the context of these environments. As several of the factors in these
environments are reflected in the theoretical underpinnings of this research, I will briefly
describe how provider-, audience-, and message-level factors influence physician
recommendation of the HPV vaccine.
Providers. Pediatricians are reported to have the highest recommendation rates,
likely due to more favorable attitudes toward and routine administration of childhood
vaccines. Building on the general consensus in the literature, Gilkey et al. (2015) found
that family physicians had second-highest recommendation rates, followed by
gynecologists and internists (Berkowitz, Malone, Rodriguez, & Saraiya, 2015; Dempsey
et al., 2015). Current surveys such as NIS-Teen include only pediatricians, general and
family practitioners, OB/GYNs, and internists in their sample (CDC et al., 2015, 2016;
Gilkey et al., 2016). Osazuwa-Peters et al. (2016) has argued that dentists should be
included in HPV vaccine interventions, given the growing rates of oropharyngeal cancer
and dentists’ yearly visits with children and adolescents. Limited data exist for
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recommendation rates among dentists, however, so I will exclude them from this
discussion of provider factors.
Across qualitative, quantitative, and mixed methods approaches with physician,
parent, and adolescent samples, researchers have observed consistent and significant
inverse relationship between HPV vaccine recommendation and provider factors:
physician comfort discussing sexuality; physician perception of parental hesitation;
physician self-efficacy of discussing HPV vaccination; and physician assessment of an
adolescent’s risk of infection. As discussed in a review by Gilkey and McRee (2016),
data reported on the association between knowledge of the HPV vaccine and
recommendation were mixed; no data were observed that supported a correlation between
perceptions of vaccine safety and recommendation, likely due to relatively less common
concerns about vaccine safety among physicians. These data are not collected in NISTeen but provide important context for interpretation and suggestions for future research.
Whether by direct admission from physicians or through indirect analyses of
physician knowledge and beliefs, physicians have limited ability to accurately assess risk
of infection and sexual activity among their adolescent patients, and reportedly
overestimate parental concern about the vaccine (Dempsey, Gebremariam, Koutsky, &
Manhart, 2008; Gilkey et al., 2015; Healy, Montesinos, & Middleman, 2014; Kepka,
Berkowitz, Yabroff, Roland, & Saraiya, 2012). Such risk-based strategies reportedly have
not been effective, given the ubiquity of HPV in the population, and researchers have
suggested these strategies are counter to guidelines and the self-reported expectations of
adolescents and parents (Alexander et al., 2014; Alexander et al., 2016; Gilkey & McRee,
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2016; Zimet, 2015). These strategies are directly linked to the behavioral economics
construct of stereotype heuristics, as described in Frank (2004), in which physicians make
decisions based on limited or erroneous information.
Although physicians reported feeling competent in taking a patient’s sexual
history, they have expressed discomfort and lack of self-confidence in discussing sex and
sexuality (Alexander et al., 2014; Alexander et al., 2016; Bynum et al., 2014; Fuzzell,
Fedesco, Alexander, Fortenberry, & Shields, 2016). This reported discomfort is not new;
Alexander et al. (2016) and Merzel et al. (2004) argued that even prior to the launch of
the HPV vaccine, physicians discussed sex and sexuality less often than what guidelines
from professional organizations recommended. When sex and sexuality are discussed
during patient visits, Alexander et al. (2014) and (2016) observed that conversations
tended to be short, vary widely in content, and omit key education on topics including
sexually transmitted infections. The lack of consistent opportunity for adolescents to
discuss questions and concerns about sex, sexuality, and behavior is a missed opportunity
for the physician to engage with the patient on healthy behaviors including HPV
vaccination. Although not captured in NIS-Teen, understanding these provider factors
can inform interpretation of physician recommendation. However, additional contexts in
which these communications take place may facilitate or hamper an effective interaction
with a patient. One is audience, the other is the message.
Audience. Disparities in HPV vaccine recommendation – in which minority
parents and adolescents receive recommendations less often than non-Hispanic Whites –
have been observed across national datasets, statewide vaccine registries, managed care
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databases, qualitative and quantitative approaches, longitudinally and in single-timepoint
studies (Gilkey & McRee, 2016; Jeudin et al., 2014; Kepka, Balch, Warner, & Spigarelli,
2015; Mohammed et al., 2016; Rahman et al., 2015; Ylitalo et al., 2013).
As discussed in Mohammed et al. (2016), recommendation rates are reportedly
lower among populations living below the poverty level; mothers with less than a high
school education; living in the South; and no well-child or preventive visits with a
physician in the prior 12 months. Even among adolescents who are adherent with wellchild visits, physicians reportedly are not consistently recommending the vaccine, so
adolescents who do not have a usual source of care are at even greater risk of a missed
opportunity for vaccine recommendation if the only physician interaction is with acute
care (Ford et al., 2016; Gilkey & McRee, 2016; Vadaparampil et al., 2011). In addition,
family physicians and internists, who are less likely than pediatricians to recommend the
HPV vaccine, tend to be the sole providers in rural or low socioeconomic areas. These
observations helped refine my selection of independent variables among the data
collected in NIS-Teen.
Gilkey and McRee (2016) and others showed that physicians cite low selfconfidence in influencing parental decision-making with vaccines through
recommendation. Aragones, Genoff, Gonzalez, Shuk, and Gany (2016) argued that these
concerns are unfounded, and showed that parents ranked physician recommendation as
one of the strongest factors in their decision to initiate, delay, or refuse the vaccine. This
argument expanded on observations by Bhatta and Phillips (2015) and Maurer, Harris,
and Uscher-Pines (2014), who found that parents are significantly more likely to trust and
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follow a physician’s advice about vaccination, whether the recommendation is for a
yearly influenza shot or the HPV vaccine. The authors maintained that levels of trust are
even higher among parents of racial and ethnic minority and low socioeconomic
populations. This discordance in trust – a behavioral economics construct – between a
physician’s lack of confidence in his or her capabilities and a parent’s trust of the
physician’s advice is a significant barrier that has not yet been addressed in research or
practice (Polonijo et al., 2016). Although outside the scope of this research, these data
link to behavioral economics, a theory underpinning this research. For example,
physicians have been reported to be influenced by biases such as omission (the potential
for harm to a relationship is worse if a physician discusses HPV vaccination, versus not
initiating a conversation), impact (physicians inaccurately estimate emotional states of
parents), and availability (physicians inaccurately estimate the likelihood of a parent
pushing back on a recommendation, or their own ability to convince a parent, based on
recall rather than evidence).
In addition to disparities by racial and ethnic minority background,
recommendation rates reportedly vary significantly by age of the patient (see Table 7).
Vadaparampil et al. (2016) and others have found that few physicians, even pediatricians,
follow the guidelines to recommend the HPV vaccine at age 11 to 12 years, despite data
supporting stronger vaccine efficacy when given at this age (Elam-Evans et al., 2014;
Reagan-Steiner et al., 2016; Vadaparampil et al., 2011; Vadaparampil et al., 2014). The
delay in vaccine initiation may reduce vaccine effectiveness as well as the likelihood of
series completion. Although I cannot assign causality to variables in my study, I will
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consider age independently, as controlling for this variable would obscure the
demonstrated differences in physician recommendation.
Table 7
HPV Vaccine Coverage (1 dose) among Females, by Age at NIS-Teen Interview
Year

13

14

15

16

17

All Ages

2013
2015

50.6%
56.4%

55.1%
61.2%

58.8%
62.7%

60.0%
63.0%

62.3%
70.6%

57.3%
62.8%

Note. Adapted from Elam-Evans et al. (2014; 2013 data) and Reagan-Steiner et al. (2016;
2015 data). ≥1 dose indicates HPV vaccine initiation. 2014 data by age not provided;
total all females ≥1 dose in 2014 was 60% (Reagan-Steiner et al., 2016).
As noted in the discussion above, physicians have been reported to express
discomfort discussing sex and sexuality, especially as parents and physicians assume
adolescents are not sexually active at such an early age, and in the first few years of the
vaccine’s availability reportedly had concerns that the vaccine may encourage sexual
behavior (Vadaparampil et al., 2016). However, consistent, replicated quantitative,
qualitative, longitudinal, and single time point studies using data from schools and
universities, population-based datasets, and medical and insurance databases in countries
around the world have shown that there is no evidence of risky sexual behavior (such as
decreased contraceptive use), age of sexual debut, number of partners, or increased STI
diagnoses after HPV vaccination (Hansen et al., 2014; Kasting, Shapiro, Rosberger,
Kahn, & Zimet, 2016; Madhivanan et al., 2016; Mullins et al., 2016; Smith, Kaufman,
Strumpf, & Levesque, 2015). Of note, many researchers observed an increase in
protective behaviors when engaging in sexual activity after HPV vaccination, although to
date, there have not been studies published addressing the drivers behind this observation
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(Mullins et al., 2016). Based on the preponderance of evidence, I will not consider
concern about increased sexual behavior as a driver of vaccine recommendation
hesitation.
Given the reported importance of physician recommendation and the high level of
intent to vaccinate among racial and ethnic minority populations, the inconsistent rate of
physician recommendation in these populations should be of great concern to public
health practitioners and physicians (Jeudin et al., 2014; Kepka et al., 2015; Perkins, 2016;
Rahman et al., 2015; Ylitalo et al., 2013). I will test physician recommendation as a
dependent variable in relation to social vulnerability (pending an appropriate sample
size). By doing so, I may provide researchers with knowledge on potential determinants
of recommendation trends as well as confirm relationships with HPV vaccination.
Message. Researchers have observed in recent years that the who and what in the
context of a recommendation plays a large role in vaccine uptake, in addition to whether
a recommendation is given (Caskey, Andes, & Walton, 2016; Darden & Jacobson, 2014;
Ford et al., 2016; Gilkey et al., 2016; Gilkey & McRee, 2016; Moss, Gilkey, Rimer, &
Brewer, 2016; Perkins, 2016; Shay et al., 2016).
Tdap and MCV vaccines, launched within the same year as HPV, are at or above
herd immunity levels and Healthy People 2020 goals (see Table 1) (Moss et al., 2016).
Darden and Jacobson (2014), Moss et al. (2016) and others have found that rather than
presenting the HPV vaccine as routine and required, some physicians presented the HPV
vaccine separately from other required adolescent vaccines, and reportedly used language
encouraging parents to question the need for the vaccine (Caskey et al., 2016; Gilkey &
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McRee, 2016; Perkins, 2016). This approach, the authors suggested, conveyed a sense of
physician ambiguity about the vaccine, and framed the vaccine as optional rather than
routine or required–creating an environment in which some parents delayed or refused
vaccination. For example, Shay et al. (2016) observed that Hispanics and Non-Hispanic
Blacks were more resistant to vaccination when the physician used a participatory style
for the HPV vaccine, encouraging questions, versus those whose physicians used a
presumptive style. These observations may in part explain why initiation and completion
are not the same within or across racial and ethnic and socioeconomic subgroups, and I
will include these considerations in my interpretation of this study’s findings.
Health Policy and Professional Guidelines
Medical organization guidelines tend to reflect best evidence-based practice for
health care providers, but in most instances, lack the compulsion of policy; health care
policies may not reflect the latest scientific evidence, and may be weakened by broad
language or provisions (Camargo & Grant, 2015; Descourouez & Hayney, 2013; Omer,
Richards, Ward, & Bednarczyk, 2012). Without clear, specific guidelines and policies,
health care providers may interpret or implement language differently and not adopt best
practices for their patients (Camargo & Grant, 2015). Both guidelines and policy are
developed using scientific data, and some guidelines dictate clinical practice. For
example, guidelines published by the National Comprehensive Cancer Network are
typically used to update treatment algorithms and determine insurance coverage for
oncology drugs (NCCN, 2017). I will briefly discuss guidelines for HPV vaccination to
provide context into professional pressure for physicians regarding vaccination.
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Guidelines. Hswen et al. (2017) and others have shown that nearly half of family
physicians and pediatricians surveyed have cited professional organizations as their
preferred source of information. Researchers also found that surveyed physicians who
reportedly perceived such organizations as influential were more likely to recommend the
HPV vaccine to patients (Bynum, Malo, Lee, Guiliano, & Vadaparampil, 2011; Gilkey &
McRee, 2016; Scherr, Augusto, Ali, Malo, & Vadaparampil, 2016). As outlined by
Saslow et al. (2016) and others, a number of professional organizations support ACIP’s
guidelines on strong, consistent recommendations for the HPV vaccine and ask their
members to follow these guidelines (Bailey et al., 2016; IPVS, 2016; Kulczycki et al.,
2016):
•

American Academy of Family Physicians

•

American Academy of Pediatrics

•

American Cancer Society

•

American College of Obstetrics and Gynecology

•

American College of Physicians

•

American Dental Association

•

American Head and Neck Society

•

American Nurses Association

•

American Pharmacists Association

•

American Society of Clinical Oncology

•

Association of Immunization Managers

•

International Papillomavirus Society
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•

Society of Adolescent Medicine

•

Society of Gynecologic Oncology

Physician practices do not always align with professional guidelines, however.
For example, Kulczycki et al. (2016) observed that many family physicians and
pediatricians do not follow evidence-based recommendations regarding HPV vaccination,
particularly among adolescents 11 years to 12 years old. Using the same American
Medical Association database, Malo, Perkins, Lee, and Vadaparampil (2016a) showed
that some family physicians, pediatricians, and obstetrician/gynecologists use HPV and
Pap test results as a pre-vaccination assessment for eligibility, contrary to evidence-based
guidelines. These findings suggest that despite expert recommendations, physicians only
moderately adhere to HPV vaccine guidelines (Malo et al., 2016a). While guidelines can
and do play a role in daily practice decisions, they may not have the same power to
compel physician behavior as policies.
In addition to the lack of full adherence to guidelines, Vadaparampil et al. (2016)
and many others have demonstrated that a majority of physicians do not use tools
developed by national organizations and agencies such as the CDC to facilitate adoption
of best practices (Askelson et al., 2016; Berkowitz, Nair, & Saraiya, 2016; Roland,
Benard, Greek, Hawkins, & Saraiya, 2014; Scherr et al., 2016). For example, Askelson et
al. (2016) and others have described the numerous evidence-based strategies for health
care providers published by the CDC and Guide to Community Preventive Service to
improve vaccination coverage (Dempsey et al., 2015; Community Preventive Services
Task Force, 2015):
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•

Implementation of an Immunization Information System for state-wide
access to patient records

•

Parent reminders and recalls when immunizations and well-child visits for
11 to 12 year olds are due or overdue

•

Provider reminders and recalls in electronic or paper records when
immunizations are due or overdue

•

Standing orders for non-physician health care providers – pharmacists,
obstetrician/gynecologists, nurses, medical assistants – to provide
education and vaccination services

•

Participation in Vaccines for Children program to reduce cost of the HPV
vaccine series

•

Reduce or eliminate clinic wait times for vaccination, such as instituting
walk-in immunizations for second and third doses

•

Partner with community organizations and services including schools as
alternate immunization service locations

•

Bundle the HPV vaccine with other routine, recommended adolescent
vaccines

Askelson et al. (2016) reported that few clinics have reminder / recall processes in
place for parents or physicians or standing orders for other health care providers to
vaccinate adolescents, yet found that clinic managers most frequently cited parents
forgetting to bring their adolescents in to complete the series as the biggest barrier to
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HPV vaccine initiation and completion. Askelson et al. (2016) and others found that
another barrier named by providers was the lack of opportunity to vaccinate adolescents,
as these patients reportedly did not visit the clinic regularly (Gilkey & McRee, 2016;
Kulczycki et al., 2016). However, rates for other adolescent vaccines are near or above
90% per guidelines and policies (see Table 1), suggesting that other factors beyond
guidelines have a stronger influence specifically on HPV vaccination (see HPV
Vaccination and Physician Recommendation) (Askelson et al., 2016; Gilkey & McRee,
2016; Kulczycki et al., 2016). Based on these observations, my interpretation of
physician recommendation data will be applicable to HPV vaccines only, rather than
immunization in general.
Policy. Public health policy is one of the most effective ways to protect
population health, as evidenced by seat belt use, tobacco control, or immunizations (Calo,
Gilkey, Shah, Moss, & Brewer, 2016; Hawkes, Kismödi, Larson, & Buse, 2014; Mello et
al., 2013). Policy, however, is often not considered as a means to changing population
health:
Law remains an underutilized resource in public health. … Some interventions
require new law, whereas others simply require stronger or more creative use of
existing authority. At the same time, some laws with unintended adverse effects
have not been amended, clarified, or repealed. (Mello et al., 2013, p. 1979)
Carey and Crammond (2015) and Embrett and Randall (2014) argued that
policymaking does not follow a rational process, in which knowledge is transferred and
policy is changed; nor does it move quickly or adopt the latest science. For example,
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current HPV vaccine policies do not reflect oropharyngeal cancer rates and the role of
HPV in the disease, how HPV is transmitted, views of adolescents receiving the vaccine,
or recent vaccine efficacy and safety data (Osazuwa-Peters, 2013; Parrella et al., 2016).
Knight, Benjamin, and Yanich (2016) and others suggested that policy cannot be
separated from politics, and the political environment is especially important when
considering health issues traditionally associated with individual behaviors such as
smoking, obesity, or sexually transmitted infections (Abiola et al., 2013; Hawkes et al.,
2014). Policymaking is a complex effort in which competing priorities, short attention
spans, and capacity for action mix with evidence, expert testimony, and values of those in
power (Carey & Crammond, 2015; Embrett & Randall, 2014; Knight, Benjamin, &
Yanich, 2016; Lillvis, Kirkland, & Frick, 2014; Moreland-Russel et al., 2015;
Speybroeck, Harper, de Savigny, & Victora, 2012). Knight et al. (2016) stated that most
efforts in health policy are focused on medical solutions to health care, rather than social
determinants of health and preventive measures. Carey and Crammond (2015) suggested
that this may in part be due to policymakers’ reported unfamiliarity with the importance
of social determinants of health, and public health advocates’ analogous “out of touch”
perceptions of the policymaking process. HPV vaccine policy is an excellent example of
this disconnect, in which policymakers have been observed to support policies not based
on evidence and best practices, and public health advocates have reportedly not engaged
the political process in an efficient way to promote health (Carey & Crammond, Knight
et al., 2016).
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States introduced and passed a number of policies after the HPV vaccine came to
market, but with a few exceptions focused solely on increasing education to parents and
adolescents, providing funding, and adjusting private insurance coverage for the vaccine
(Brandt et al., 2016; Laugesen et al., 2014). However, education policies reportedly have
had little if any return on investment; for example, Moghtaderi and Adams (2016) found
that vaccination rates in states with education policies were not significantly different
from states with no education policies. The authors argued that this finding may in large
part be due to the lack of evidence that parents access and understand educational
materials, and school districts are not required to include information about HPV in the
curriculum.
In contrast to education policies, Durham et al. (2016) observed that funding and
coverage policies had significantly improved HPV vaccination rates, albeit inconsistently
across states. Although the United States does not have a national vaccination program,
Brandt et al. (2016) stated that the federal government does fund some immunizations
through the Vaccines for Children program for un- or under-insured, Medicaid-eligible,
or American Indian / Alaska Native children up to 18 years old, but states have the final
say on who qualifies. Of the states and jurisdictions with expanded coverage and
supplemental resources from the CDC’s Prevention Public Health Fund and national
organizations, Durham et al. (2016) concluded that these areas had higher rates of
vaccination compared with those that did not. However, given the extended latency
period between exposure and HPV-associated cancer and the prevalence of interstate
travel, states may not capture the true benefit of their policies (Durham et al., 2016).
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School-entry mandates. Perkins et al. (2016) and others have claimed that the two
most potent and polarizing policy options to influence vaccination rates are school-entry
mandates and exemptions (Brandt et al., 2014; Califano, Calo, Weinberger, Gilkey, &
Brewer, 2016; Calo et al., 2016). Both the state legislature and state health agency have
the power to require vaccines for school entry, but the legislature must allocate funds for
the logistics in implementing the mandate, and the vaccine must meet several criteria to
be considered for mandated status (Calo et al., 2016; Perkins, Lin, Wallington, &
Hanchate, 2016). Perkins et al. (2016) concluded that the HPV vaccine meets most
criteria: ACIP recommendation; proven efficacy, safety, cost-effectiveness; reduction of
transmission risk; prevention of significant morbidity and mortality related to the disease;
and reasonable burdens on parents and adolescents to comply with the mandate. Perkins
et al. (2016) contended that HPV vaccine does not meet the two remaining criteria: the
potential administrative burden on schools and health care providers may be considered
unreasonable given low vaccination rates and disjointed immunization infrastructure; and
vaccine acceptability to the community and the public is not uniformly positive.
For example, researchers have found low to moderate support among parental and
physicians for a school-entry mandate if religious, personal, or philosophical exemptions
are not allowed (Brandt et al., 2016; Califano et al., 2016; Calo et al., 2016; Horn,
Howard, Waller, & Ferris, 2010; Perkins et al., 2016; Robitz et al., 2011). If these
exemptions are allowed alongside school-entry mandates, the level of support increases
significantly. Calo et al. (2016) found that parents’ willingness to accept a mandate
increased from 21% to 57%. The authors reported that parents had several reasons for
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opposing a mandate, including infringement of their autonomy in making decisions for
their children and the perception from physician interactions that the HPV vaccine is
optional. In this study, Calo et al. (2016) observed that parents of racial and ethnic
minority background and lower socioeconomic status had slightly higher approval ratings
of a school entry mandate, compared with non-Hispanic White, higher socioeconomic
parents. Separately, Califano et al. (2016) showed that physicians’ support increased from
47% to 74%. Despite this strong support from physicians, and considering nearly 90% of
pediatricians and family physicians believe delaying vaccination is risky for adolescents,
Califano et al. (2016) reported that just over 70% of physicians were willing to
accommodate parents’ wishes in order to build trust.
Although several states have attempted to pass legislation requiring the HPV
vaccine for school entry, currently the HPV vaccine is mandated only in two states and
one jurisdiction (Barraza, Weidenaar, Campos-Outcalt, & Yang, 2016; Brandt et al.,
2016; Lemons, 2016; Perkins et al., 2016). As of 2008, girls in Virginia must initiate the
vaccine prior to entering sixth grade; as of 2009, girls and boys in the District of
Columbia must initiate the vaccine at 11 years old and prior to entering the sixth grade;
and as of 2015, girls and boys in Rhode Island must initiate the first dose prior to entering
seventh grade and complete the series prior to entering ninth grade (Barraza et al., 2016;
Brandt et al., 2016; Calo et al., 2016; Lemons, 2016; Perkins et al., 2016). Virginia and
D.C. passed the mandate through the legislative process, while Rhode Island used the
Department of Health’s authority to require vaccination for school entry (Barraza et al.,
2016). Since October 1, 2017, only New York has proposed legislation in the 2017
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session requiring HPV vaccination for all children entering seventh grade (S.B. 132, A.B.
933, 2017). Although outside the scope of this research, it will be important for future
scholars to consider the political context in which physicians must operate in each of the
select local areas in the results discussion.
HPV Vaccination: Theoretical Considerations
Glanz et al. (2015) noted that theory and practice are not diametrically opposed,
but inform each other and provide a foundation for transforming data and experience into
evidence-based interventions. For particularly complex issues, such as HPV vaccination,
theories and practices must reflect the milieu in which vaccination decisions are made
(Ferrer et al., 2015). However, as Ferrer et al. (2015) outlined in a systemic review, the
most frequently cited theories in HPV literature are individual, rational models such as
the theory of planned behavior and the health belief model. The authors reported that
fewer than half of reviewed interventions based on individual-level theory were effective
or sustainable, with determinants varying widely across populations. Ferrer et al. (2015)
argued that these interventions could not account for interactions among individuals and
their environments, or for scenarios in which people do not make decisions and behave in
a rational manner. The following two models, fundamental cause theory and behavioral
economics, address each of these shortcomings in the individual, rational models. I will
use these theories as the lens through which I will interpret the data, focusing on the
importance of considering systemic variables and the irrational players that make up
these systems.
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Fundamental cause theory. Link and Phelan (1995) developed the fundamental
cause theory during the time period in which epidemiologists could not explain why
elimination of risk factors for certain diseases did not reduce inequalities in morbidity
and mortality, and in some instances, gave rise to new risk factors. In the first iteration of
the FCT, Link and Phelan (1995) observed that a relationship between socioeconomic
status and mortality persists in modifiable risk factors and disease outcomes despite, and
sometimes as a result of, advances in knowledge and treatment (Phelan et al., 2010).
Clouston, Rubin, Phelan, and Link (2016) maintained that in the two decades since its
introduction, FCT has been tested and refined, with its constructs applied across
conditions including HIV, cardiovascular disease, a number of cancers, suicides, kidney
infections, diabetes, multiple sclerosis, tuberculosis, polio, and others.
Øversveen, Rydland, Bambra, and Eikemo (2017) contended that in developing
the FCT, Link and Phelan introduced the importance of fundamental or root causes, or
the “risk of being at risk,” focusing on upstream social determinants and the complex
interactions leading to health outcomes. Phelan et al. (2010) defined a cause as
fundamental if it gives rise to multiple diseases, affects disease outcomes through
multiple risk factors, involves access to flexible resources, and persists over time. As
reviewed in Mackenbach (2017) and others, access to flexible resources is a unique and
key component of the FCT, and encompasses a person’s access to money, knowledge,
power, prestige, and social connections (Goldberg, 2014; Polonijo & Carpiano, 2013).
Clouston et al. (2016) and Mackenbach (2017) argued that if access to such resources is
unequal, the benefits of any innovation in technology or knowledge will be distributed
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unequally; thus, the capacity to avoid risks or minimize consequences of a disease will be
unequal and give rise to social inequalities in health and health outcomes. Polonijo and
Carpiano (2013) maintained that the HPV vaccine may act as an empirical test of the
FCT, as the fundamental causes behind HPV-related morbidity and mortality give rise to
other diseases, HPV vaccines are the result of an innovation in cancer knowledge, the
vaccines themselves are innovations in preventive care, and significant disparities exist in
HPV vaccine uptake.
Two well-researched fundamental causes of HPV vaccine rates and other diseases
are low socioeconomic and racial and ethnic minority status (Goldberg, 2014; Phelan et
al., 2010). When an innovation or improvement occurs, a new mechanism appears in
which an individual’s health outcome will change disproportionately with their income
level or racial and ethnic minority status (Øversveen et al., 2017; Polonijo & Carpiano,
2013). Øversveen et al. (2017) stated that as long as the structural and social determinants
of a population remain stable, inequalities in health based on root causes will persist.
Similarly, Goldberg (2014) noted that targeting only proximal risk factors, as in the riskreduction model practiced in medicine, will be ineffective in addressing health disparities
as the risk factors arise from the underlying structural and social determinants of disease.
For example, during infectious diseases outbreaks in the mid-1800s, wealthy
Americans had resources to flee their cities or prevent entry of infected people into their
neighborhoods; as public health efforts in the 1900s improved structural determinants
such as sanitation and hygiene standards – indoor plumbing, chlorination of drinking
water, animal and pest control, universal vaccination, and improved housing conditions –
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the socioeconomic gradient disappeared and many of these diseases were eradicated
(CDC, 1999; Phelan et al., 2010). Expanding on these ideas, Epstein (2017) claimed that
these innovations in public health played a significant role in reducing inequalities long
before modern medical interventions.
In contrast, Viens et al. (2016) and others asserted that despite the introduction of
the innovative Pap screening test for cervical cancer nearly 70 years ago, disparities in
cervical cancer screening, incidence, and mortality by SES and racial and ethnic minority
status persist today (Malagón, Drolet, Boily, Laprise, & Brisson, 2015; Phelan et al.,
2010; Polonijo & Carpiano, 2013). Efforts to increase access to resources such as health
insurance and screening programs for cervical cancer, which is highly preventable, have
not mitigated disparities in outcomes – even in countries such as England and Canada,
where universal safety nets are designed to reduce such inequalities (Phelan et al., 2010;
Polonijo & Carpiano, 2013). Based on these examples, I agree with Polonijo and
Carpiano (2013) that HPV vaccination could be an appropriate test of FCT, and will
discuss this idea in the context of future directions based on my findings.
For example, Phelan et al. (2010) predicted that, as alluded to in the FCT,
disparities will persist and new mechanisms will arise as individual risk factors for
cervical cancer change if the underlying structural population issues are not addressed.
An effective intervention such as a vaccine to prevent cervical cancer may reduce or
eliminate disparities in the population if administered universally, but researchers have
shown a strong gradient for physician recommendation of vaccination along racial and
ethnic minority and socioeconomic status lines (Jokinen-Gordon, 2014; Polonijo &
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Carpiano, 2013). Therefore, through the lens of the FCT, disparities in HPV-associated
cancer rates will persist as long as researchers focus on individual behaviors or isolated
risk factors, such as cost of the vaccine (Polonijo & Carpiano, 2013). In my study, I will
test relationships among variables on multiple levels in order to provide potential targets
for future fundamental cause research in HPV vaccination.
While the assumptions of the FCT are generally borne out in studies, Øversveen
et al. (2017) and others have noted some limitations of the theory’s application to
practice, including the temporal nature of rising and declining mechanisms of
inequalities; the difficulty in conducting systemic research; and the definition of variables
and at-risk populations (Clouston et al., 2016; Goldberg et al., 2014; Mackenbach, 2017;
Phelan et al., 2010).
For example, Clouston et al. (2016) used FCT to link the control of preventable
disease with development of social inequalities, suggesting that the time period in which
inequality mechanisms rise, stabilize, and decline may vary. The authors proposed adding
a four-stage temporal component to the FCT: (a) natural mortality of a disease, prior to
any knowledge or capacity to control disease; (b) increasing inequalities, in which
innovations and resources are diffused unequally; (c) reducing inequalities, perhaps
through increased access to health knowledge and resources; and (d) reduced mortality,
in which prevention and treatment resources are universally available. Clouston et al.
(2016) contended that the time spent in each stage will vary by disease type, risk factors,
the innovation, and the underlying social, economic, and political structures. In the case
of HPV infection and vaccination, the underlying mechanisms are multifaceted, and thus
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the time to equitable vaccine uptake and reduced mortality may be longer than other
infectious disease scenarios (Clouston et al., 2016). Any reductions in mortality due to
HPV vaccination will not be detected for decades, given the long latency period between
infection and cancer, so I will focus my analysis only on the factors related to HPV
vaccine initiation and completion.
Regarding the difficulty in conducting systemic research, Mackenbach (2017) and
others suggested that upstream interventions may result in more equitable outcomes than
individual downstream interventions by changing underlying power structures that
contribute to inequity, but are less feasible to conduct and may face stronger opposition
by those in power (Golden, McLeroy, Green, Earp, & Lieberman, 2015). Mackenbach
(2017) and Golden et al. (2015) stated that most research conducted, even on
organizational or political levels, is done with individual behavior change as an end goal;
while less efficient and sustainable, individual and interpersonal variables and
relationships tend to be more easily defined and the results more immediate and tangible.
For example, socioeconomic status is a multi-faceted, dynamic measure that
would require changes to education, employment, and wage; nested within each of these
metrics are issues surrounding transportation, nutrition, perinatal care, childhood
development, safe housing, and many more ancillary variables that contribute to the
capacity of an individual to learn, work, and earn a living wage (Joshua, Zwi, Moran, &
White, 2015; Mechanic & Tanner, 2007). Researchers may have limited ability to
identify the true causes of persistent unequal distribution of resources, but by using
known and suspected fundamental cause variables, they may be able to test potential
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relationships on many levels (Øversveen et al., 2017). How these variables are defined,
however, can change the statistical analyses and interpretation of findings (Ratnapradipa,
McDaniel, & Barger, 2017; Willis & Fitton, 2016). Given the importance of social
determinants of health in the FCT and inequalities in HPV vaccine uptake specifically,
and my use of social vulnerability as a variable in this study, a brief discussion of how
social vulnerability is defined is warranted.
Social vulnerability. Ratnapradipa et al. (2017) argued that determinants of
vulnerability and exposure to risk factors are multifaceted and evolving, and direct
measurement may not be possible. The Institute of Medicine and the National Research
Council (2011) claimed that there is no universal consensus on how to determine
vulnerability; for convenience, most assessments use symptoms of vulnerability such as
poverty or low educational attainment as proxy measures of risk factors or outcomes
(Joshua et al., 2015). Burnell (2012) suggested that exposure to a risk factor does not
always equate to vulnerability; for example, while the entire population may have a
similar likelihood of exposure to an infectious agent such as HPV, not everyone will
share the same burden of morbidity and mortality. Researchers have found that
relationships exist between social vulnerability and incidence of Lyme’s Disease, erectile
dysfunction treatment, physician recommendation in prostate cancer, diabetes,
acceptance of an oral cholera vaccine, and HIV treatment outcomes (An & Xiang, 2015;
Grabovschi, Loignon, & Fortin, 2013; Ratnapradipa et al., 2017; Socio-economic
Inequalities and HIV Working Group, 2017; Sundaram et al., 2016). If not addressed, the
inequities in systemic structures governing a hierarchy of human value and differential
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resource allocation will persist horizontally and vertically across generations (Quiroga,
Medina, & Glick, 2014).
At a high level, social vulnerability may be defined as the differential capacity of
an individual or population to anticipate, cope with, resist, and recover from the impact of
cumulative external stressors (Gallagher et al., 2016; Joshua et al., 2015). Stressors, such
as determinants in the built, natural, social, economic, and political environments, may be
difficult to measure, but if identified could be mitigated to maximize the opportunity for
healthy choices (Ratnapradipa et al., 2017; Willis & Fitton, 2016). The bulk of
vulnerability literature focuses on mapping vulnerability predictors to protect against
natural and human-made disasters, but a tool developed by the Agency for Toxic
Substances and Disease Registry (ATSDR) has the potential for linking social
vulnerability with HPV vaccination uptake and providing context to the predictors of
vaccination in the NIS-Teen survey (Gay, Robb, Benson, & White, 2016; Juster et al.,
2016). I will be the first, to my knowledge, to test the relationships between scores from
the Social Vulnerability Index and HPV vaccine uptake. By using this tool, I may identify
new variables for future researchers to consider in systemic interventions.
Social Vulnerability Index. Flanagan et al. (2011) stated that until the mid-2000s,
disaster management mapping tools focused exclusively on natural and built environment
hazards at the local and population level. In response to a growing recognition of the
importance of social vulnerability in outcomes and the need to identify particularly
vulnerable communities for disaster planning, ATSDR collaborated with the CDC and
National Center for Environmental Health to create the Social Vulnerability Index (SVI)
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(ATSDR, 2014; Flanagan et al., 2011). The SVI draws from U.S. Census data and ranks
each census tract or county on 15 factors contributing to social vulnerability; each tract or
county is then given a vulnerability score on four different themes (encompassing the 15
social factors) and an overall vulnerability score (see Section 2 for more details)
(ATSDR, 2014). The tool was constructed to support resource allocation before, during,
and after a disaster, but a small number of researchers have recognized the utility in
linking compounded vulnerability factors and disparities in health care (An & Xiang,
2015; Grabovschi et al., 2013). To date, researchers have used the tool to assess the level
of vulnerability with physical fitness and obesity (An & Xiang, 2015; Gay et al., 2016).
Individuals and populations living in areas of social vulnerability experience
economic, physical, political, and social barriers to understanding and making healthy
choices, yet few studies consider multiple barriers simultaneously (An & Xiang, 2015;
Gay et al., 2016; Grabovschi et al., 2013). Many of these same barriers exist for HPV
vaccine uptake, such as low socioeconomic and racial and ethnic minority status (see
Table 8).
Table 8
Correlating Social Vulnerability Index Themes and Predictors of HPV Vaccine Uptake
SVI Themes a

Example SVI Variables a

Association with HPV
Vaccination b

Minority
Status and
Language

Minority Race / Ethnicity
Speak English “Less than Well”

Significant and persistent
relationship among racial and
ethnic minority status, physician
recommendation, language, and
HPV vaccine uptake
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Household
Composition
and Disability

Aged 17 or Younger
Single-Parent Households

Socioeconomic Below Poverty
Status
Unemployed
Income
No High School Diploma
Housing and
Transportation

Multi-Unit Structures
No Vehicle

Significant relationship between
age of patient and physician
recommendation and marital
status of parent and vaccine
uptake
Significant and persistent
relationship among
socioeconomic status variables,
HPV vaccine uptake, and
physician recommendation
Significant difference in HPV
vaccine uptake by urban versus
rural location, as well as within
urban centers

Note. Adapted from Gay et al., 2016. a ATSDR, 2017. b Reagan-Steiner et al., 2016.
The SVI is a useful tool to indicate available flexible resources and understand
community-level social factors that influence health and health decisions, such as HPV
vaccination. No researchers testing the relationship between social vulnerability and
health to date have connected a theoretical perspective to their published research, and to
my knowledge only five articles to date have examined sociodemographic and
geographic variation in HPV vaccination (one in a 7-county region, one in the
Intermountain West region of the United States., and three in the United States overall)
(Bodson et al., 2017; Grabovschi et al., 2013; Henry et al., 2017; Monnat, Rhubart, &
Wallington, 2016; Pruitt & Schootman, 2010; Rutten et al., 2017). A small number of
researchers also have recently published articles looking at geographic factors and HPV
vaccination (Henry et al., 2016; Tsui et al., 2013). Given the FCT’s emphasis on flexible
resources, which may be limited in areas of vulnerability, and the need to identify
fundamental causes to best mitigate disparities in health outcomes, the use of the SVI in
this research will add context to the quantitative data in the NIS-Teen database.
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FCT, SVI, and HPV. Few studies have tested the association between multiple
social variables and predictors of HPV vaccine (Jokinen-Gordon, 2014). By testing
relationships among known fundamental causes of disease such as socioeconomic status
and racial and ethnic background, as well as other influences specific to HPV vaccine
such physician recommendation, this research may help researchers design more
comprehensive interventions that reduce disparities in vaccine uptake (Schmeler &
Sturgis, 2016).
Dovidio and Fiske (2012) asserted that even with access to flexible resources or
professional commitment to optimizing health, human decision-making is not always
rational (Phelan et al., 2010; Polonijo & Carpiano, 2013). Mackenbach (2017) and others
contended that researchers should consider these implicit or cognitive biases that may
result in irrational behaviors when assessing factors influencing the unequal distribution
of resources in a free market economy (Arrow, 1963; Dovidio & Fiske, 2012). I will use
a theory of action describing these behaviors; behavioral economics will complement
FCT’s theory of the problem in identifying why health disparities exist and how
interventions should be designed (Glanz et al., 2015). Although testing specific
components of behavioral economics and HPV vaccine rates is not feasible for this study,
the theory has been linked to physician decision-making and could provide important
context for interpreting physician recommendation.
Behavioral economics. Emanuel et al. (2016), Hoff and Stiglitz (2016), and
others suggested that standard economic theory and many public health promotion
programs rely on the assumptions that, given sufficient information about specific choice

71
sets and motivation to act, individuals will make rational decisions to improve their
circumstances out of self-interest. However, Hansen, Skov, and Skov (2016) and others
argued that individuals often include seemingly irrelevant factors in their decisionmaking processes and are predictably unpredictable, whether making an economic
decision such as buying a new or used car, or a health decision such as going to the gym
or sitting on the couch (Dovidio & Fiske, 2012; Hoff & Stiglitz, 2016). As MacLeod
(2016) noted, “rational choice per se is not required to explain why humans are able to
perform at such a high level in a wide variety of tasks, while at the same time capable of
making some really dumb mistakes” (p. 24).
In addition, behavior change is more than just increasing or decreasing frequency;
individuals may adopt or reverse behaviors at different rates or need more help than
others to stabilize behavior change (Bickel et al., 2016; Bickel, Quisenberry, & Snider,
2016). Frank (2004) and Hansen et al. (2016) asserted that, given the potential for
irrational decision-making at different rates, health policies and interventions created
using rational, linear models fall short in bridging the gaps between preferences,
decision-making, and behavior change. These observations are particularly important
when interpreting physician behavior, as physicians are expected to be sufficiently
informed and motivated to act in the best interests of the patient. As described in the HPV
Vaccination and Physician Recommendation section, however, physicians may
unconsciously and unintentionally act in their own self-interests (Mohammed et al,
2016). Understanding the key processes in behavioral economics may help provide
context to any differences in physician recommendation in this study.
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Social determinants play a role in physician and patient decisions about health,
whether through access to flexible resources or influence on cognitive development,
preferences, and perceptions (Hansen et al., 2016; Hoff & Stiglitz, 2016). Expanding on
this observation, Alm and Sheffrin (2017) suggested that the way a choice is framed, the
individual’s cognitive capacity, perceptions of the costs, self-control, social norms, and
the current environment all play a role in the decision process. Researchers designing
interventions and advocating for policies, therefore, should take cognitive processes,
social determinants, and structural factors into account. The theory of behavioral
economics provides researchers with a conceptual approach to understanding behavioral
decision-making in light of these important influencers, potentially improving the
efficiency and efficacy of interventions and policies (Alm & Sheffrin, 2017).
Behavioral economics (a) allows researchers the opportunity to measure behavior
change beyond simply increasing or decreasing in frequency; (b) highlights the
application of learnings across diseases and contexts, much like a fundamental cause; (c)
uses technology to maximize cost-effectiveness, generalizability, and efficacy of
interventions; and (d), integrates economic, psychological, and social frameworks to
inform more real-world programs and policies (Alm & Sheffrin, 2017; Bickel et al.,
2016; Gennetian, Darling, & Aber, 2016). Behavioral economics is both a complement
and counterpoint to the FCT; the two theories informing this study are used to highlight
the importance of social determinants and the need to address behavior on multiple levels
(Link & Phelan, 1995; Bickel et al., 2016). However, the FCT is often used to identify
bottom-up causes of disparities, while behavioral economics is often used to identify top-
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down cognitive processes in the context of bottom-up causes and promote behavior
change (Link & Phelan, 1995; Bickel et al., 2016). A small number of researchers have
considered HPV vaccination using the FCT or behavioral economics, but no one to my
knowledge has considered the two theories together.
Arrow (1963) and Frank (2004) argued that nowhere are these advantages of
using behavioral economics more closely linked than with physician behavior. Physicians
may unconsciously and repeatedly make suboptimal choices in the face of clinical
uncertainty regarding patient response and outcomes (Bickel et al., 2016; Frank, 2004).
Researchers have found that physicians are creatures of habit and may unconsciously
work through a number of cognitive processes to make health care decisions (Arrow,
1963; Bickel et al., 2016; Frank, 2004). Saposnik, Redelmeier, Ruff, and Tobler (2016)
observed that few studies on cognitive processes that influence physician decisions in
health care exist, despite the strong link between physician recommendation and HPV
vaccination. I argue that the dearth of published research on this topic is a missed
opportunity for researchers designing physician-targeted interventions, and will note in
my discussion of the results how reporting quantifiable data on physician
recommendation has limited use for researchers without the context of why physicians
vary in their recommendations. While collecting these qualitative data is outside the
scope of my research, I will provide a brief description of key processes cited in
behavioral economics for context in this later discussion.
Heuristics. Given time constraints and clinical uncertainty, physicians reportedly
often rely on heuristics, or rules of thumb to make decisions (Frank, 2004; Shuval et al.,
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2017). The availability heuristic is reliance on a personal memory, a story from a
colleague, or discussion at a local meeting – in other words, a physician may extrapolate
the probability of a singular outcome or small number of events to the population, as a
personal story is more top-of-mind than representative data (Blumenthal-Barby &
Krieger, 2015). Frank (2004) proposed that this heuristic is in large part responsible as
one of the two core questions of health economics: what causes persistent geographic
variation in treatment patterns. The author reported that physicians, whether consciously
or not, follow the advice of trusted colleagues, even at the expense of using newer or
evidence-based practices, as these sources are readily available and more personal. The
availability heuristic is a critical process to consider when assessing physician
recommendation patterns and designing programs or policies to influence HPV vaccine
recommendation, as it highlights the importance of intervening at the local level
(Blumenthal-Barby & Krieger, 2015; Saini et al., 2017).
As first mentioned in Tversky and Kahneman’s (1975) seminal article on
heuristics and biases, the stereotype heuristic is a reliance on a physician’s perception of
how closely the patient resembles another patient based on personal attributes. When the
resemblance is perceived to be high, then the probability that one patient’s outcomes will
be similar to another also is perceived to be high (Blumenthal-Barby & Krieger, 2015;
Frank, 2004; Tversky & Kahneman, 1975). For example, if a physician believes that
White female adolescents are less likely to engage in sexual activity at a younger age and
her parents are more likely to challenge the HPV vaccination, the physician will likely
stereotype the next young White female adolescent patient and delay recommendation.
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The limited ability of physicians to accurately assess patient and parental needs and
wishes already has been discussed, and can lead to biases in care that unintentionally
influence patient outcomes (Frank, 2004). Thus, heuristics may play a role in influencing
physician recommendation, particularly if this differs by geography. I will test physician
recommendation by select local areas listed in NIS-Teen.
Biases. Cognitive bias, or a systematic error in decision-making informed by
heuristics, leads to the second core question of health economics: what accounts for
disparities in health care (Blumenthal-Barby & Krieger, 2015; Frank, 2004). Biases are
not all negative, nor are they all explicit; rather, implicit (unconscious) biases often
influence physician behavior and impact recommendations and communication with
patients (Dovidio & Fiske, 2012). In a large, critical review of studies on heuristics and
biases among health care providers, Blumenthal-Barby and Krieger (2016) found
confirmation of biases in 80% of the studies (Blumenthal-Barby & Krieger, 2015).
Blumenthal-Barby and Krieger (2015) and Hoff and Stiglitz (2016) argued that
physicians may allow their beliefs and expectations to affect interpretation of a patient,
data, or patient outcomes (confirmatory bias), and reportedly recommended the current
practice or default option (default or status quo bias) rather than change prescribing
habits. The authors also found that when considering a recommendation or a particular
course of therapy for a patient, physicians reportedly focused on the losses rather than the
gains of the action (loss / gain framing bias), under- or over-estimated the future impact
of an action (impact bias), or viewed the harm from an action as more damaging than the
harm of doing nothing at all (omission bias).
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Finally, Blumenthal-Barby and Krieger (2015) showed that family physicians
reportedly had a greater susceptibility to biases and heuristics (91%), followed by
obstetricians and gynecologists (85%). Again, while not all biases and heuristics are
explicit or negative, they significantly influence a physician’s ability to process
information and estimate probabilities, which are central to the practice of health care
(Dovidio & Fiske, 2012). While data on biases and heuristics are not collected for NISTeen and are thus outside the scope of my analysis, I will consider these factors when
discussing my findings of physician recommendation.
Discounting. Delayed or hyperbolic discounting is a well-researched process in
economics (Bickel et al., 2016). In simple terms, the value of a reward received at a
future point is perceived to be worth less than the value of a reward received immediately
– individuals discount the reward if it is delayed (Bickel & Marsch, 2001; Bickel et al.,
2016; Emanuel et al., 2016; Murphy & Dennhardt, 2016). While delayed discounting is
accounted for in traditional economics, Bickel et al. (2016) suggested that behavioral
economics expands the concept and considers that individuals may reverse their
preference for immediate versus future rewards. Supporting this idea, Emanuel et al.
(2016) and others showed that not all individuals discount delayed rewards to the same
degree, with some having greater self-control and a more balanced consideration of
future benefits than others (Murphy & Dennhardt, 2016; Shuval et al., 2017).
Although the most frequently reported discounting studies are with patients and
use financial incentives for smoking cessation, weight loss, or sobriety, delayed
discounting may be an important process for physicians as well (Bickel et al., 2016;
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Buttenheim et al., 2016). For example, Siegler, Kable, and Chatterjee (2016) argued that
the benefits of prescribing opioids for patients in pain or antibiotics to a child with an
illness are more immediate on many levels, while the risks of not adhering to best
practices and potentially contributing to opioid dependence or antibiotic resistance are
delayed. In HPV specifically, the benefit of not recommending the vaccine to parents (or
giving a weak recommendation) may allay the physician’s immediate discomfort of
discussing sex or fear of upsetting the parents, while the risk that the adolescent will not
be vaccinated or develop a disease is delayed. Given the responsibility costs of the
physician’s decision for the patient’s health and wellbeing, a physician may err on the
side of caution as a near-term reward (Frank, 2004). These observations may play a role
in researchers’ findings that physicians reportedly discuss the HPV vaccine more often
with older adolescents, rather than with 11 and 12-year-olds as advised by ACIP. I will
consider these factors when discussing my findings of physician recommendation by age.
Nudging. Bickel et al. (2016) and Hansen et al. (2016) concluded that nudging is
a cost-effective population-level strategy, as it makes use of framing and default bias
processes to nudge individuals toward optimal choices and minimize some of the
irrational factors influencing decision-making. The authors suggested that behavior
patterns influenced by heuristics and biases could be shifted by promoting salient,
endorsed choices, creating a choice architecture in which the easiest course of action is
the optimal one. As with discounting, nudging has been tested in a variety of health
settings with patients, such as placing fruit and vegetables at eye level in grocery stores,
providing graphic warning images on cigarette packages, changing organ donation on
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driver’s license applications to opt-out, smaller plates in restaurants, or showcasing a
choice that a majority of the population makes to leverage social norms (Bickel et al.,
2016; Hansen et al. 2016).
With the increased use of technology in daily medical practice and knowledge of
behavioral economics processes, however, nudges may be a useful tool in shifting
physician behavior. For example, a small number of researchers have demonstrated that
automatic prompts during a patient visit increased the number of conversations
physicians had with patients about a particular health issue; setting specific treatment
algorithms or diagnostics as the default in automated systems reduced unnecessary
ordering and spending; and bundling adolescent vaccines that were often ordered together
decreased the focus on any one component, such as HPV (Bickel et al., 2016; Olson,
Hollenbeak, Donaldson, Abendroth, & Castellani, 2015; Patel et al., 2016). Such nudges
were particularly effective when physicians were given immediate and public feedback,
such as sharing vaccination rates with peers or the public (MacLeod, 2016).
Nudging may be particularly useful in HPV vaccination, as the strategy inherently
avoids restricting freedom of choice (Hansen et al., 2016). Mariner (2014) asserted that
the fundamental argument against vaccine mandates is the tension between government
authority to protect the public from harm and parental rights to decide for their children.
As outlined in Mariner (2014) and Hansen et al. (2016), nudging does not take away or
ban choices, impose mandatory obligations, regulate a specific individual’s behavior, or
rely on rational behavior. Rather, the modified choice architecture targets cognitive
biases to protect the public from harm and makes the optimal choice easier to make
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(Mariner, 2014). By designing and evaluating policies that reduce cognitive errors that
influence health outcomes, rather than policies that restrict individual freedom of choice,
nudging may be a more palatable strategy to address disparities in health (Frank, 2004).
These observations on nudging will provided context in my interpretation of the data.
Definitions
The independent and dependent variables and covariates are defined as follows.
Ethnic and racial minority status. A categorical independent variable describing
the race/ethnicity of the teen. Options are Hispanic, Non-Hispanic White Only, NonHispanic Black Only, Non-Hispanic Other + Multiple Races, and Other + Multiple Race
(a recode of NHO + Multiple Races) (CDC et al., 2015; 2016).
HPV vaccination completion. A nominal dependent variable indicating the teen
has received three or more doses of the HPV vaccine among those who have initiated the
series (Gilkey et al., 2016). Some teens may have received more than three recommended
doses; a secondary calculation by the CDC refers to a teen who, among those who
received one or more HPV dose and over a minimum of 24 weeks between the first dose
and the interview date, received a total of three or more doses (Reagan-Steiner et al.,
2015). However, using the Gilkey et al. (2016) measure allows for capturing teens who
continue the vaccine series, albeit not in the recommended time-frame.
HPV vaccination initiation. A nominal dependent variable indicating the teen
has received one or more doses of the HPV vaccine (Reagan-Steiner et al., 2015).
Physician recommendation. A categorical dependent variable (research question
4) indicating whether the person participating in the survey recalls receiving a
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recommendation from a physician or health care professional for the teen to receive the
HPV vaccination (CDC et al., 2015; 2016).
Selected local areas. Seven specific estimation areas highlighted in the 2015
NIS-Teen dataset (Bexar County, TX; Chicago, IL; El Paso County, TX; Hidalgo
County, TX; Houston, TX; New York City; and Philadelphia County, PA) (CDC et al.,
2015; 2016). As Washington, D.C. is sampled separately, I will include D.C. as one of
the select local areas. These local areas receive federal Section 317 funds to purchase
vaccines, particularly for priority populations, are sampled and analyzed separately
(Reagan-Steiner et al., 2016). Given the demonstrated differences in HPV vaccination by
geography, as well as the hypothesized relationship between social vulnerability and
HPV vaccination, inclusion of local areas will add significant value to the research. In
order to compare county-level data from the Social Vulnerability Index (described below)
and the NIS-Teen database, I will include only selected local areas that are stand-alone
counties from the 2014 NIS-Teen in the SVI portion of my analysis: Bexar County, El
Paso County, Philadelphia, and Washington, D.C. (Hidalgo County was added in 2015.)
Social vulnerability. As defined by the CDC and Agency for Toxic Substances
and Disease Registry [ATSDR], social vulnerability refers to the extent to which the
health of communities is likely to be affected by socioeconomic and demographic factors
(CDC & ATSDR, 2017). Vulnerable populations are those who are disproportionately
burdened by a combination of factors, are less likely to be able to cope with stressors, and
whose needs are inadequately accounted for in resource allocation plans (Flanagan et al.,
2011). The CDC and ATSDR’s Social Vulnerability Index ranks each census tract or
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county on overall vulnerability, comprised of four themes and 15 social factors affecting
health: socioeconomic status (below poverty, unemployed, income, no high school
diploma); household composition and disability (aged 65 and older, aged 17 or younger,
civilian with a disability, single-parent households); minority status and language
(minority, speak English less than well); and housing and transportation (multi-unit
structures, mobile homes, crowding, no vehicle, group quarters) (CDC & ATSDR, 2017).
Socioeconomic status. Categorical independent variables including income
(poverty status, family income), health insurance status, and education (the current level
of education of the mother) (CDC et al., 2015; 2016).
Assumptions
Multiple government agencies developed the questionnaires and provided the
datasets for NIS-Teen, as well as the index and dataset for the Social Vulnerability Index.
For the NIS-Teen, participants self-report the data, and I assume they answer honestly.
Boakye et al. (2016) demonstrated that parental and provider recall of HPV vaccine
initiation in the 2014 NIS-Teen dataset is comparable; parental and provider recall are
slightly less comparable for HPV vaccine completion, although still substantial (κ =
0.64). Although sensitivity and specificity may differ in other NIS-Teen dataset years, I
assume this level of agreement indicates the self-report data is generally trustworthy.
Scope and Delimitations
The scope of this study is to test the relationship between HPV vaccine initiation
and completion, socioeconomic status, and demographic variables in eight select local
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areas in the United States. In addition, I will test the relationship between HPV vaccine
initiation, physician recommendation, and social vulnerability in four select local areas.
Internal validity of the study data is supported by random sample selection in the
NIS-Teen using landline and cell phone numbers across the United States, application of
sampling weights, and validation of both the NIS-Teen and Social Vulnerability Index
instruments and outcomes (Brewer, 2004; Flanagan et al., 2011; Reagan-Steiner et al.,
2016). External validity of the study data is supported by the national sample set and realworld observation rather than a laboratory setting (Ondercin, 2004). However, there are
limitations that affect the ability to draw causal inferences about the data and generalize
the findings to the entire U.S. population. Overall, there may be unknown confounders
influencing the relationship between the independent and dependent variables; these may
be masked by aggregate data, not currently measurable, or be in flux as dynamic
processes influencing health and health outcomes.
The NIS-Teen survey is cross-sectional, and thus it can support inferences but not
prove causality. The household response rates for NIS-Teen vary from year to year, with
approximately 60% and 31% response rates for landline and cell phones, respectively, in
2014 (compared with 56% and 30% in 2015), and approximately half of respondents
have adequate provider data (Reagan-Steiner et al., 2015; Reagan-Steiner et al., 2016).
Estimates may be biased due to errors in respondent recall, non-responders or small
sample sizes in specific variables or selected local areas (Reagan-Steiner et al., 2016).
As with the NIS-Teen, the SVI is cross-sectional. Although the SVI incorporates
multiple facets of social vulnerability, it is an incomplete list; others may include specific
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built environment structures or diffusion of information (Flanagan et al., 2011). In
addition, the SVI uses decennial census data, and may not accurately reflect the most
current measurements in a community (Flanagan et al., 2011).
Conclusions
Human papillomavirus (HPV) is the most common sexually transmitted infection
in the world and causes an estimated 700,000 cancer cases each year worldwide (Perkins,
2016). In the decade since the first vaccine against HPV came to market, researchers and
health care providers have made progress in reducing disparities in vaccine uptake among
racial and ethnic minority and low socioeconomic status populations (Galbraith et al.,
2016; Rahman et al., 2017). However, sociodemographic and geographic variation in
HPV vaccine uptake persists, as do differences in physician recommendation,
determinants of vulnerability, and state laws regarding vaccination (Perkins, 2016; Rutten
et al., 2017). Given the multifactorial influences on cognitive and behavioral decisionmaking in HPV vaccination, a more ecological approach to research may uncover
relationships influencing HPV vaccine uptake that are missed when studying
determinants in isolation (Yanez, McGinty, Buitrago, Ramirez, & Penedo, 2016).
This study may lend support to findings of experts in the field regarding variation
in vaccine uptake by a number of variables, including sociodemographic factors and
physician recommendation. In addition, this study may expand on data supporting
geographic variation in HPV vaccination. This study may advance knowledge in the
discipline by being the first, to my knowledge, to test the influence of the socioeconomic,
demographic, cultural, and health history variables on HPV vaccine initiation and
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completion alongside the social vulnerability context in which these relationships exist.
This will also be the first test of a potential relationship between social vulnerability and
HPV vaccination nationwide in the literature.
These implications, such as the identification of the variables most strongly
associated with HPV vaccination and local factors in physician recommendation, can
advance social change by highlighting the need to consider local socioeconomic and
demographic influences on health behavior, with a focus on physician recommendation.
Informed interventions may help local, state, and national efforts to improve vaccination
efforts and reduce disparities in health care.
The following chapter describes the research methodology, including the design
and data collection procedures.
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Section 2: Research Design and Data Collection
Introduction
The purpose of this study is to test the relationship between HPV vaccine
initiation and completion, socioeconomic status, and demographic variables in eight
select local areas in the United States. In addition, I will test the relationship between
HPV vaccine initiation, physician recommendation, and social vulnerability in four select
local areas.
The remainder of this chapter will describe the research design and rationale,
followed by the methodology, including sampling, data analysis, threats to validity, and
ethical considerations.
Research Design and Rationale
I will conduct a quantitative secondary analysis of the NIS-Teen, a cross-sectional
study, and the Social Vulnerability Index, a cross-sectional analysis tool, to test
relationships among the study variables. The independent variables are socioeconomic
status indicators, demographic variables, and county-level social vulnerability. The
dependent variables are HPV vaccine initiation and completion and physician
recommendation.
Secondary analysis is an efficient and cost-effective way to generalize findings
from a large sample size to a population for greater external validity, analyze the findings
using statistical procedures, and identify subgroups with sufficient sample size for
additional analyses (Creswell, 2009; Dale, 2004). In addition, use of validated, reliable
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instruments increases confidence in internal validity and the minimization of bias in data
collection to the extent possible (Creswell, 2009).
Quantitative analysis of county- and national-level databases will advance
knowledge in the field regarding relationships likely to influence HPV vaccine uptake by
identifying specific variables to assess and resources needed at each level.
Methodology
The NIS-Teen is a well-known and much-used instrument to examine
relationships among variables of interest and immunization behaviors in the United
States. The Social Vulnerability Index is used frequently by emergency planners and
other officials responsible for disaster planning and recovery.
Population
The Centers for Disease Control and Prevention conducts the annual NIS-Teen to
monitor vaccination initiation and completion of adolescents aged 13 to 17 years in noninstitutionalized households in the United States. In 2015, NIS-Teen collected data from
61 geographic strata: all 50 states, the District of Columbia, three territories, and seven
selected local areas (Chicago, New York, Philadelphia, Bexar County [TX], Houston, El
Paso County [TX], and Hidalgo County [TX]).
Sampling and Sampling Procedures
NIS-Teen uses dual-frame sampling, with both landline and cell-phone sampling
frames with households, followed by a mailed questionnaire to the identified vaccine
providers. Interviewers use independent, quarterly updated samples provided by
Marketing Systems Group; the landline sampling frame includes banks of numbers with
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at least one directory-listed telephone number, while the cell-phone sampling frame
includes all banks of cell phone numbers (CDC, 2015). Numbers that are non-working,
non-residential, or on the NIS do-not-call list are eliminated prior to release to a
telephone center. Interviewers contact households to identify those with adolescents aged
13 to 17 years; if more than one child is eligible, one child is randomly selected to be the
subject of the interview. Households that do not have adolescents at this age are
excluded. Interviewers use the NIS-Teen household questionnaire to collect householdreported vaccination and health information, demographic and socioeconomic
information, geographic information, and vaccine provider information from a parent or
guardian (CDC, 2015). As adolescents and teens under age 18 must have parental or
guardian consent to be vaccinated, the parent or guardian is the appropriate respondent
(Burdette et al., 2017).
For households who provide sufficient information and consent to contact the
vaccine provider, a questionnaire is mailed to vaccine providers to obtain immunization
history from an adolescent’s medical records. The provider is asked to mail or fax the
immunization history form; in some instances, histories are completed over the phone
during follow-up phone calls to providers who have not yet responded. In 2015, 61.4% of
parents or guardians from the landline sample gave consent to contact providers (2014:
64.4%), while 58.1% from the cell-phone sample gave consent (2014: 61.2%) (CDC et
al., 2015; 2016). Of the questionnaires mailed to providers, 93.4% of questionnaires from
the landline sample and 93.6% of questionnaires from the cell-phone sample were
returned (2014: 94.9% and 94.8%, respectively) (CDC et al., 2015; 2016). Finally, of the
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questionnaires returned, 53.4% of adolescents from the landline sample had adequate
provider data, and 48.9% of adolescents from the cell-phone sample had adequate
provider data (2014: 57.1% and 52.3%, respectively) (CDC et al., 2015; 2016).
The sample size was designed specifically with a target coefficient of variation of
6.5% from provider-reported vaccine histories in each geographic area, to give a true
coverage parameter of 50% (CDC et al., 2015; 2016). Overall, the coverage parameter in
2015 was 49.9% (2014: 54.4%); for landlines, a total of 84.4% of households were
successfully screened, 5.7% of households had an age-eligible teen, and 81.3% of these
households completed the interview (2014: 87.2%, 6.2%, and 83.8%, respectively) (CDC
et al., 2015; 2016). For cell phones, 73.4% of households were successfully screened,
6.9% were eligible, and 71.7% completed the interview (2014: 72.9%, 6.9%, and 72.7%,
respectively) (CDC et al., 2015; 2016). A total sample of 10.1 million telephone numbers
resulted in completed household interviews for 44,773 teens, of which 22,214 [including
133 unvaccinated children] had adequate provider data to verify whether the adolescent
was up to date on vaccines (2014: a total of 38,703 teens, 21,057 [including 92
unvaccinated adolescents] with adequate provider data) (CDC et al., 2015; 2016). The
revised definition of adequate provider data, beginning in 2014, is any adolescent for
whom a provider reports vaccine history, or any adolescent who is unvaccinated as
reported by parent or provider (CDC et al., 2015; 2016).
Selected local areas that receive federal Section 317 funds to purchase vaccines,
particularly for priority populations, are sampled and analyzed separately (ReaganSteiner et al., 2016). Researchers may analyze all completed household interviews or
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only those with adequate provider data, as well as choose whether to include adolescents
from territories in the analysis (CDC et al., 2015; 2016). Adolescents from the territories
are excluded from national estimates (CDC et al., 2015; 2016).
Both the NIS-Teen and Social Vulnerability Index are public-use data files and do
not require permission to gain access to the data.
Instrumentation
The National Immunization Survey was launched in 1994 to monitor vaccine
coverage among children ages 19 months to 35 months after a series of measles outbreaks
in the early 1990s (CDC, 2017d). The NIS-Teen was launched in 2006 to monitor
vaccine coverage among adolescents and teens for routine immunizations and provide a
consistent dataset for tracking needs and outcomes related to routine vaccines in a single
year and over time (CDC, 2017d; Jain, Singleton, Montgomery, & Skalland, 2009). Prior
surveys, such as the National Health Interview Survey, relied on personal immunization
cards or parental recall, but few households kept immunization cards and parental recall
was less accurate than the cards (Jain et al., 2009). Other surveys relied on local data or
registries. In NIS-Teen, analysts use weights to estimate vaccine coverage for the entire
nation, as well as by state and selected local area; researchers can also stratify by
variables of interest (CDC, 2017d).
Researchers collect data from both parents and vaccine providers of adolescents
to enhance the validity and reliability of the self-reported data in NIS-Teen (CDC,
2017d). Dorell, Jain, and Yankey (2011) and others reported that parent-reported vaccine
histories varied by vaccine, especially for recently recommended vaccines, and the use of
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provider validation of parent reports increased the validity of the NIS-Teen. Analysts also
use adequate-provider data when reporting estimates of vaccine coverage, given the
differences between estimates obtained from households with and without adequate
provider data in the early years of the survey (Jain et al., 2009).
Researchers use the dual-frame design to increase reliability of sampling in NISTeen and validity of survey results (Dorell et al., 2011). Shin, Molinari, and Wolter
(2008) determined that dual-frame sampling, versus the single random-digit dialing
frame, increased statistical efficiency and cost-effectiveness of the survey without
introducing new bias into immunization coverage estimates. For example, the public-use
data file for the 2014 NIS-Teen includes only dual-frame weights as a way to minimize
any bias resulting from incomplete landline sampling (CDC et al., 2015; 2016).
In addition to these methodological designs, validity and reliability of NIS-Teen
can be assessed by comparing results with other immunization data sources, such as
registries, the National Health Interview Survey-Child, or the Behavioral Risk Factor
Surveillance System, and by comparing results among researchers using the same data set
and the same questions (Boakye et al., 2016; Jain et al., 2009).
Operationalization of Variables
The objective of this study is to test the relationship between HPV vaccine
initiation and completion, socioeconomic status, and demographic variables in eight
select local areas in the United States. In addition, I will test the relationship between
HPV vaccine initiation, physician recommendation, and social vulnerability in four select
local areas.
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What follows is a description of the dependent and independent variables (see
Table 9 for a brief overview of the variable levels).
Table 9
Measurement Levels of Variables in Analysis
Measurement
Level

Variables

Nominal

HPV vaccine initiation
HPV vaccine completion
Physician recommendation
Ethnicity and racial background
Health insurance status
Gender
Select local area
Poverty
Education
Social Vulnerability Index ratings
Age

Ordinal

Interval

Note. HPV vaccine initiation, completion, and physician recommendation are
dichotomous variables, which indicates binomial logistic regression as the appropriate
final statistical model.
HPV vaccination completion. One of the key dependent variables, HPV
vaccination completion reflects whether the respondent indicates that his or her
adolescent child had received three or more doses of the HPV vaccine series. Although
the NIS-Teen survey collects data on up to 9 reported HPV shots received for variable
HPVI_NUM_TOT (HPV1_NUM_REC in 2014; position 113-114), the series is made up
of 3 shots, with recent recommendations to administer 2 shots for eligible adolescents.
Only 145 responses of 33,809 completed household interviews and 89 of 16,875
interviews with adequate provider data answered 4 or more shots, with the majority
answering 4. I will consider 3 and 4 shots as ≥3 shots received, indicating completion,
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and will recode as 3 in analysis.
HPV vaccination initiation. Another key dependent variable, HPV vaccination
initiation reflects whether the respondent indicates that his or her adolescent child had
received at least one dose of the HPV vaccine series. I will consider 1 and 2 shots as
reported for variable HPVI_NUM_TOT as ≥1 shot received, indicating initiation, and will
recode as 2 in the analysis. For adolescents reporting 0 HPV shots received, I will recode
as 1 to indicate unvaccinated status.
Physician recommendation. As a dependent variable in research question 4,
physician recommendation reflects whether the respondent recalls receiving a
recommendation from a physician or health care professional for the adolescent or teen to
receive the HPV vaccination. As indicated in the NIS-Teen codebook for variable
HPVI_RECOM (position 167-168), I will code yes as 1 and no as 2. Based on prior
research, I will exclude don’t know, refused, or missing responses from my analysis, as
these answers comprise only 4,630 responses of the 44,773 completed interviews and
2,005 responses of 22,214 interviews with adequate provider data.
Ethnic and racial status. One of the key independent variables, ethnic and racial
status reflects the race / ethnicity of the adolescent. Responses to the question in NISTeen for variable RACEETHK (position 311-311) may be Hispanic, Non-Hispanic White
Only, Non-Hispanic Black Only, and Non-Hispanic Other + Multiple Races. Based on
prior studies in which researchers focus on Hispanic, White, and Black in their studies
given the sufficient sample size in the survey, and the lack of any additional
subcategorization for the 4,488 responses for other out of 44,773 household interviews

93
(2,202 responses of the 22,214 teens with adequate provider data) in the public-use data
file, I will use only Hispanic, White, and Black in my analysis. As indicated in the
codebook, I will code Hispanic as 1, White as 2, and Black as 3.
Social vulnerability. The CDC and ATSDR’s Social Vulnerability Index ranks
each census tract or county on overall vulnerability, comprised of four themes and 15
social factors affecting health: socioeconomic status (below poverty, unemployed,
income, no high school diploma); household composition and disability (aged 65 and
older, aged 17 or younger, civilian with a disability, single-parent households); minority
status and language (minority, speak English less than well); and housing and
transportation (multi-unit structures, mobile homes, crowding, no vehicle, group quarters)
(CDC & ATSDR, 2017). Two adjunct variables, estimates for uninsured persons and
daytime population, are included in the SVI 2014 data but are excluded from the ranking
calculations.
SVI data can be mapped and analyzed at the national level, ranking tracts or
counties against each other, or at the individual state level, where tracts or counties are
ranked only against those in the same state. I will use counties in this research as a more
appropriate comparison for counties in NIS-Teen. Percentile ranks closer to zero indicate
lower vulnerability, while ranks closer to 1 indicate high vulnerability. CDC and ATSDR
calculate percentile ranks for each county for the 15 variables, and sum the percentiles to
generate the theme score (variables RPL_THEME1 for socioeconomic, RPL_THEME2
for housing composition and disability, RPL_THEME3 for minority status and language,
and RPL_THEME4 for housing and transportation). Finally, the sum of each theme is
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added together to calculate the overall percentile ranking (variable RPL_THEMES). I will
code the themes using their designated numbers from the SVI (1 through 4), and the
overall ranking as 5.
Socioeconomic status. Socioeconomic status is reflected through a collection of
independent variables including income and education. While American Psychological
Association (2007) and Diemer, Mistry, Wadsworth, Lopez and Reimers (2013)
suggested including a number of measures such as resources, absolute and relative
poverty, and subjective social status, data are collected only on resource-based measures
(total family income) and absolute poverty (federal poverty threshold). While family
income is a more nuanced measure, there may not be sufficient sample size for subgroup
analysis, and poverty status is an accepted variable in reports by CDC and other
researchers.
As noted in the NIS-Teen codebook, poverty status, the variable INCPOV1
(position 298-298), is calculated as above poverty (income greater than $75,000, coded
1), above poverty (income less than or equal to $75,000, coded 2), and below poverty
(coded 3). Responses to variable EDUC1 (position 279-279), the mother’s level of
education, are less than 12 years (coded 1), 12 years (coded 2), more than 12 years / noncollege graduate (coded 3), and college graduate (coded 4).
Selected local areas. An independent variable describing where the teen lives at
the time of the survey. Responses are drawn from ESTIAPT15 and ESTIAPT14 from the
2015 and 2014 NIS-Teen surveys, respectively. Eight specific estimation areas in 2015
will be tested, as well as the four that are stand-alone counties from the 2014 NIS-Teen in
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the SVI portion of my analysis: Bexar County, District of Columbia, El Paso County, and
Philadelphia.
Health insurance. An independent variable describing whether an adolescent has
no insurance, employee or union insurance, or other government insurance. Responses
are drawn from variables TIS_INS_1 (position 1207-1208 in 2015, 1190-1191 in 2014) to
indicate whether an adolescent is covered through the respondent’s employer or union
(responding yes, coded as 1), TIS_INS_2, _3, _3A, and _4_5 (2015: positions 1211-1212,
1213-1214, 1215-1216, and 1217-1218; 2014: positions 1194-1195, 1196-1197, 11981199, and 1200-1201, respectively) to indicate other government insurance (responding
yes to Medicaid, S-CHIP, Tricare, or Indian Health Service, coded as 2), or TIS_INS_11
(position 1209-1210, 2014: 1192-1193) to indicate uninsured (responding yes, coded as
3).
Sex. An independent variable, sex reflects the gender of the adolescent as
identified by the respondent. Responses for the variable SEX (position 315-315) can be
male or female; as noted in the codebook, male will be coded as 1 and female will be
coded as 2.
Control variables. Researchers have identified a number of correlates to HPV
vaccine initiation, completion, and physician recommendation: age of the adolescent, age
of the mother, number of children under 18 years in the household, relationship of the
respondent to the adolescent, mother’s marital status, and number of adolescent visits to a
healthcare profession in the past 12 months (Burdette et al., 2017). These correlates may
confound results, and therefore I will control for each in my four research questions.

96
However, age of the adolescent will be included as an independent variable in research
question 4, as researchers have shown a significant relationship between age of the
adolescent and physician recommendation. Any additional confounding variables among
the aforementioned independent variables will be determined using logistic regression
(described in the Data Analysis Plan section).
Data Analysis Plan
The datasets, formats, and codebooks will be downloaded from the NIS-Teen
website, and all analyses will be conducted using the Complex Samples procedures in
SPSS version 24 for Mac OS Sierra when possible to account for the complexity of the
weighted survey data.
CDC analysts prepare and process the household and provider data collected
through NIS-Teen (CDC et al., 2015; 2016). Editing and cleaning procedures follow the
standards set by the National Health Interview Survey, and are completed after every
quarter of data collection (CDC et al., 2015; 2016). The CDC uses a computer-assisted
telephone interviewing system to reconcile any critical errors during the household
interview in real time, followed by a review of data values for any out-of-range values
and extraneous codes, production of cross tabulations, recoding of any verbatim
responses, and creation of several composite variables (CDC et al., 2015; 2016). Provider
data are edited through an initial manual review of the returned immunization history
forms, removal of any responses for the incorrect adolescent, consolidation of multipleprovider responses for a single teen merged into one single history, and then cleaned.
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Household and provider data are merged, with any multiple-provider responses
for a single adolescent merged into one single history. Analysts conduct a quality
assessment using an adolescent’s date of birth, gender, and name to confirm eligibility of
the teen (by age) and to ensure the correct adolescent is matched with the correct provider
(CDC et al., 2015; 2016). Finally, analysts perform imputations using a sequential hotdeck method for any non-responses to socioeconomic and demographic variables used in
weighting. Missing value codes are used for household data, while missing or other
provider data are recoded using a vaccination recoding table and reviewed by the
National Center for Immunization and Respiratory Diseases (CDC et al., 2015; 2016).
NIS-Teen is the only survey that includes provider-reported vaccination data
along with household-reported history; even with this corroboration and standardized
editing and cleaning procedures, there may be some inconsistent data present in the data
file, as households are not re-contacted to verify any differences in provider reporting
(CDC et al., 2015; 2016). As provider data are considered more accurate than householdreported vaccine history, the CDC uses the subset of data of adolescents with adequate
provider data for reported estimations of vaccine coverage, and assigns a separate weight
to these records (CDC et al., 2015; 2016).
Research questions. The objective of this study is to test the relationship between
HPV vaccine initiation and completion, socioeconomic and demographic variables, and
physician recommendation. In addition, I will test the relationship between HPV vaccine
initiation, physician recommendation, and social vulnerability. I will attempt to answer
four research questions:
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Research Question 1: Is there a relationship between HPV vaccination initiation
(1 dose) and socioeconomic status and demographic variables in selected local areas,
using data from the 2015 NIS-Teen?
H01: There is no relationship between HPV vaccination initiation and
socioeconomic and demographic variables in selected local areas.
Ha1: There is a relationship between HPV vaccination initiation and at least one
socioeconomic or demographic in selected local areas.
Research Question 2: Is there a relationship between HPV vaccination completion
(3 doses) and socioeconomic status and demographic variables in selected local areas
using data from the 2015 NIS-Teen?
H02: There is no relationship between HPV vaccination completion and
socioeconomic and demographic variables in selected local areas.
Ha2: There is a relationship between HPV vaccination completion and at least one
socioeconomic or demographic variable in selected local areas.
Research Question 3: Is there a relationship between HPV vaccination initiation
(1 dose) and social vulnerability by select local area county in the United States using
data from the 2014 NIS-Teen and 2014 Social Vulnerability Index?
H03: There is no relationship between HPV vaccination initiation and social
vulnerability by select local area county in the United States.
Ha3: There is a relationship between HPV vaccination initiation and social
vulnerability by select local area county in the United States.
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Research Question 4: Is there a relationship between physician recommendation
(yes/no) and social vulnerability by select local area county in the United States using
data from the 2014 NIS-Teen and 2014 Social Vulnerability Index?
H04: There is no relationship between physician recommendation and social
vulnerability by select local area county in the United States.
Ha4: There is a relationship between physician recommendation and social
vulnerability by select local area county in the United States.
Statistical analyses. The pre-determined α level for all tests is < 0.05. First, I will
conduct a descriptive, univariate analysis to calculate weighted frequencies and 95%
confidence intervals for all study variables to describe the survey respondent population.
Second, I will conduct inferential bivariate analyses, using chi-square tests, to
determine the interactions between adolescent characteristics and the three dependent
variables: HPV vaccine initiation, completion, and physician recommendation.
Third, I will conduct a preliminary series of logistic regression models to test for
multicollinearity, which indicates if two or more independent variables are highly
correlated. Multicollinearity, which increases the standard errors of the coefficients and
thus decreases the reliability of the outcome data, can be tested by calculating the
Variance Inflation Factors. A VIF greater than 10 indicates multicollinearity; depending
on the variable in question, I may remove the variable, recode it, or control for it in the
analysis. In addition, I will assess the results of the Wald test in the regression output to
understand the contribution of each independent variable to the model, as well as its
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statistical significance. I will include independent variables with p ≤ 0.05 in the final
model and exclude those with p > 0.05.
Finally, I will conduct a binomial logistic regression to test associations between
the independent and selected dependent variables that were statistically significant in the
preliminary regression analysis. My study meets the assumptions for binomial logistic
regression, as I have dichotomous dependent variables (all are yes or no), one or more
independent variables measured on a continuous or nominal scale (with ordinal variables
treated as continuous or nominal), the data have independence of observations, and no
multicollinearity (as tested in the third analysis step). The final results will be presented
as odds ratios with 95% confidence intervals.
Threats to Validity
Threats to validity may arise from external, internal, statistical conclusion, or
construct factors. External threats include extrapolating inferences from the sample data
to populations or settings that do not reflect the sample population, as well as the
interaction between population selection, taking the survey, and the setting in which they
take the survey. The CDC employs oversampling techniques and weights responses to the
NIS-Teen survey in order to calculate a population-level estimate of vaccine coverage
and minimize any interaction between selection and taking the survey. In addition, CDC
collects data at a number of administrative levels (such as national, state, and select local
area) to address the interaction between selection and the setting in which the population
live and experience differing external events. However, I cannot control for any unknown
confounders that may influence the relationships between the independent and dependent
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variables, especially if these confounders are not measurable or vary according to
unidentified population characteristics.
Internal threats to validity include the procedures or experiences of the
respondents that influence whether I can correctly infer conclusions about the population.
As NIS-Teen is a one-time survey, factors such as history, maturation, experimental
mortality, diffusion of treatment, or statistical regression do not apply to the survey or
analysis. In addition, respondents are selected through random digit-dialing for both
landline and cell phones, phone numbers are updated quarterly, and the CDC uses
probability sampling adjustments to reduce any potential for sampling errors; these
efforts address threats of selection bias and history. Respondents are not compensated,
mitigating any compensatory demoralization or rivalry factors. The CDC collects data
from both parents and providers of the HPV vaccine to verify parental recall. There are
no pre- or post-test interviews and the survey is routinely reviewed, thus removing any
concerns about instrumentation. Finally, I will conduct analyses to determine any
presence of multicollinearity in research variables, and will not assign causality to
variable relationships as my statistical model is not designed for that purpose.
Threats to construct validity result from insufficient measures or definitions of
variables in the study. To minimize this threat, the CDC reports on data from respondents
with adequate provider verification; in addition, comparison to other health surveys such
as the National Health Interview Survey, which uses different methodology and sampling
procedures, shows comparable coverage estimates. In my study, I have defined the
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variables using the body of HPV literature and the CDC’s reports as guides to ensure I
will be measuring and defining the same variables for testing.
Finally, threats to statistical conclusion can occur if the analysis is not powered
adequately, or statistical assumptions are violated. According to a preliminary analysis of
sample size using the G*Power (version 3.1.9.2), the sample size required for 95% power
ranges from 1,649 to 1,653 for females and 1,629 to 2,318 for males in 2014, far below
the 10,084 females and 10,743 males in the 2014 sample (the smaller of the two years’
samples in the full U.S. sample). To obtain this sample estimate, I used the following
parameters: a two-tailed test, an odds ratio of 1.2 for a small effect size, α > 0.05, and
hypothesized HPV vaccine coverage ranging from 39.7% to 60.0% in females and 21.6%
to 41.7% in males, based on 2014 data (the lower of the two years’ samples) (ReaganSteiner et al., 2015). Using the same parameters, the sample size required for 95% power
for the select local area ranges from 310 for females and 274 for males, again below the
367 females and 394 males in 2014 (the smaller of the two years’ samples in the select
local area sample).
In addition, the statistical assumptions for the planned statistical tests are met: for
chi-square goodness of fit and independence, I have categorical variables, independence
of observations, cross-sectional sampling, and an expected frequency of at minimum 5
cases per group in each categorical variable. For binomial logistic regression, I have a
dichotomous dependent variable, two or more independent variables (continuous or
nominal), independence of observations, mutually exclusive and exhaustive categories
within each variable, a lack of multicollinearity, and an expected frequency of at
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minimum 15 cases per group in each variable. If the assumptions are not met in the chisquare tests, I may collapse the cells with other sample groups where possible to increase
the sample. If the assumptions are not met in the binomial logistic regression test, I may
collapse the cells or transform or remove outliers where applicable.
Ethical Procedures
The CDC and all other staff involved with the NIS-Teen are bound by
confidentiality agreements to protect the privacy and confidentiality of protected health
information, including disclosure of data (CDC et al., 2015; 2016). The collected data can
be used only for research, and the public-use data file is reviewed by the National Center
for Health Statistics Disclosure Review Board prior to release to ensure privacy and
confidentiality are maintained (CDC et al., 2015; 2016). In addition, some variables that
could potentially identify participants are not included in the public-use data file or have
the categories collapsed and reported in aggregate.
Summary
I will conduct a quantitative secondary analysis of the NIS-Teen and Social
Vulnerability Index databases to test the relationship between HPV vaccine initiation,
completion, socioeconomic and demographic variables, physician recommendation, and
social vulnerability in selected local areas in the United States. Specifically, I will use
descriptive, univariate analysis to calculate weighted frequencies and 95% confidence
intervals for all study variables to describe the survey respondent population, followed by
chi-square tests and weighted frequencies to determine the interactions between HPV
vaccination, physician recommendation, and select adolescent characteristics. Next, I will
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test for multicollinearity using logistic regression, followed by binomial logistic
regression to test associations between the independent and selected dependent variables
that were statistically significant in the preliminary regression analysis. Finally, I will
evaluate my research questions in the context of what is known in the literature and how
this study can contribute to progress in the field. Data collection and results will be
discussed in the following section.
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Section 3: Presentation of the Results and Findings
Introduction
The purpose of this study was to test the relationship between HPV vaccine initiation and
completion, socioeconomic and demographic variables, and physician recommendation.
In addition, I tested the relationship between HPV vaccine initiation and completion,
physician recommendation, and social vulnerability using the 2014 NIS-Teen and 2014
Social Vulnerability Index databases. I attempted to answer four research questions:
Research Question 1: Is there a relationship between HPV vaccination initiation
(1 dose) and socioeconomic status and demographic variables in selected local areas,
using data from the 2015 NIS-Teen?
H01: There is no relationship between HPV vaccination initiation and
socioeconomic and demographic variables in selected local areas.
Ha1: There is a relationship between HPV vaccination initiation and at least one
socioeconomic or demographic in selected local areas.
Research Question 2: Is there a relationship between HPV vaccination completion
(3 doses) and socioeconomic status and demographic variables in selected local areas
using data from the 2015 NIS-Teen?
H02: There is no relationship between HPV vaccination completion and
socioeconomic and demographic variables in selected local areas.
Ha2: There is a relationship between HPV vaccination completion and at least one
socioeconomic or demographic variable in selected local areas.
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Research Question 3: Is there a relationship between HPV vaccination initiation
(1 dose) and social vulnerability by select local area county in the United States using
data from the 2014 NIS-Teen and 2014 Social Vulnerability Index?
H03: There is no relationship between HPV vaccination initiation and social
vulnerability by select local area county in the United States.
Ha3: There is a relationship between HPV vaccination initiation and social
vulnerability by select local area county in the United States.
Research Question 4: Is there a relationship between physician recommendation
(yes/no) and social vulnerability by select local area county in the United States using
data from the 2014 NIS-Teen and 2014 Social Vulnerability Index?
H04: There is no relationship between physician recommendation and social
vulnerability by select local area county in the United States.
Ha4: There is a relationship between physician recommendation and social
vulnerability by select local area county in the United States.
The remainder of this chapter will describe the data collection for the study,
followed by the results of the retrospective, quantitative analysis of the secondary dataset.
Data Collection of Secondary Data Set
As noted above in Sampling and Sampling Procedures, 2015 recruitment resulted
in completed household interviews for 44,773 teens, of which 22,214 had adequate
provider data, while in 2014 there were a total of 38,703 teens, 21,057 with adequate
provider data (CDC et al., 2015; 2016). For the 2015 NIS-Teen, data were collected
between January 26, 2014 and February 15, 2015 for the household interviews and from
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March 2015 through April 2016 for the provider surveys (CDC et al., 2016). For the 2014
NIS-Teen, data were collected between January 9, 2014 and February 8, 2015 for the
household interviews and between from February 2014 through April 2015. For the 2014
SVI, data were collected using the Census Bureau’s 2010-2014 American Community
Survey (CDC & ATSDR, 2017).
For the 2015 NIS-Teen data, this study was limited to 11,855 adolescents in the
full U.S. sample and 1,564 adolescents in selected local areas, while the 2014 dataset was
limited to 11,488 adolescents in the U.S. sample and 1,235 adolescents in selected local
areas (see Figure 2). Adolescents in the sample met the following criteria: adequate
provider data; between 0 and 3 HPV shots received; fewer than 8 visits to a physician in
the past 12 months; of Non-Hispanic White, Hispanic, or Non-Hispanic Black race and
ethnicity; and living in one of the eight select local areas (for the select local area sample
only). Finally, respondents answering don’t know or refused or marked as missing data
were excluded from the analysis. No variables contained more than 10% missing data,
with the exception of whether an adolescent had a well-child visit at ages 11 or 12 years
(13.6% [2015] and 15.0% [2014] of the full U.S. sample). Assessments using listwise
deletion and imputation showed the differences in the population were not significant,
t(83379) = 0.03, p > .05 for 2015 and t(71715) = 0.05, p > .05 for 2014.
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Figure 2. Criteria used to determine the final full U.S. sample and Select Local Area
sample from the 2015 NIS-Teen. The same criteria were used for the 2014 dataset.
In addition, Little’s MCAR test showed that the 2015 well-check data were missing
completely at random, χ2(1) = 0.53, p > .05 for select local area and χ2(1) = 2.78, p > .05
for age of teen. The missing data were missing completely at random in 2014 as well,
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according to Little’s MCAR test, χ2(1) = 0.35, p > .05 for select local area and χ2(1) =
0.03, p > .05 for age of the teen.
Survey design allows respondents to recall the teen receiving up to 9 HPV shots,
despite the series having only three shots at the time of the interviews; as such, those
answering 4 or more shots (n = 78) were excluded from the sample. In addition, a number
of researchers have reported that physicians typically do not offer vaccines during acute
illness visits or if the adolescent has a chronic illness or is immunocompromised (Malo et
al., 2016b; Richards, Peters, & Sheeder, 2016; Vadaparampil et al., 2011). Therefore,
respondents answering that the teen had seen a health care professional more frequently
than every two months (n = 866, or 5.6% of the sample, having 8 or more visits per year)
were excluded from the sample.
Tests indicated a low level of multicollinearity, as assessed by the tolerance and
VIF collinearity statistics in a linear regression analysis. All independent variables had a
tolerance greater than .10 and a VIF between 1 and 10, suggesting the independent
variables were not correlated and the effects of each on the dependent variable were
similar regardless of other independent variables in the model (see Tables B1-2 in
Appendix B).
Data Analysis Plan Revisions
The SPSS program did not account for the weighted sample’s total population, so
when weighting cases using the provider-phase weight variable (PROVWT_D) the
standard error assumed √ using the sum of the weight variable rather than the sum of
the sample population and predictors were all highly significant (IBM Support, 2016). To

110
account for this, I used two methodologies, the Complex Samples option in SPSS and a
scaled weight approach, and compared the two regarding agreement on rejection or
acceptance of the null hypothesis on each research question. In the Complex Samples
approach, I created a sample plan using the sum of the provider-phase weight variable,
stratified by the STRATUM variable, and included a Bonferroni correction for multiple
comparisons (Glantz, 2005; IBM Support, n.d.). In the scaled weight approach, I applied
a factor ([∑PROVWT_D/N) to the provider-phase weight variable to create a scaled √
for the standard error (IBM Support, 2016).
As the dependent variables were dichotomous, I had more than three variables,
and the independent variables were measured at nominal and continuous levels, binomial
logistic regression was more appropriate than a chi-square test to analyze the dataset
(Laerd Statistics, 2015). Given this determination, running chi-square analyses to identify
variables to include in the binomial logistic regression model was not necessary. Last,
independent variables must be either continuous or nominal when using binomial logistic
regression analyses, so I recoded the ordinal variables from Table 9 and included them as
categorical variables (Laerd Statistics, 2015).
Finally, with the SVI rankings recoded as categorical variables, and with the SVI
ranking and select local area county variables containing more than two categories, the
chi-square test for independence was more appropriate than a binomial logistic regression
(Laerd Statistics, 2016).
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Baseline Sample Characteristics
The 2015 NIS-Teen unweighted dataset included 11,855 teens in the full U.S.
sample and 1,564 teens in the select local area sample. Table 10 summarizes the
descriptive and sociodemographic characteristics of the sample.
Table 10
Characteristics of adolescents aged 13-17 years with adequate provider data: 2015 NISTeen

Gender
Male
Female
Adolescent’s age (years)
13
14
15
16
17
Race/ethnicity
Non-Hispanic White
Hispanic
Non-Hispanic Black
Poverty status
Above $75K
Poverty to $75K
Below
Mother’s education
Less than high school
High school graduate
Some college
College graduate
Physician recommendation of HPV
vaccine
Yes
No
HPV vaccination status
No shots

United States

Local Area

50.9
49.1

50.1
49.9

12.6
20.6
23.6
22.6
20.7

12.2
22.2
22.3
21.8
21.5

63.0
22.3
14.7

24.3**
48.6**
27.2**

44.9
34.5
20.6

30.9**
36.0
33.1**

10.0
21.4
26.0
42.7

17.6**
22.5
23.4*
36.4**

71.9
28.1

74.7*
25.3*

43.5

37.8**
(table continues)
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Initiation (1 shot)
Completion (3 shots)
Well-child checkup
Yes
No
Type of health insurancea
Employee-based
Public (government)
Ever uninsured, since age 11
Yes
No
Mother’s marital status
Married
Not married
Mother’s age (years)
≤ 34
35-44
≥ 45
Number of children under 18 years
in house
One
Two to three
Four or more
Number of visits to HCP in past 12
months
None
One
Two to three
Four to five
Five to six
Relationship to teen
Mother / female guardian
Father / male guardian
Grandparent
Other

United States

Local Area

23.6
32.9

30.1**
32.0

95.8
4.2

96.6
3.4

62.8
37.2

48.2**
51.8**

7.6
92.4

9.7**
90.3**

64.2
35.8

50.7**
49.3**

7.9
43.1
49.0

9.2
48.2**
42.6**

32.4
55.6
12.0

32.3
53.6
14.1*

11.0
32.4
39.1
12.8
4.7

9.6
32.6
41.8*
13.3
2.6**

72.6
21.5
3.8
2.1

77.2**
16.2**
4.2
2.4

Note. In the Complex Samples columns, all percentages were weighted with the
PROVWT_D sampling weight using a weighted sum population size of 10,773,199 (U.S.
sample) and 550,303 (local area sample) and stratified by the STRATUM variable. In the
Scaled Sample columns, all percentages were weighted with the scaled factor weight
[(Sum[PROVWT_D])/unweighted sample size]. Frequencies were identical between the
Complex and Scaled populations. a Of the teens who were insured.
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* p < .05
** p < .01
Overall the 2015 sample was split between males and females, with the majority
of teens in the U.S. sample ages 14 years or older (87.5%), Non-Hispanic White (63.0%),
lived above the poverty line (79.4%), had a college-educated mother (42.7%), had
received a physician recommendation for the HPV vaccine (71.9%), had initiated or
completed the HPV vaccine series (67.1%), had a well-child checkup at age 11 or 12
years (95.8%), and had employee-based insurance (62.8% of the teens who were
insured). Regarding the control variables, the majority of teens had a married mother
(64.2%), a mother aged 35 years or older (92.1%), two to three children under 18 in the
household (55.6%), between one and three visits to a health care professional in the past
12 months (71.5%), and the mother completed the survey (72.6%). When compared to
the select local area subset, the U.S. sample proportions were significantly different for
most variables as assessed by the chi-square test, with the exception of gender, age, and
well-checkup at ages 11 or 12. Given the differences between the two populations, I
analyzed the select local area sample first, followed by the U.S. sample, as I would not be
able to generalize the results of the select local area sample to the U.S. sample.
The 2014 NIS-Teen unweighted dataset included 11,488 teens in the full U.S.
sample and 1,235 teens in the select local area sample. Table 11 summarizes the
descriptive and sociodemographic characteristics of the sample.
Table 11
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Characteristics of adolescents aged 13-17 years with adequate provider data: 2014 NISTeen

Gender
Male
Female
Adolescent’s age (years)
13
14
15
16
17
Race/ethnicity
Non-Hispanic White
Hispanic
Non-Hispanic Black
Poverty status
Above $75K
Poverty to $75K
Below
Mother’s education
Less than high school
High school graduate
Some college
College graduate
Physician recommendation of HPV
vaccine
Yes
No
HPV vaccination status
No shots
Initiation (1 shot)
Completion (3 shots)
Well-child checkup
Yes
No
Type of health insurancea
Employee-based
Public (government)
Ever uninsured, since age 11
Yes

United States

Local Area

51.4
48.6

48.7
51.3

12.3
21.0
21.1
23.0
22.5

15.6**
21.3
16.4**
23.7
23.0

64.5
20.5
15.0

20.6**
47.0**
32.4**

44.2
36.6
19.2

27.8**
35.4
36.7**

9.6
20.7
27.3
42.3

19.4**
24.1**
24.7
31.8**

68.0
32.0

72.7**
27.3**

46.6
23.6
29.8

39.5**
30.2**
30.3

94.8
5.2

94.8
5.2

64.3
35.7

47.2**
52.8**

8.5

7.5
(table continues)
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No
Mother’s marital status
Married
Not married
Mother’s age (years)
≤ 34
35-44
≥ 45
Number of children under 18 years
in house
One
Two to three
Four or more
Number of visits to HCP in past 12
months
None
One
Two to three
Four to five
Five to six
Relationship to teen
Mother / female guardian
Father / male guardian
Grandparent
Other

United States

Local Area

91.5

92.5

68.7
31.3

51.9**
48.1**

7.6
41.9
50.5

9.8**
43.1
47.1*

33.2
55.7
11.1

33.1
52.5*
14.4**

13.7
30.4
39.4
12.8
3.7

6.3**
30.9
47.5**
11.5
3.9

74.4
20.5
3.4
1.7

78.1**
14.8**
3.6
3.4**

Note. In the Complex Samples columns, all percentages were weighted with the
PROVWT_D sampling weight using a weighted sum population size of 10,799,442 (U.S.
sample) and 478,148 (local area sample) and stratified by the STRATUM variable. In the
Scaled Sample columns, all percentages were weighted with the scaled factor weight
[(Sum[PROVWT_D])/unweighted sample size]. Frequencies were identical between the
Complex and Scaled populations. a Of the teens who were insured.
* p < .05
** p < .01
Overall the 2014 sample was split between males and females; the majority of
teens in the U.S. sample were ages 14 years or older (87.6%), Non-Hispanic White
(64.5%), lived above the poverty line (80.8%), had a college-educated mother (42.3%),
had received a physician recommendation for the HPV vaccine (68.0%), had initiated or
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completed the HPV vaccine series (53.4%), had a well-child checkup at age 11 or 12
years (94.8%), and had employee-based insurance (64.3% of teens who were insured).
Regarding the control variables, the majority of teens had a married mother (68.7%), a
mother aged 35 years or older (92.4%), two to three children under 18 in the household
(55.7%), between one and three visits to a health care professional in the past 12 months
(69.8%), and the mother completed the survey (74.4%). When compared to the select
local area subset, the U.S. sample proportions were significantly different as assessed by
the chi-square test, with the exception of gender, well-child checkup at ages 11 or 12, and
ever being uninsured. As with the 2015 population, given the differences between the two
populations, I analyzed both the select local area and U.S. samples, focusing specifically
on select local area for my research questions.
Results
Research Question One
In RQ1, I used binomial logistic regression to examine whether there is a
relationship between initiation of the HPV vaccine series and socioeconomic and
demographic variables in the 2015 select local area dataset, controlling for known
confounders (Table 12). Model 1 included gender, race and ethnicity, poverty status,
mother’s education level, and select local areas of interest; Model 2 added clinical
parameters: well-check visits, number of visits in the past 12 months, type of health
insurance, and if the teen was ever uninsured since age 11. Model 3 added control
factors: age of teen, relationship of respondent to teen, number of children in house under
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18, mother’s marital status, and age of the teen’s mother. Variables meeting statistical
significance (p < .05) were carried into the next iteration.
Table 12
Relationships between HPV vaccine initiation and socioeconomic and demographic
variables, Select Local Area, 2015

Gender
Male
Female
Race/ethnicity
Hispanic
Black
White
Poverty
Below
Poverty to $75K
Above $75K
Mother’s
education
< 12 years
High school
Some college
College
Select local area
New York
Washington,
D.C.
Philadelphia
Hidalgo County
El Paso County
Houston
Bexar County
Chicago

Model 1
OR [95% CI]

Model 2
OR [95% CI]

Model 3
OR [95% CI]

1.18 [.94-1.47]
-

-

-

1.10 [.80-1.52]
.95 [.67-1.35]
-

-

-

1.35 [.95-1.92]
1.49 [1.10-2.03]**
-

1.34 [.90-1.98]
1.41 [1.02-1.97]

-

1.74 [1.20-2.53]**
1.06 [.76-1.49]
1.31 [.95-1.80]
-

1.74 [1.19-2.53]**
1.06 [.76-1.49]
1.30 [.95-1.79]

1.87 [1.34-2.62]***
1.16 [.84-1.60]
1.41 [1.04-1.93]*

1.08 [.78-1.49]

1.14 [.83-1.58]

1.15 [.84-1.60]

1.00 [.47-2.10]

.99 [.47-2.09]

1.00 [.47-2.11]

.95 [.59-1.53]
.45 [.26-.80]**
.59 [.34-1.03]
.43 [.27-.69]***
.75 [.49-1.15]
-

.95 [.59-.1.53]
.49 [.28-.84]**
.68 [.40-1.16]
.43 [.27-.68]***
.85 [.56-1.29]

.98[.60-1.59]
.51 [.29-.89]*
.66 [.39-1.12]
.42 [.26-.68]***
.85 [.56-1.29]

Note. CI, Confidence Interval. OR, odds ratio. Model 3 was the best fit as determined by
-2 Log likelihood at α = .05, χ2(4) < 21.92. Fit was calculated by comparing the chisquare distribution value given degrees of freedom (the difference in parameters between
the two models) with the difference of -2LL between the two models. If the chi-square
value was larger, H0 was accepted and the smaller model was the better fit (IBM
Knowledge Center, n.d.).
* p < .05
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** p < .01
*** p < .001
Model 1 was statistically significant, χ2(15) = 55.53, p < .001. The model
explained 4.9% (Nagelkerke R2) of the variance in vaccine initiation and correctly
classified 70.4% of cases. Of the five predictors, education (p < .05), poverty (p < .05),
and select local area (p < .001) were significantly associated with initiation of the HPV
vaccine series (Table 12). Teens with mothers having less than 12 years of education
were 74% were more likely to initiate the series than teens with college-educated mothers
(OR = 1.74, CI [1.20-2.53], p < .01). Teens living just above the poverty line were 49%
more likely to initiate the HPV vaccine series compared to those living at the highest
income level (OR = 1.49, CI [1.10-2.03], p < .01). Finally, teens living in Hidalgo County
and Houston were 55% and 57% less likely, respectively, to initiate the series than teens
living in Chicago (OR = .45, CI [.26-.80], p < .01 and OR = .43, CI [.27-.69], p < .001).
Model 2 was statistically significant, χ2(19) = 63.37, p < .001. The model
explained 5.6% (Nagelkerke R2) of the variance in vaccine initiation and correctly
classified 69.3% of cases. Of the predictors, education, select local area (p < .001), and
ever being uninsured (p < .05), were statistically significant. Teens with mothers having
less than 12 years of education were 74% more likely to initiate the series than teens with
college-educated mothers (OR = 1.74, CI [1.19-2.53], p < .01). Teens living in Hidalgo
County and Houston were 51% and 57% less likely, respectively, to initiate the series
than teens living in Chicago (OR = .49, CI [.28-.84], p < .01 and OR = .43, CI [.27-.68], p
< .001). Of the clinical variables added to the model, teens who had not been covered by
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insurance at least once since age 11 were 52% more likely to initiate the vaccine than
teens who had been covered since age 11 (OR = 1.52, CI [1.02-2.27], p < .05).
Model 3 was statistically significant, χ2(23) = 85.29, p < .001. The model
explained 7.5% (Nagelkerke R2) of the variance in vaccine initiation and correctly
classified 69.5% of cases. Of the predictors, education (p < .01), select local area (p <
.001), and respondent’s relationship to the teen (p < .05) were statistically significant.
Teens with mothers having less than 12 years of education or some college were 87% and
41% more likely, respectively, to initiate the series than teens with college-educated
mothers (OR = 1.87, CI [1.34-2.62], p < .001 and OR = 1.41, CI [1.04-1.93], p < .05).
Teens living in Hidalgo County and Houston were 49% and 58% less likely, respectively,
to initiate the series than teens living in Chicago (OR = .51, CI [.29-.89], p < .01 and OR
= .42, CI [.26-.68], p < .001). Of the remaining variables added to the model, teens whose
friends or other family members and grandparents answered the survey were 108% and
74% more likely, respectively, to have initiated the HPV vaccine (OR = 2.08, CI [1.054.13], p < .05, and OR = 1.74, CI [1.02-2.97], p < .05).
Overall, for RQ1 I rejected the null hypothesis, showing instead that there was a
relationship between initiation of the HPV vaccine series and at least one socioeconomic
or demographic variable in select local areas in unadjusted and adjusted models. Across
all three models, teens whose mothers had less than a college degree were more likely to
initiate the HPV vaccine, while teens living in Houston and Hidalgo County were less
likely to initiate the HPV vaccine. The null hypothesis was rejected using the Complex
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Samples methodology as well, based on significant relationships between initiation and
select local area (Table A1 in Appendix A).
Research Question Two
In RQ2, I examined whether there is a relationship between completion of the
HPV vaccine series and socioeconomic and demographic variables in the 2015 select
local area dataset, controlling for known confounders (Table 13). As with RQ1, Model 1
included gender, race and ethnicity, poverty status, mother’s education level, and select
local areas of interest; Model 2 added clinical parameters: well-check visits, number of
visits in the past 12 months, type of health insurance, and if the teen was ever uninsured
since age 11. Model 3 added control factors: age of teen, relationship of respondent to
teen, number of children in house under 18, mother’s marital status, and age of the teen’s
mother.
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Table 13
Relationships between HPV vaccine completion and socioeconomic and demographic
variables, Select Local Area, 2015

Gender
Male
Female
Race/ethnicity
Hispanic
Black
White
Poverty
Below
Poverty to $75K
Above $75K
Mother’s education
< 12 years
High school
Some college
College
Select local area
New York
Washington, D.C.
Philadelphia
Hidalgo County
El Paso County
Houston
Bexar County
Chicago

Model 1
OR [95% CI]

Model 2
OR [95% CI]

Model 3
OR [95% CI]

.65 [.52-.81]***
-

.67 [.54-.84]***

.64 [.51-.80]***

1.28 [.93-1.74]
1.12 [.79-1.57]
-

-

-

1.15 [.82-1.63]
1.07 [.80-1.44]
-

-

-

.55 [.38-.81]**
.82 [.60-1.13]
.57 [.41-.78]***
-

.64 [.45-.92]*
.90 [.66-1.21]
.60 [.44-.81]***

.71 [.51-.1.00]
1.11 [.82-1.50]
.69 [.51-.95]*

.95 [.68-1.32]
1.41 [.68-2.90]
2.00 [1.25-3.19]**
1.18 [.70-1.99]
1.24 [.74-2.09]
1.46 [.96-2.21]
1.09 [.71-1.67]
-

.95 [.68-1.34]
1.37 [.67-2.83]
1.98 [1.25-3.16]**
1.29 [.78-2.15]
1.34 [.81-2.21]
1.46 [.97-2.22]
1.13 [.75-1.71]

.93 [.66-1.31]
1.35 [.65-2.82]
2. 03 [1.26-3.26**
1.33 [.79-2.22]
1.41 [.84-2.35]
1.64 [1.07-2.51]*
1.09 [.72-1.66]

Note. CI, Confidence Interval. OR, odds ratio.
* p < .05
** p < .01
*** p < .001
Model 1 was statistically significant, χ2(15) = 48.65, p < .001. The model
explained 4.3% (Nagelkerke R2) of the variance in vaccine initiation and correctly
classified 68.2% of cases. Of the five predictors, gender, education (p < .001), and select
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local area (p < .05) were statistically associated with completion of the HPV vaccine
series (Table 13). Males were 35% less likely than females to complete the series (OR =
.65, CI [.52-.81], p < .001). Teens with mothers having less than 12 years of education or
some college were 45% and 43% less likely, respectively, to complete the series than
teens with college-educated mothers (OR = .55, CI [.38-.81], p < .01, and OR = .57, CI
[41-.78], p < .001). Last, teens living in Philadelphia were 100% more likely to complete
the series than teens living in Chicago (OR = 2.00, CI [1.25-3.19], p < .01).
Model 2 was statistically significant, χ2(18) = 53.12, p < .001. The model
explained 4.7% (Nagelkerke R2) of the variance in vaccine initiation and correctly
classified 67.8% of cases. Of the predictors, gender (p < .010), education (p < .01), and
select local area (p < .05) were statistically associated with completion of the HPV
vaccine series. Males were 33% less likely than females to complete the series (OR = .67,
CI [.54-.84], p < .001). Teens with mothers having less than 12 years of education or
some college were 36% and 40% less likely, respectively, to complete the series than
teens with college-educated mothers (OR = .64, CI [.45-.92], p < .05, and OR = .60, CI
[.44-.81], p < .001). Last, teens living in Philadelphia were 98% more likely to complete
the series than teens living in Chicago (OR = 1.98, CI [1.25-3.16], p < .01). None of the
clinical variables added to the model were significantly associated with completing the
HPV vaccine series.
Model 3 was statistically significant, χ2(23) = 111.56, p < .001. The model
explained 9.6% (Nagelkerke R2) of the variance in vaccine initiation and correctly
classified 69.5% of cases. Of the predictors, education (p < .05), select local area (p <
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.01), relationship of the respondent to the teen, age of the teen, and gender (p < .001)
were significantly associated with completing the HPV vaccine series. Males were 36%
less likely than females to complete the series (OR = .64, CI [.51-.80], p < .001). Teens
with mothers having some college were 31% less likely to complete the series than teens
with college-educated mothers (OR = .69, CI [.51-.95], p < .05). Teens living in
Philadelphia and Houston were 103% and 64% more likely, respectively, to complete the
series than teens living in Chicago (OR = 2.03, CI [1.26-3.26], p < .01, and OR = 1.64, CI
[1.07-2.51], p < .05). Teens were less likely to complete the series if other family
members or friends (70% less likely), grandparents (67%), or fathers (39%) answered the
survey rather than mothers (all p < .01). Last, teens were 41% less likely to complete the
series if they were 14 years old (p < .01) but 63% more likely to complete the series if
they were 15 years old (p < .01) compared to teens aged 17 years old.
Overall, for RQ2 I rejected the null hypothesis, showing instead that there was a
relationship between completion of the HPV vaccine series and at least one
socioeconomic or demographic variable in select local areas in unadjusted and adjusted
models. Across all three models, males and teens whose mothers had less than a college
education were less likely to complete the HPV vaccine series, while teens living in
Philadelphia and Houston were more likely to complete the series. The null hypothesis
was rejected using the Complex Samples methodology as well, based on significant
relationships between completion and gender (Table A2 in Appendix A).
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Research Question Three
In RQ3, I examined whether there is a relationship between initiation of the HPV
vaccine series and social vulnerability by select local area county, using a chi-square test
of independence and data from the 2014 NIS-Teen and the 2014 Social Vulnerability
Index (Table 14). All expected cell frequencies were greater than five.
Table 14
Relationship between HPV vaccine initiation and overall county social vulnerability
ranking, 2014
Social Vulnerability
percentile ranking
Washington, D.C.
Count
Expected Count
Adjusted Residuals
Philadelphia
Count
Expected Count
Adjusted Residuals
El Paso County
Count
Expected Count
Adjusted Residuals
Bexar County
Count
Expected Count
Adjusted Residuals

HPV Vaccine Initiation
Yes

No

20
19.7
0.1

54
54.3
-0.1

73
58.9
2.6

148
162.1
-2.6

47
49.6
-.05

139
136.4
0.5

63
74.9
-2.0

218
206.1
2.0

.59 (Med-High)

.91 (High)

.95 (High)

.82 (High)

Note. Med-High indicates a medium-high vulnerability, or being in the third-highest
percentile of vulnerability.
There was not a statistically significant association found between the two
variables, χ2(3) = 7.37, p = .06. The adjusted standardized residuals were greater than or
equal to 2 in Philadelphia and Bexar County, with the largest difference between
observed and expected counts in Philadelphia.
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For RQ3 I could not reject the null hypothesis, as the relationship between HPV
vaccine initiation and social vulnerability ranking did not meet statistical significance.
The null hypothesis was not rejected using the Complex Samples methodology as well, as
there was no significant relationship between the variables (Table A3 in Appendix A).
Research Question Four
In RQ4, I examined whether there is a relationship between physician
recommendation of the HPV vaccine series and social vulnerability by select local area
county, using a chi-square test of independence and data from the 2014 NIS-Teen and the
2014 Social Vulnerability Index (Table 15).
Table 15
Relationship between physician recommendation and overall county social vulnerability
ranking, 2014
Social Vulnerability
percentile ranking
Washington, D.C.
Count
Expected Count
Adjusted Residuals
Philadelphia
Count
Expected Count
Adjusted Residuals
El Paso County
Count
Expected Count
Adjusted Residuals
Bexar County
Count
Expected Count
Adjusted Residuals

Physician Recommendation
Yes

No

60
51
2.4

14
23
-2.4

168
152.2
2.7

53
68.8
-2.7

128
127.4
.1

57
57.6
-.1

168
193.5
-4.1

113
87.5
4.1*

.59 (Med-High)

.91 (High)

.95 (High)

.82 (High)

Note. Med-High indicates a medium-high vulnerability, or being in the third-highest
percentile of vulnerability.
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* p < .05
There was a statistically significant association between the two variables, χ2(3) =
21.23, p < .001, and the association was small, Cramer’s V = 0.17, p < .001. The adjusted
standardized residuals were greater than 2 in Washington, D.C., Philadelphia, and Bexar
County, with the largest difference between observed and expected counts in Bexar
County.
For RQ4 I rejected the null hypothesis, as the relationship between physician
recommendation and social vulnerability ranking was statistically significant. The null
hypothesis was rejected using the Complex Samples methodology as well, as there was a
significant relationship between the two variables (Table A4 in Appendix A).
Although the following analyses were not included in the original research
questions, they provide additional context in the testing of relationships between HPV
vaccination, physician recommendation, and select independent variables.
U.S. Sample Analyses
Initiation. In the U.S. sample (Table 16), initiation of the HPV vaccine series
correlated with gender, race and ethnicity, poverty status, and select local area across all
three models.
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Table 16
Relationships between HPV vaccine initiation and socioeconomic and demographic
variables, United States, 2015

Gender
Male
Female
Race/ethnicity
Hispanic
Black
White
Poverty
Below
Poverty to $75K
Above $75K
Mother’s education
< 12 years
High school
Some college
College
Select local area
New York
Washington, D.C.
Philadelphia
Hidalgo County
El Paso County
Houston
Bexar County
Chicago

Model 1
OR [95% CI]

Model 2
OR [95% CI]

Model 3
OR [95% CI]

.80 [.74-.87]***
-

.80 [.73-.87]***

.80 [.74-.87]***

1.11 [.98-1.26]
1.13 [1.00-1.28]*
1.15 [1.02-1.31]*
1.28 [1.12-1.45]*** 1.25 [1.09-1.42]*** 1.27 [1.11-1.45]***
1.37 [1.19-1.58]*** 1.33 [1.16-1.53]*** 1.33 [1.16-1.51]***
.97 [.87-1.08]
.95 [.85-1.06]
.95 [.86-1.06]
1.13 [.95-1.34]
.97 [.85-1.10]
1.00 [.89-1.12]
-

-

-

1.09 [.66-1.81]
.89 [.27-2.90]
.90 [.42-1.92]
.53 [.22-1.26]
.69 [.30-1.60]
.45 [.21-.95]*
.81 [.42-1.58]
-

1.06 [.64-1.76]
.90 [.27-2.94]
.95 [.59-.1.53]
.52 [.22-1.25]
.68 [.29-1.58]
.43 [.20-.90]*
.84 [.43-1.62]

1.06 [.64-1.76]
.88 [.27-2.90]
.89 [.42-.1.91]
.51 [.21-1.22]
.68 [.29-1.58]
.41 [.20-.88]*
.82 [.42-1.59]

Note. CI, Confidence Interval. OR, odds ratio.
* p < .05
** p < .01
*** p < .001
Model 1 was statistically significant, χ2(65) = 192.49, p < .001. The model
explained 2.4% (Nagelkerke R2) of the variance in vaccine initiation and correctly
classified 76.4% of cases. Of the five predictors, gender, race, poverty (p < .001), and
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select local area (p < .01) were significantly associated with initiation of the HPV vaccine
series (Table 16). This differed from the select local area sample, in which mother’s
education level was significant and gender was not (Table 12). Teens were less likely to
initiate the HPV vaccine series if they were male (20% less) or lived in Houston (55%),
compared to females or teens who lived in Chicago. Teens were more likely to initiate the
series if they were Black (28% more) or lived below the poverty level (37%) than teens
who were White or lived at the highest income level.
Model 2 was statistically significant, χ2(69) = 235.77, p < .001. The model
explained 3.0% (Nagelkerke R2) of the variance in vaccine initiation and correctly
classified 76.4% of cases. Of the predictors, gender, poverty, number of visits to a health
care professional in the past year, (p < .001), race, and select local area (p < .01) were
significantly associated with initiation of the HPV vaccine series (Table 16). This
differed from the select local area sample, in which only mother’s education level, ever
being uninsured, and select local area were significant (Table 12). Teens were less likely
to initiate the HPV vaccine series if they were male (20% less) or lived in Houston (57%
less), compared to females or teens who lived in Chicago. Teens were more likely to
initiate the series if they were Hispanic (13% more), Black (25%) or lived below the
poverty level (33%) compared to teens who were White or lived at the highest income
level. Last, teens who had between one and five visits with a health care professional in
the past 12 months were 43% to 58% more likely to initiate the vaccine than teens who
had no visits.
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Model 3 was statistically significant, χ2(76) = 306.40, p < .001. The model
explained 3.8% (Nagelkerke R2) of the variance in vaccine initiation and correctly
classified 76.5% of cases. Of the predictors, gender, poverty, race, select local area,
number of visits to a health care professional in the past year, relationship of the
respondent to the teen, number of children in the household under age 18 years, age of
the teen, (p < .001), and mother’s marital status (p < .05) were significantly associated
with initiation of the HPV vaccine series (Table 16). This differed from the select local
area sample, in which only mother’s education level and select local area were significant
(Table 12). Teens were less likely to initiate the HPV vaccine series if they were male
(20% less) or lived in Houston (59%), compared to females or teens who lived in
Chicago. Teens were more likely to initiate the series if they were Hispanic (15% more),
Black (27%) or lived below the poverty level (33%) compared to teens who were White
or lived at the highest income level.
Completion. In the U.S. sample (Table 17), completion of the HPV vaccine series
was associated with gender, mother’s education, and select local area across all three
models.
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Table 17
Relationships between HPV vaccine completion and socioeconomic and demographic
variables, United States, 2015

Gender
Male
Female
Race/ethnicity
Hispanic
Black
White
Poverty
Below
Poverty to $75K
Above $75K
Mother’s education
< 12 years
High school
Some college
College
Select local area
New York
Washington, D.C.
Philadelphia
Hidalgo County
El Paso County
Houston
Bexar County
Chicago

Model 1
OR [95% CI]

Model 2
OR [95% CI]

Model 3
OR [95% CI]

.52 [.48-.56]***
-

.52 [.48-.56]***

.52 [.48-.56]***

1.13 [1.00-1.26]*
.93 [.82-1.05]
-

1.12 [1.00-1.26]*
.94 [.83-1.07]

1.10 [.98-1.24]
.91 [.80-1.04]

.98 [.83-1.15]
.81 [.72-.92]***
.86 [.77-.95]**
-

.97 [.83-1.14]
.79 [.71-.89]***
.85 [.76-.94]***

1.01 [.87-1.18]
.85 [.76-.96]**
.86 [.77-.95]**

.98 [.58-1.68]
1.50 [.47-4.77]
2.20 [1.05-4.63]*
1.13 [.50-2.54]
1.28 [.57-2.87]
1.46 [.75-2.86]
1.12 [.58-2.18]
-

1.03 [.60-1.76]
1.54 [.48-4.95]
2.24 [1.06-4.72]*
1.11 [.49-2.52]
1.33 [.59-2.99]
1.46 [.75-2.86]
1.21 [.62-2.35]

1.04 [.61-1.79]
1.60 [.49-5.19]
2.30 [1.08-4.90]*
1.17 [.51-2.67]
1.38 [.61-3.13]
1.52 [.77-3.00]
1.24 [.63-2.42]

.94 [.82-1.07]
.90 [.82-1.00]
-

Note. CI, Confidence Interval. OR, odds ratio.
* p < .05
** p < .01
*** p < .001
Model 1 was statistically significant, χ2(65) = 482.08, p < .001. The model
explained 5.5% (Nagelkerke R2) of the variance in vaccine completion and correctly
classified 66.8% of cases. Of the predictors, gender, mother’s education level, select local
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area (p < .001), and race (p < .05) were significantly associated with completion of the
HPV vaccine series (Table 17). This differed from the select local area sample, in which
only gender, mother’s education level, and select local area were significant (Table 13).
Teens were less likely to complete the HPV vaccine series if they were male (48% less),
if their mothers were high school graduates (19%) or had some college education (14%)
compared to females or teens whose mothers had less than 12 years of education or a
college degree. Teens were more likely to complete the vaccine series if they were
Hispanic (13% more) or lived in Philadelphia (120%) compared to teens who were White
or lived in Chicago.
Model 2 was statistically significant, χ2(70) = 576.64, p < .001. The model
explained 6.6% (Nagelkerke R2) of the variance in vaccine completion and correctly
classified 67.7% of cases. Of the predictors, gender, mother’s education level, select local
area, a well-check visit at age 11 or 12, number of visits to a health care professional in
the past 12 months (p < .001), and race (p < .05) were significantly associated with
completion of the HPV vaccine series (Table 17). This differed from the select local area
sample, in which only gender, mother’s education level, and select local area were
significant (Table 13). Teens were less likely to complete the HPV vaccine series if they
were male (48% less), if their mothers were high school graduates (21%) or had some
college education (15%) compared to females or teens whose mothers had less than 12
years of education or a college degree. Teens were more likely to complete the vaccine
series if they were Hispanic (12% more) or lived in Philadelphia (124%) compared to
teens who were White or lived in Chicago.
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Model 3 was statistically significant, χ2(80) = 847.79, p < .001. The model
explained 9.6% (Nagelkerke R2) of the variance in vaccine completion and correctly
classified 69.4% of cases. Of the predictors, gender, select local area, a well-check visit at
age 11 or 12, number of visits to a health care professional in the past 12 months, number
of children in the household under 18 years, age of the teen, (p < .001) mother’s
education level (p < .01), and mother’s age (p < .05) were significantly associated with
completion of the HPV vaccine series (Table 17). This differed from the select local area
sample, in which only gender, mother’s education level, and select local area were
significant (Table 13). Teens were less likely to complete the HPV vaccine series if they
were male (48% less), if their mothers were high school graduates (15%) or had some
college education (14%) compared to females or teens whose mothers had less than 12
years of education or a college degree. Teens were more likely to complete the vaccine
series if they lived in Philadelphia (130% more) compared to teens who lived in Chicago.
Finally, the relationship between HPV initiation and completion was significant
across the United States (Table D1 in Appendix D). Teens were less likely to initiate the
vaccine series if they lived in Arizona, Florida, Iowa, Louisiana, Missouri, New Mexico,
Ohio, Pennsylvania, Tennessee, and Texas than teens who lived in Chicago. Teens were
more likely to complete the series if they lived in Arizona, California, Iowa, Maine,
Massachusetts, New Hampshire, Oklahoma, Pennsylvania, and Rhode Island.
No Shots Analysis
Binominal logistic regression was used to test the relationship between receiving
no shots in the HPV vaccine series in the United States and select local areas (Table 18).
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Table 18
Relationships between no receipt of HPV vaccine and socioeconomic and demographic
variables, United States and Select Local Areas, 2015

Gender
Male
Female
Race/ethnicity
Hispanic
Black
White
Poverty
Below
Poverty to $75K
Above $75K
Mother’s education
< 12 years
High school
Some college
College
Select local area
New York
Washington, D.C.
Philadelphia
Hidalgo County
El Paso County
Houston
Bexar County
Chicago

U.S. sample
OR [95% CI]

Select Local Area sample
OR [95% CI]

2.14 [1.98-2.31]***
-

1.30 [1.05-1.60]*

.83 [74-.93]***
.88 [.78-.99]*
-

.73 [.54-.98]*
.94 [.68-1.30]

0.82 [.72-.93]**
1.13 [1.03-1.24]*
-

.69 [.49-.95]*
.67 [.51-.89]**

.91 [.77-1.06]
1.24 [1.11-1.38]***
1.15 [1.04-1.27]**
-

1.04 [.72-1.51]
1.15 [.84-1.58]
1.33 [.98-1.79]

.95 [.58-1.58]
.77 [.24-2.52]
.48 [.22-1.09]
1.57 [.72-3.41]
1.13 [.52-2.48]
1.35 [.70-2.58]
1.11 [.59-2.08]
-

.98 [.71-1.34]
.73 [.35-1.52]
.50 [.30-.83]**
1.69 [1.03-2.78]*
1.29 [.78-2.13]
1.37 [.92-2.06]
1.20 [.80-1.79]

Note. CI, Confidence Interval. OR, odds ratio.
* p < .05
** p < .01
*** p < .001
In the U.S. sample, teens were more likely to receive no shots if they were male
(114% more likely), living just above the poverty level (13%), or had mothers with a high
school (24%) or some college education (15%) compared to the reference groups. Teens
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were less likely to receive no shots if they were Hispanic (17% less likely), Black (12%),
or lived below the poverty level (18%).
In the select local area sample, teens were more likely to receive no shots if they
were male (30% more likely) compared to females or lived in Hidalgo County (69%)
versus Chicago; teens were less likely to receive no shots if they lived below (31% less
likely) or just above the poverty line (33%), were Hispanic (27%), or lived in
Philadelphia (50%) compared to the reference groups.
Select Local Area and Vulnerability Analyses
Using a chi-square test of independence, I tested the relationships between receipt
of no HPV shots, completion of the HPV series, and select local area county using data
from the 2014 NIS-Teen and the 2014 Social Vulnerability Index (Table 19).
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Table 10
Relationship between no shots, completion of the series, and overall county social
vulnerability ranking, 2014
SVI rank
Washington, D.C.
Count
Expected Count
Adjusted
Residuals
Philadelphia
Count
Expected Count
Adjusted
Residuals
El Paso County
Count
Expected Count
Adjusted
Residuals
Bexar County
Count
Expected Count
Adjusted
Residuals

Yes

No shots
No

Completion
Yes
No

23
29

51
45

31
25.5

43
48.5

-1.5

1.5

1.4

-1.4

62
86.5

159
134.5

86
76.1

135
144.9

-4.0

4.0*

1.7

-1.7

67
72.4

118
112.6

72
63.7

113
121.3

-.9

.9

1.5

-1.5

146
110

135
171

73
96.7

208
184.3

5.5

-5.5**

-3.8

3.8*

.59 (Med-High)

.91 (High)

.95 (High)

.82 (High)

Note. Med-High indicates a medium-high vulnerability, or being in the third-highest
percentile of vulnerability.
* p < .05
* p < .01
There was a statistically significant association between the counties and receipt
of no shots, χ2(3) = 33.46, p < .001, and the association was small to moderate, Cramer’s
V = 0.21, p < .01. The adjusted standardized residuals were greater than 2 in Bexar
County and Philadelphia. With completion of the series and the select counties, there was
a statistically significant association, χ2(3) = 14.34, p < .01, and the association was
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small, Cramer’s V = 0.14, p < .001. The adjusted standardized residuals were greater than
2 in Bexar County.
Select Local Areas Versus States Analysis
As select local area samples were removed from states as a whole in NIS-Teen, I
conducted a chi-square test of independence to test the association between no shots,
HPV vaccine initiation, vaccine completion, and physician recommendation between
select local areas and their states (Table 20).
Table 11
Significant Relationships between Select Local Areas and States, 2015

New York City vs.
New York
Philadelphia vs.
Pennsylvania

No shots
χ2(df)
(Cramer’s V)

Initiation
χ2(df)
(Cramer’s V)

Completion
χ2(df)
(Cramer’s V)

Recommendation
χ2(df)
(Cramer’s V)

χ2(1) = 2.13

χ2(1) = 12.32***

χ2(1) = 2.99

χ2(1) = .09

(.06)

(.13)***

(.07)

(.01)

χ2(1) = 5.35*

χ2(1) = 5.06*

χ2(1) = .28

χ2(1) = .96

(.11)*

(.11)*

(.03)

(.05)

Chicago vs.
Illinois

χ2(1) = 3.71

χ2(1) = 5.68*

χ2(1) = .01

χ2(1) = 1.73

(.08)

(.10)*

(.01)

(.06)

Hidalgo County vs.
Texas

χ (1) = 1.18

χ (1) = .06

χ (1) = 1.45

χ (1) = .30

(.04)

(.01)

(.04)

(.02)

χ2(1) = 2.96

χ2(1) = .38

χ2(1) = 2.45

χ2(1) = .78

El Paso County vs.
Texas

2

2

2

2

(-.06)

(.02)

(.05)

(.03)

Houston vs.
Texas

χ2(1) = 2.71

χ2(1) = .21

χ2(1) = 5.99*

χ2(1) = 4.66*

(.05)

(.02)

(.08)*

(.07)*

Bexar County vs.
Texas

χ (1) = 4.68*

χ (1) = 1.38

χ (1) = 2.21

χ (1) = 2.31

(.07)*

(.04)

(.04)

(.05)

2

Note. df, degrees of freedom.
* p < .05

2

2

2
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*** p < .001
There was a significant relationship between Philadelphia and Pennsylvania and
Bexar County and Texas in receiving no HPV shots, both with small effects as measured
by Cramer’s V. Fewer teens than expected received no shots in Philadelphia and Bexar
County. Regarding HPV vaccine initiation, there was a significant relationship between
New York City, Philadelphia, and Chicago and their respective states, all with small
effects. Fewer teens than expected initiated the HPV vaccine in New York state,
Pennsylvania, and Illinois. The only significant relationship for completion of the HPV
vaccine series was observed between Houston and Texas, in which fewer teens than
expected in Texas completed the series, with a small effect. Last, there was a significant
relationship between Houston and Texas regarding physician recommendation, in which
fewer teens than expected in Texas had a physician recommendation, with small effect.
Finally, physician recommendation differed significantly by state (Table D1 in
Appendix D). Teens who lived in Alabama, Arkansas, Mississippi, Missouri, Tennessee,
and Texas were less likely to receive a physician recommendation, while teens who lived
in Rhode Island were more likely to receive a physician recommendation.
Summary
In summary, I rejected the null hypothesis for research question 1, as there was a
significant relationship between HPV vaccine initiation, the mother’s level of education,
and select local area. Teens whose mothers had less than a college degree were more
likely to initiate the HPV vaccine, while teens living in Houston and Hidalgo County
were less likely to initiate the HPV vaccine.
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I rejected the null hypothesis for research question 2, as there was a significant
relationship between HPV vaccine completion, teen’s gender, the mother’s level of
education, and select local area. Teens living in Philadelphia and Houston were more
likely to complete the series, while males and teens whose mothers had less than a
college education were less likely to complete the HPV vaccine series.
I did not reject the null hypothesis for research question 3, as there was not a
significant relationship between HPV vaccine initiation and select local area county.
Finally, I rejected the null hypothesis for research question 4, as there was a significant
relationship between physician recommendation of the HPV vaccine and select local area
county.
I presented several additional analyses of the 2014 and 2015 NIS-Teen data,
including analyses of the U.S. sample; relationships between receipt of no HPV shots and
independent variables; relationships between receipt of no shots, completion of the series,
and select local area county; and relationships between select local area and respective
states with the dependent variables.
In the following chapter, I discuss the interpretation of the results and how these
results reflect findings in the peer-reviewed literature, as well as present
recommendations for professional practice and the implications for social change.
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Section 4: Application to Professional Practice and Implications for Social Change
Introduction
Rates of the HPV vaccine and physician recommendation for the vaccine continue
to be lower than any other adolescent vaccine, and vary across gender, socioeconomic
status, racial and ethnic background, and geographic location (Henry et al., 2017;
Mohammed et al., 2016; Reagan-Steiner et al., 2016; Rutten et al., 2017). Researchers
have focused on inter- and intra-personal efforts to promote behavior change regarding
vaccination, but these interventions have had little effect on increasing HPV vaccination
rates (Askelson et al., 2016; Brandt et al., 2016). Additional research on other potential
factors influencing vaccination is needed to increase rates, as well as physician
recommendation of the HPV vaccine, to better protect against multiple HPV-related
cancers (Maness et al., 2016; Perkins, 2016).
The purpose of this quantitative, retrospective, secondary analysis of national,
publicly available data was to test the relationships between HPV vaccine initiation and
completion, socioeconomic and demographic variables, physician recommendation, and
social vulnerability in select local areas in the United States. In these analyses, I showed
that teens were more likely to initiate the HPV vaccine series if their mothers had less
education than a college degree versus teens whose mothers had graduated college; teens
were less likely to initiate the series if they lived in Houston or Hidalgo County versus
teens living in Chicago. Teens were more likely to complete the HPV vaccine series if
they lived in Philadelphia or Houston versus teens living in Chicago; teens were less
likely to complete the series if they were males or their mothers had less than a college
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education versus those who had graduated college. Finally, I did not find a relationship
between initiation of the series and select local area, but did find a relationship between
physician recommendation of the vaccine and select local area.
Interpretation of the Findings
Socioeconomic Variables
The definition of socioeconomic status is complex and dynamic, and how it is
measured within a study affects the findings and interpretations (Joshua et al., 2015;
Ratnapradipa et al., 2017; Willis & Fitton, 2016). In peer-reviewed literature, most
researchers used metrics including poverty level and the mother’s level of education, and
have found an inverse relationship between HPV vaccination, poverty, and education
level in the United States (Galbraith et al., 2016; Henry et al., 2017; Jeudin et al., 2014;
Monnat et al., 2016; Perkins, 2016; Polonijo et al., 2016; Reagan-Steiner et al., 2016).
My findings reflected the literature regarding a significant relationship between
mother’s level of education and HPV vaccination, in which an inverse relationship has
been demonstrated between educational attainment, the teen’s vaccination, and physician
recommendation (Mohammed et al., 2016; Henry et al., 2017). Of note, teens whose
mothers had less than a high school education or some college were more likely to
initiate the HPV vaccine, but teens whose mothers had some college were less likely to
complete the series than teens whose mothers had a college education. The higher
likelihood of initiation may have reflected greater access to the HPV vaccine through the
Vaccines For Children program to initiate the series, while the lower likelihood of
completion may have been due to lower rates of physician recommendation within lower
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educational attainment levels, or less awareness of the importance of completing the
series (Mohammed et al., 2016; Henry et al., 2017).
My findings within the select local area sample regarding the relationship
between poverty and vaccination were not consistent with current literature, although my
findings using the U.S. sample did align with published findings that teens living below
the poverty level were more likely to be vaccinated than teens at the highest income
levels (see Additional Analyses section below). Poverty was not significantly associated
with HPV vaccine initiation or completion in the final models in research questions 1 and
2. The discrepancy between my findings regarding poverty and those in the literature may
have been due to the differences in sample selection, both geographically and in the
dataset.
Researchers have demonstrated variations in relationships using the same
socioeconomic data across different geographic levels, a phenomenon known as the
modifiable area unit problem (Krieger et al., 2005; Pruitt & Schootman, 2010; Rutten et
al., 2017). For example, Henry et al. (2017) found an inverse relationship between
poverty level and Zip code tabulation areas across the United States using 2012-2013
NIS-Teen data; Rutten et al. (2017) showed a positive relationship between
socioeconomic status and census block group with American Community Survey data;
and Pruitt and Schootman (2010) and Krieger et al. (2005) demonstrated that the
relationship between socioeconomic status and variables changed across state, county,
block group, census tract, and Zip code. While I could not discount the small sample size
in the select local areas as a potential influence on my findings, I believe the
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inconsistency between my findings at the select local area versus other published research
supported the importance of using multiple geographic areas of analysis and working
within each local community when assessing public health needs to distribute resources
where they are most needed.
Demographic Variables
In peer-reviewed literature, the majority of researchers have shown a relationship
between gender, race, age, and HPV vaccination, as well as physician recommendation,
across geographic levels (Bodson et al., 2016; Gilkey et al., 2016; Jeudin et al., 2014;
Mohammed et al., 2016; Malo et al., 2016b; Rahman et al., 2015; Reagan-Steiner et al.,
2016; Rutten et al., 2017; Vadaparampil et al., 2016). My findings regarding HPV
vaccine completion were consistent with the current literature, in that males were
significantly less likely to complete the vaccine series than females. These results were
consistently demonstrated across datasets, geographic levels, and over time, and were
likely due to the 5-year delay in approval and insurance coverage of the HPV vaccine for
males, as well as lower rates of physician recommendation for males versus females
(ACIP, 2016; Jeudin et al., 2014; Vadaparampil et al., 2016; Walker et al., 2017).
In addition, researchers have argued that knowledge and awareness of HPV’s role
in several male cancers was low, as was male awareness of the HPV vaccine (Boakye et
al., 2017; Osazuwa-Peters et al., 2017). I did not find a significant relationship between
gender and HPV vaccine initiation in the select local area sample, although I did find
males were less likely to be vaccinated in the U.S. sample as reported in the literature
(see Additional Analyses). This may have been due to the lower rates of physician
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recommendation for males, as once males began the series based on a recommendation,
they would have been more likely to complete it (see Limitations). However, this
hypothesis was not testable using the NIS-Teen database. In addition, while males living
below the poverty line were more likely to initiate the vaccine series, there was a higher
frequency of males in the above poverty categories in this study.
My findings regarding HPV vaccination and race were not consistent with the
current literature, as there was no relationship between the two variables, or with
physician recommendation. I did find a significant relationship between race and
ethnicity and HPV completion in the U.S. sample, however, with Hispanics and NonHispanic Blacks more likely to initiate the HPV vaccine series than Non-Hispanic Whites
(see Additional Analyses). This may have been due to the small number of select local
areas used for comparison, as well as the significant difference in race and ethnicity
populations between the United States and select local area samples (Table 11). In
addition, there was not a significant relationship between physician recommendation and
race and ethnicity (see Limitations).
Social Vulnerability
As noted previously, direct measurement of vulnerability may not be possible,
and within geographic areas the same exposure to a risk factor does not mean each
individual has the same vulnerability (Burnell, 2012; Ratnapradipa et al., 2017).
Researchers recently have begun to test vulnerability rankings from the Social
Vulnerability Index with a variety of health behaviors. For example, An and Xiang
(2015) demonstrated differences in physical inactivity and vulnerability in a national
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sample, while Ratnapradipa et al. (2017) found a difference in incidence of Lyme Disease
by vulnerability ranking across the United States. Given the importance of social
determinants of health connected with vulnerability and with HPV vaccination, I used a
novel approach to test any potential links between vulnerability and factors contributing
to HPV vaccination by matching vulnerability rankings from the SVI with data in NISTeen at the county level (Gay et al., 2016; Grabovschi et al., 2013; Juster et al., 2016).
There was a significant relationship between overall social vulnerability ranking
at the county level and physician recommendation, as teens who lived in Washington,
D.C. and Philadelphia were more likely to receive a physician recommendation than
teens in Bexar County, but not with initiation of the HPV vaccine series. There was a
relationship between no shots and completion of the series as well; teens who lived in
Philadelphia were less likely to receive no shots, while teens who lived in Bexar county
were more likely to receive no shots and less likely to complete the vaccine series (see
Additional Analyses). The findings were an important proof of concept in showing
differences in dependent variables at the county level within NIS-Teen, and can provide a
foundation for a number of questions for future research examining vulnerability in HPV
vaccination and physician recommendation.
Additional Analyses
As noted above, my findings regarding the relationships between poverty, gender,
race and ethnicity, HPV vaccination, and physician recommendation were consistent with
findings in the current literature, as the sample population in this study reflected other
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research with national samples (Tables 16 and 17; Henry et al., 2017; Reagan-Steiner et
al., 2016; Walker et al., 2017).
Few researchers have examined the relationship between socioeconomic and
demographic variables and receipt of no HPV shots, as they would be expected to be the
reverse of relationships with initiation and completion. While most of the independent
variables were in line with these expectations, the findings regarding poverty were of
note. In the United States, teens living just above the poverty level were more likely to
receive no HPV shots. This may have been due to several factors; for example, the teens
may not have qualified for free shots through Vaccines For Children, or they may have
lived in marginally impoverished or wealthier areas with little access to free or low-cost
health care clinics (Lin et al., 2015; Monnat et al., 2016; Tsui et al., 2013). In the select
local area sample, teens living just above the poverty line were less likely to receive no
shots; this may have reflected the influence of the federal Section 317 funds to purchase
vaccines in these select local areas (Reagan-Steiner et al., 2016).
Theoretical Considerations
The theories underpinning this study were the fundamental cause theory (FCT)
and bhavioral economics (BE). Together, the two stress the value in considering multiple
levels of behavior and social determinants when assessing problems and solutions in
public health (Bickel et al., 2016; Link & Phelan, 1995).
Link and Phelan (1995) posited in the FCT that resources and the capacity to use
resources and innovations to avoid risks or minimize morbidity and mortality are
distributed unequally. I found that resources such as education and poverty were unequal

146
within the U.S. and select local area samples, as well as between the two samples,
suggesting that the capacity to be proactive or to cope with health issues differs among
populations (Clouston et al., 2016; Link & Phelan, 1995; Mackenbach, 2017). In
addition, I found that uptake of the innovative HPV vaccine was unequal within and
between populations in my study. While testing FCT directly is outside the scope of my
study, I believe my findings support considering HPV vaccination as a modern empirical
test of the FCT (Polonijo & Carpiano, 2013).
However, even if individuals have similar access (or lack of access) to healthpromoting resources, Frank (2004) and Dovidio and Fiske (2012) argued that humans
tend to make irrational decisions about health despite evidence pointing to the benefit of a
more rational choice. The authors and others have advanced the use of BE in patient and
physician decision-making, and in particular with physicians (Arrow, 1963; Mackenbach,
2017). I found that physician recommendation differs across geographic areas, as well as
a number of socioeconomic and demographic variables that have been associated with
HPV vaccination (Table C1 in Appendix C). Although NIS-Teen does not collect data on
physician decision-making, and direct testing of behavioral economics is outside the
scope of this study, I believe my findings provide initial evidence that physician decisionmaking (as measured by recommendation) is not consistent across geographic areas
despite the body of evidence supporting HPV vaccination. In addition, I believe that the
difference in recommendation across select local areas highlighted the role local biases
and heuristics play in decision-making, as well as the importance of assessing and
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intervening in public health issues at the local level (Blumenthal-Barby & Krieger, 2015;
Saini et al., 2017).
Limitations of the Study
There were several limitations to generalizability and validity in my study. First,
as a national survey reliant on current, active telephone numbers for non-institutionalized
heads of household, the NIS-Teen may have been subject to non-response and sampling
biases. For example, data for teens whose guardians did not have a cell phone or landline
number, or those with institutionalized guardians, were not captured. CDC used randomdigit dialing methods and probability sampling adjustments to reduce any potential for
sampling errors in the eligible population, but the data were not reflective of the abovementioned population and should not be used to generalize to teens ineligible for the
survey (CDC et al., 2015; 2016). Second, guardian recall or understanding of the
questions in the self-reported survey may have been inaccurate or biased. CDC collected
data from providers to verify household-reported data, and I used only data from teens
with adequate provider data verification; using both household- and provider-collected
data may have altered my findings and interpretation of the data (CDC et al., 2015;
2016). Third, provider data collected by NIS-Teen could not be analyzed for individual
teens, given privacy and confidentiality constraints, and therefore analyzing trends in
provider recommendation by specialty, facility type, or other characteristics was not
possible. While quantifiable data on physician recommendation could provide direction
to researchers, the use of such data would be of limited use without an understanding of
the context in which physicians practice, as this may have influenced their
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recommendations. Fourth, sample sizes for states and select local areas were smaller than
those of the nation as a whole, and therefore the confidence intervals were wider; as such,
estimates of vaccine coverage were interpreted with caution (CDC et al., 2015; 2016). In
addition, population characteristics were significantly different between the U.S. and
select local area samples, preventing any generalizability from my select local area
findings to the states or U.S. population as a whole. Fifth, the cross-sectional design of
the NIS-Teen survey precluded any causal inferences about the relationships among
variables.
The two limitations with the highest potential to influence my findings were the
exclusion of physician recommendation from research questions one through three, and
the specific geographic areas in which data for the NIS-Teen and SVI were collected.
Physician recommendation across select local areas was tested in research question four,
and would have been a redundant independent variable in the prior three questions.
However, researchers consistently have shown the importance of physician
recommendation on HPV vaccine initiation and completion (Burdette et al., 2017; Gilkey
et al., 2016; Mohammed et al., 2016).
For example, in the select local area sample, physician recommendation was
significantly associated with gender, poverty, mother’s education level, select local area,
number of visits to a health care professional in the past 12 months, mother’s age, and
age of the teen (Table C1 in Appendix C). In addition, in the absence of any confounding
variables, the odds of initiating the series if a physician recommended the HPV vaccine
were 5.21 times greater (95% CI, [3.68-7.37]) than if the physician did not recommend
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the HPV vaccine; the odds of completion were 35.69 times greater (95% CI, [17.5372.46]) with a physician recommendation; and the odds of not receiving a shot if the
physician recommended the vaccine were .04 times smaller than if a physician did not
recommend the vaccine (Table C2 in Appendix C). While outside the scope of my study,
the exclusion of physician recommendation from research questions one through three
may have influenced my findings and interpretation of the data.
Finally, while Social Vulnerability Index data were available at the census tract
level, the smallest geographic levels in NIS-Teen data were the teen’s county in the
public-use data file and Zip codes in the restricted data set. One strength of the SVI was
the demonstration of intra-county variability in vulnerability among several factors;
however, the reported vulnerability ranking scores were reported for the county as a
whole, and each individual in that county had the same vulnerability score (CDC et al.,
2017). As a result, comparisons to dependent variables could be made only between
counties as a whole, rather than variations within a county compared to variations within
another county, and a single value may have masked underlying disparities. While
additional granularity could shed light on any flexible resources described in the
fundamental cause theory, and Henry et al., (2017) recently demonstrated the value of
using Zip code tabulation areas in NIS-Teen analyses, the scope of this study and the
level of measurement in the SVI precluded testing relationships at this level of detail.
Recommendations for Professional Practice
Analyzing the NIS-Teen data in the context of social vulnerability is a unique
contribution to the existing literature, and my findings indicate that additional exploration
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into the relationships among social vulnerability, HPV vaccination, and physician
recommendation is warranted. Given the limitations of one vulnerability score being
applied to each person within a county, however, future researchers may want to consider
using more granular geographic areas, such as Zip codes or census tracts, to understand
the true effect of variation of fundamental causes and vulnerability on health outcomes.
In addition, assessing vaccination and physician recommendation by the four SVI themes
may help researchers identify specific local factors that influence patient and physician
behavior, and provide a foundation for testing the FCT through HPV vaccination. In
particular, given the continued diversification of the U.S. population, an understanding of
the racial and ethnic makeup of a specific area may be critical in interpreting results in
the future (Chin, 2017). These recommendations highlight the importance of data
collection and needs assessment by public health practitioners at the local level when
allocating public health resources, as well as moving away from individual- and
interpersonal-level models toward an ecological approach to managing HPV infection
and related cancers. In doing so, researchers can design and practitioners can implement
more cost-effective and tailored interventions for the specific environments in which
vaccine initiation and completion decisions are made (Burger et al., 2016; Ferrer et al.,
2015).
My findings regarding differences in physician recommendation across teen
variables and geographic area suggest the need for future researchers to better understand
what drives physician behavior on a structural, interpersonal, and individual level.
Assessing recommendations rates from a quantitative perspective tells only part of the
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story; the lack of behavioral economics-informed studies is a missed opportunity, and in
the future researchers should investigate how and why physicians make patient care
decisions to supplement their quantitative data. Public health practitioners could apply
these findings in efforts to nudge physician behavior qualitatively and quantitatively to
reflect evidence-based health care.
Implications for Social Change
While overall HPV vaccination in the United States is rising slowly, incidence
and prevalence of HPV-associated cancer in the United States are growing quickly, and
disparities in vaccination rates and cancer mortality persist. As there is not consensus on
which population and structural variables are most strongly associated with HPV vaccine
initiation and completion, public health practitioners may continue to struggle to reduce
disparities in vaccination, physician recommendation, and future HPV-related outcomes
(Ferrer et al., 2015; Oliver et al., 2016). Using national and local data can help elucidate
the influential factors in HPV infection, HPV morbidity and mortality, and HPV
vaccination, as well as how these factors interact.
This locally-focused, ecological approach may help identify populations,
geographic areas, and multi-level factors relating to HPV infection and vaccination
(McCree, Purcell Cleveland, & Brooks, 2017; Montez, Zajacova, & Hawyard, 2017).
This knowledge could advance positive social change by encouraging evaluation and
management of the fundamental causes of social and health disparities at the local level;
fostering an environment in which healthy choices about HPV vaccination can be made;
and equitably improving HPV vaccination rates among teens across the United States.
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Conclusion
The HPV vaccine has been available for a decade, but physician recommendation,
initiation and completion of the series is persistently low and varies across
socioeconomic, demographic, and geographic variables (Henry et al., 2017; Perkins,
2016). Disparities also are noted in HPV-associated genital warts and cancers (Burger et
al., 2016). The purpose of this study was to test the relationship between HPV vaccine
initiation and completion, socioeconomic and demographic variables, and physician
recommendation using data from the NIS-Teen 2015 survey. In addition, I tested the
relationship between HPV vaccine initiation and completion, physician recommendation,
and social vulnerability using the 2014 NIS-Teen and 2014 Social Vulnerability Index
databases. I found that significant relationships between variables within select local
areas in the United States differed from other select local areas as well as relationships
detected at the national level. These findings could contribute to positive social change by
identifying local structural, interpersonal, and individual factors that affect HPV
vaccination and informing more effective interventions. Future studies should examine
needs and population patterns at the local level, as well as seek to determine the context
in which HPV vaccination decisions are made among physicians and teens in the United
States. By reducing incidence and prevalence of HPV infections through vaccination,
practitioners and providers may reduce disparities in HPV-associated cancers and
facilitate improved health and wellbeing in individuals and communities.

153
References
A.B. 933. Assemb. Reg. Sess. 2017-2018. (N.Y. 2017) Retrieved from
http://assembly.state.ny.us/leg/?bn=A00933&term=2017
Abdus, S., & Selden, T. M. (2013). Adherence With Recommended Well-Child Visits
Has Grown, But Large Gaps Persist Among Various Socioeconomic Groups.
Health Affairs, 32(3), 508–515. https://doi.org/10.1377/hlthaff.2012.0691
Abiola, S. E., Colgrove, J., & Mello, M. M. (2013). The Politics of HPV Vaccination
Policy Formation in the United States. Journal of Health Politics, Policy and
Law, 38(4), 645–681. https://doi.org/10.1215/03616878-2208567
Advisory Committee for Immunization Practices. (2016). ACIP HPV Vaccine
Recommendations | CDC. Retrieved May 5, 2017, from
https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/hpv.html
Agawu, A., Buttenheim, A. M., Taylor, L., Song, L., Fiks, A. G., & Feemster, K. A.
(2015). Sociodemographic Differences in Human Papillomavirus Vaccine
Initiation by Adolescent Males. Journal of Adolescent Health, 57(5), 506–514.
https://doi.org/10.1016/j.jadohealth.2015.07.002
Agency for Toxic Substances & Disease Registry. (2014). The Social Vulnerability Index
(SVI) [Fact sheet]. Retrieved from
https://svi.cdc.gov/Documents/FactSheet/SVIFactSheet.pdf
Agency for Toxic Substances & Disease Registry. (2017). SVI 2014 Documentation
[updated March 1, 2017]. Retrieved from
https://svi.cdc.gov/Documents/Data/2014_SVI_Data/SVI2014Documentation.pdf

154
Alexander, S. C., Christ, S. L., Fortenberry, J. D., Pollak, K. I., Østbye, T., Bravender, T.,
& Shields, C. G. (2015). Identifying types of sex conversations in adolescent
health maintenance visits. Sexual Health. https://doi.org/10.1071/SH15080
Alexander, S. C., Fortenberry, J. D., Pollak, K. I., Bravender, T., Davis, J. K., Østbye, T.,
… Shields, C. G. (2014). Sexuality Talk During Adolescent Health Maintenance
Visits. JAMA Pediatrics, 168(2), 163.
https://doi.org/10.1001/jamapediatrics.2013.4338
Alligood-Percoco, N., & Kesterson, J. P. (2016). Addressing the Barriers to Cervical
Cancer Prevention Among Hispanic Women. Journal of Racial and Ethnic Health
Disparities, 3(3), 489–495. https://doi.org/10.1007/s40615-015-0166-z
Allison, D. B., & Maleki, Z. (2016). HPV-related head and neck squamous cell
carcinoma: An update and review. Journal of the American Society of
Cytopathology, 5(4), 203–215. https://doi.org/10.1016/j.jasc.2015.12.001
Alm, J., & Sheffrin, S. M. (2017). Using Behavioral Economics in Public Economics.
Public Finance Review, 45(1), 4–9. https://doi.org/10.1177/1091142116661411
American Psychological Association, Task Force on Socioeconomic Status. (2007).
Report of the APA Task Force on Socioeconomic Status. Retrieved from
https://www.apa.org/pi/ses/resources/publications/task-force-2006.pdf
Amini, A., Jasem, J., Jones, B. L., Robin, T. P., McDermott, J. D., Bhatia, S., … Karam,
S. D. (2016). Predictors of overall survival in human papillomavirus-associated
oropharyngeal cancer using the National Cancer Data Base. Oral Oncology, 56,
1–7. https://doi.org/10.1016/j.oraloncology.2016.02.011

155
An, R., & Xiang, X. (2015). Social Vulnerability and Leisure-time Physical Inactivity
among US Adults. American Journal of Health Behavior, 39(6), 751–760.
https://doi.org/10.5993/AJHB.39.6.2
Andre, F. E., Booy, R., Bock, H. L., Clemens, J., Datta, S. K., John, T. J., … Schmitt, H.
J. (2008). Vaccination greatly reduces disease, disability, death and inequity
worldwide. Bulletin of the World Health Organization, 86(2), 140–146.
https://doi.org/10.1590/S0042-96862008000200016
Aragones, A., Genoff, M., Gonzalez, C., Shuk, E., & Gany, F. (2016). HPV Vaccine and
Latino Immigrant Parents: If They Offer It, We Will Get It. Journal of Immigrant
and Minority Health, 18(5), 1060–1065. https://doi.org/10.1007/s10903-0150225-x
Arrow, K. J. (1963). Uncertainty and the Welfare Economics of Medical Care. The
American Economic Review, 53(5), pp. 941-973. Retrieved from
http://www.jstor.org/stable/1812044
Askelson, N. M., Edmonds, S. W., Momany, E. T., & Tegegne, M. A. (2016).
Understanding Clinic Practices for Human Papilloma Virus Vaccination Series
Completion in Clinics That Provide Primary Care: Survey of Clinic Managers in
Iowa. Sexually Transmitted Diseases, 43(7), 445–449.
https://doi.org/10.1097/OLQ.0000000000000462
Bailey, H. H., Chuang, L. T., duPont, N. C., Eng, C., Foxhall, L. E., Merrill, J. K., …
Blanke, C. D. (2016). American Society of Clinical Oncology Statement: Human
Papillomavirus Vaccination for Cancer Prevention. Journal of Clinical Oncology,

156
34(15), 1803–1812. https://doi.org/10.1200/JCO.2016.67.2014
Bakir, A. H., & Skarzynski, M. (2015). Health Disparities in the Immunoprevention of
Human Papillomavirus Infection and Associated Malignancies. Frontiers in
Public Health, 3. https://doi.org/10.3389/fpubh.2015.00256
Barnett, J. C., & Vornovitsky, M. S. (2016). Health Insurance Coverage in the United
States: 2015 (No. P60–257(RV)). U.S. Census Bureau. Retrieved from
https://www.census.gov/content/dam/Census/library/publications/2016/demo/p60257.pdf
Barraza, L., Weidenaar, K., Campos-Outcalt, D., & Yang, Y. T. (2016). Human
Papillomavirus and Mandatory Immunization Laws: What Can We Learn From
Early Mandates? Public Health Reports, 131(5), 728–731.
https://doi.org/10.1177/0033354916663184
Baum, F., & Fisher, M. (2014). Why behavioural health promotion endures despite its
failure to reduce health inequities. Sociology of Health & Illness, 36(2), 213–225.
https://doi.org/10.1111/1467-9566.12112
Benz, J. K., Espinosa, O., Welsh, V., & Fontes, A. (2011). Awareness Of Racial And
Ethnic Health Disparities Has Improved Only Modestly Over A Decade. Health
Affairs, 30(10), 1860–1867. https://doi.org/10.1377/hlthaff.2010.0702
Berenson, A. B., Laz, T. H., & Rahman, M. (2016). Reduction in Vaccine-Type Human
Papillomavirus Prevalence Among Women in the United States, 2009–2012.
Journal of Infectious Diseases, 214(12), 1961–1964.
https://doi.org/10.1093/infdis/jiw515

157
Berkowitz, Z., Malone, M., Rodriguez, J., & Saraiya, M. (2015). Providers’ beliefs about
the effectiveness of the HPV vaccine in preventing cancer and their recommended
age groups for vaccination: Findings from a provider survey, 2012. Preventive
Medicine, 81, 405–411. https://doi.org/10.1016/j.ypmed.2015.10.007
Berkowitz, Z., Nair, N., & Saraiya, M. (2016). Providers’ practice, recommendations and
beliefs about HPV vaccination and their adherence to guidelines about the use of
HPV testing, 2007 to 2010. Preventive Medicine, 87, 128–131.
https://doi.org/10.1016/j.ypmed.2016.02.030
Bharmal, N., Tseng, C.-H., Kaplan, R., & Wong, M. D. (2012). State-Level Variations in
Racial Disparities in Life Expectancy. Health Services Research, 47(1pt2), 544–
555. https://doi.org/10.1111/j.1475-6773.2011.01345.x
Bhatta, M. P., & Phillips, L. (2015). Human Papillomavirus Vaccine Awareness, Uptake,
and Parental and Health Care Provider Communication Among 11- to 18-YearOld Adolescents in a Rural Appalachian Ohio County in the United States: HPV
Vaccine Uptake Among Appalachian Adolescents. The Journal of Rural Health,
31(1), 67–75. https://doi.org/10.1111/jrh.12079
Bickel, W. K., & Marsch, L. A. (2001). Toward a behavioral economic understanding of
drug dependence: delay discounting processes. Addiction, 96(1), 73–86.
https://doi.org/10.1046/j.1360-0443.2001.961736.x
Bickel, W. K., Moody, L., & Higgins, S. T. (2016). Some current dimensions of the
behavioral economics of health-related behavior change. Preventive Medicine.
https://doi.org/10.1016/j.ypmed.2016.06.002

158
Bickel, W. K., Quisenberry, A. J., & Snider, S. E. (2016). Does impulsivity change rate
dependently following stimulant administration? A translational selective review
and re-analysis. Psychopharmacology, 233(1), 1–18.
https://doi.org/10.1007/s00213-015-4148-y
Blumenthal-Barby, J. S., & Krieger, H. (2015). Cognitive Biases and Heuristics in
Medical Decision Making: A Critical Review Using a Systematic Search
Strategy. Medical Decision Making, 35(4), 539–557.
https://doi.org/10.1177/0272989X14547740
Boakye, E., Tobo, B. B., Osazuwa-Peters, N., Mohammed, K. A., Geneus, C. J., &
Schootman, M. (2016). A Comparison of Parent- and Provider-Reported Human
Papillomavirus Vaccination of Adolescents. American Journal of Preventive
Medicine. https://doi.org/10.1016/j.amepre.2016.10.016
Boakye, E., Tobo, B. B., Rojek, R. P., Mohammed, K. A., Geneus, C. J., & OsazuwaPeters, N. (2017). Approaching a decade since HPV vaccine licensure: racial and
gender disparities in knowledge and awareness of HPV and HPV vaccine. Human
Vaccines & Immunotherapeutics. Advanced online publication.
https://doi.org/10.1080/21645515.2017.1363133
Bodson, J., Ding, Q., Warner, E. L., Hawkins, A. J., Henry, K. A., & Kepka, D. (2017).
Sub-Regional Assessment of HPV Vaccination Among Female Adolescents in the
Intermountain West and Implications for Intervention Opportunities. Maternal
and Child Health Journal. https://doi.org/10.1007/s10995-017-2274-3
Booth, C. M., Li, G., Zhang-Salomons, J., & Mackillop, W. J. (2010). The impact of

159
socioeconomic status on stage of cancer at diagnosis and survival: A populationbased study in Ontario, Canada. Cancer, 116(17), 4160–4167.
https://doi.org/10.1002/cncr.25427
Boscoe, F. P., Johnson, C. J., Sherman, R. L., Stinchcomb, D. G., Lin, G., & Henry, K.
A. (2014). The relationship between area poverty rate and site-specific cancer
incidence in the United States: Poverty and Cancer Incidence in the USA. Cancer,
120(14), 2191–2198. doi:10.1002/cncr.28632
Brandt, H. M., Pierce, J. Y., & Crary, A. (2016). Increasing HPV vaccination through
policy for public health benefit. Human Vaccines & Immunotherapeutics, 12(6),
1623–1625. https://doi.org/10.1080/21645515.2015.1122145
Braun, K. L., Stewart, S., Baquet, C., Berry-Bobovski, L., Blumenthal, D., Brandt, H. M.,
… Dignan, M. (2015). The National Cancer Institute’s Community Networks
Program Initiative to Reduce Cancer Health Disparities: Outcomes and Lessons
Learned. Progress in Community Health Partnerships: Research, Education, and
Action, 9(S), 21–32. https://doi.org/10.1353/cpr.2015.0017
Braveman, P. A., Cubbin, C., Egerter, S., Williams, D. R., & Pamuk, E. (2010).
Socioeconomic Disparities in Health in the United States: What the Patterns Tell
Us. American Journal of Public Health, 100(S1), S186–S196.
https://doi.org/10.2105/AJPH.2009.166082
Brewer, M. (2004). Internal Validity. In M. Lewis-Beck, A. Bryman, & T. Futing Liao
(Eds.), The SAGE Encyclopedia of Social Science Research Methods. 2455 Teller
Road, Thousand Oaks California 91320 United States of America: Sage

160
Publications, Inc. Retrieved from http://methods.sagepub.com/reference/the-sageencyclopedia-of-social-science-research-methods/n436.xml
Bruno, D. M., Wilson, T. E., Gany, F., & Aragones, A. (2014). Identifying human
papillomavirus vaccination practices among primary care providers of minority,
low-income and immigrant patient populations. Vaccine, 32(33), 4149–4154.
https://doi.org/10.1016/j.vaccine.2014.05.058
Burdette, A. M., Webb, N. S., Hill, T. D., & Jokinen-Gordon, H. (2017). Race-specific
trends in HPV vaccinations and provider recommendations: persistent disparities
or social progress? Public Health, 142, 167–176.
https://doi.org/10.1016/j.puhe.2016.07.009
Burger, E. A., Lee, K., Saraiya, M., Thompson, T. D., Chesson, H. W., Markowitz, L. E.,
& Kim, J. J. (2016). Racial and ethnic disparities in human papillomavirusassociated cancer burden with first-generation and second-generation human
papillomavirus vaccines: Racial/Ethnic Disparities in Cancer Burden. Cancer,
122(13), 2057–2066. https://doi.org/10.1002/cncr.30007
Burnell, J. (2013). Small Change: understanding cultural action as a resource for
unlocking assets and building resilience in communities. Community
Development Journal, 48(1), 134–150. https://doi.org/10.1093/cdj/bss059
Buttenheim, A. M., Fiks, A. G., Burson II, R. C., Wang, E., Coffin, S. E., Metlay, J. P., &
Feemster, K. A. (2016). A behavioral economics intervention to increase pertussis
vaccination among infant caregivers: A randomized feasibility trial. Vaccine,
34(6), 839–845. https://doi.org/10.1016/j.vaccine.2015.11.068

161
Byers, T., Wender, R. C., Jemal, A., Baskies, A. M., Ward, E. E., & Brawley, O. W.
(2016). The American Cancer Society challenge goal to reduce US cancer
mortality by 50% between 1990 and 2015: Results and reflections: ACS 2015
Cancer Mortality Goal. CA: A Cancer Journal for Clinicians.
https://doi.org/10.3322/caac.21348
Bynum, S. A., Brandt, H. M., Sharpe, P. A., Williams, M. S., & Kerr, J. C. (2011).
Working to Close the Gap: Identifying Predictors of HPV Vaccine Uptake among
Young African American Women. Journal of Health Care for the Poor and
Underserved, 22(2), 549–561. https://doi.org/10.1353/hpu.2011.0060
Bynum, S. A., Staras, S. A. S., Malo, T. L., Giuliano, A. R., Shenkman, E., &
Vadaparampil, S. T. (2014). Factors Associated With Medicaid Providers’
Recommendation of the HPV Vaccine to Low-Income Adolescent Girls. Journal
of Adolescent Health, 54(2), 190–196.
https://doi.org/10.1016/j.jadohealth.2013.08.006
Califano, S., Calo, W. A., Weinberger, M., Gilkey, M. B., & Brewer, N. T. (2016).
Physician support of HPV vaccination school-entry requirements. Human
Vaccines & Immunotherapeutics, 12(6), 1626–1632.
https://doi.org/10.1080/21645515.2016.1149275
Calo, W. A., Gilkey, M. B., Shah, P. D., Moss, J. L., & Brewer, N. T. (2016). Parents’
Support for School-Entry Requirements for Human Papillomavirus Vaccination:
A National Study. Cancer Epidemiology Biomarkers & Prevention, 25(9), 1317–
1325. https://doi.org/10.1158/1055-9965.EPI-15-1159

162
Camargo, K., & Grant, R. (2015). Public Health, Science, and Policy Debate: Being
Right Is Not Enough. American Journal of Public Health, 105(2), 232–235.
https://doi.org/10.2105/AJPH.2014.302241
Carey, G., & Crammond, B. (2015). Action on the social determinants of health: Views
from inside the policy process. Social Science & Medicine, 128, 134–141.
https://doi.org/10.1016/j.socscimed.2015.01.024
Caskey, R., Andes, S., & Walton, S. M. (2016). HPV vaccine: Less is more. Vaccine,
34(16), 1863–1864. https://doi.org/10.1016/j.vaccine.2016.02.022
Castanon, A., Landy, R., & Sasieni, P. D. (2016). Is cervical screening preventing
adenocarcinoma and adenosquamous carcinoma of the cervix?: Cervical
screening leads to early diagnosis and down-staging of adenocarcinoma.
International Journal of Cancer, 139(5), 1040–1045.
https://doi.org/10.1002/ijc.30152
Centers for Disease Control and Prevention. (1999). Achievements in Public Health,
1900-1999 Impact of Vaccines Universally Recommended for Children – United
States, 1990-1998. In Morbidity and Mortality Weekly Report, 48(12), pp. 243248. Retrieved from
http://www.cdc.gov/mmwr/preview/mmwrhtml/00056803.htm
Centers for Disease Control and Prevention. (2013). CDC Health Disparities and
Inequalities Report — United States, 2013. In Morbidity and Mortality Weekly
Report, 62(Suppl. 3), pp. 184-186. Retrieved from
https://www.cdc.gov/mmwr/pdf/other/su6203.pdf

163
Centers for Disease Control and Prevention. (2016a). Questions & Answers About
Vaccination Coverage in the U.S. Retrieved from
https://www.cdc.gov/vaccines/imz-managers/coverage/nis/teen/qa-faqs.html
Centers for Disease Control and Prevention. (2016b). 2015 Sexually Transmitted
Diseases Surveillance: Other Sexually Transmitted Diseases. Retrieved from
https://www.cdc.gov/std/stats15/other.htm#hpv
Centers for Disease Control and Prevention. (2017a). Genital HPV Infection - Fact Sheet.
Retrieved from https://www.cdc.gov/std/hpv/stdfact-hpv.htm
Centers for Disease Control and Prevention. (2017b). HPV Vaccine Information for
Clinicians. Retrieved from https://www.cdc.gov/hpv/hcp/need-to-know.pdf
Centers for Disease Control and Prevention. (2017c). Human Papillomavirus (HPV)
Statistics. Retrieved from https://www.cdc.gov/std/hpv/stats.htm
Centers for Disease Control and Prevention. (2017d). About the National Immunization
Surveys. Retrieved from https://www.cdc.gov/vaccines/imzmanagers/nis/about.html
Centers for Disease Control and Prevention & Agency for Toxic Substances and Disease
Registry. (2017). SVI 2014 Documentation (updated March 1, 2017). Retrieved
from
https://svi.cdc.gov/Documents/Data/2014_SVI_Data/SVI2014Documentation.pdf
Centers for Disease Control and Prevention, National Center for Immunization and
Respiratory Diseases, & National Center for Health Statistics. (2015). National
Immunization Survey-Teen: A User’s Guide for the 2014 Public-Use Data File.

164
Retrieved from
ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NIS/NIST
EENPUF14_DUG.pdf
Centers for Disease Control and Prevention, National Center for Immunization and
Respiratory Diseases, & National Center for Health Statistics. (2016). National
Immunization Survey-Teen: A User’s Guide for the 2015 Public-Use Data File.
Retrieved from https://www.cdc.gov/vaccines/imz-managers/nis/downloads/NISteen-puf15-dug.pdf
Chan, S. L., Wong, V. W. S., Qin, S., & Chan, H. L. Y. (2016). Infection and Cancer:
The Case of Hepatitis B. Journal of Clinical Oncology, 34(1), 83–90.
https://doi.org/10.1200/JCO.2015.61.5724
Chang, M.-H., Moonesinghe, R., Athar, H. M., & Truman, B. I. (2016). Trends in
Disparity by Sex and Race/Ethnicity for the Leading Causes of Death in the
United States—1999-2010: Journal of Public Health Management and Practice,
22, S13–S24. https://doi.org/10.1097/PHH.0000000000000267
Chaturvedi, A. K., Engels, E. A., Anderson, W. F., & Gillison, M. L. (2008). Incidence
Trends for Human Papillomavirus-Related and -Unrelated Oral Squamous Cell
Carcinomas in the United States. Journal of Clinical Oncology, 26(4), 612–619.
https://doi.org/10.1200/JCO.2007.14.1713
Chaturvedi, A. K., Engels, E. A., Pfeiffer, R. M., Hernandez, B. Y., Xiao, W., Kim, E.,
… Gillison, M. L. (2011). Human Papillomavirus and Rising Oropharyngeal
Cancer Incidence in the United States. Journal of Clinical Oncology, 29(32),

165
4294–4301. https://doi.org/10.1200/JCO.2011.36.4596
Chen, H., Cohen, P., & Chen, S. (2010). How Big is a Big Odds Ratio? Interpreting the
Magnitudes of Odds Ratios in Epidemiological Studies. Communications in
Statistics - Simulation and Computation, 39(4), 860–864.
https://doi.org/10.1080/03610911003650383
Chesson, H. W., Dunne, E. F., Hariri, S., & Markowitz, L. E. (2014). The Estimated
Lifetime Probability of Acquiring Human Papillomavirus in the United States:
Sexually Transmitted Diseases, 41(11), 660–664.
https://doi.org/10.1097/OLQ.0000000000000193
Chesson, H. W., Markowitz, L. E., Hariri, S., Ekwueme, D. U., & Saraiya, M. (2016).
The impact and cost-effectiveness of nonavalent HPV vaccination in the United
States: Estimates from a simplified transmission model. Human Vaccines &
Immunotherapeutics, 12(6), 1363–1372.
https://doi.org/10.1080/21645515.2016.1140288
Chin, K. K. (2017). Improving Public Health Surveillance About Asian Americans,
Native Hawaiians, and Pacific Islanders. American Journal of Public Health,
107(6), 827-828.
Choi, Y., Eworuke, E., & Segal, R. (2016). What explains the different rates of human
papillomavirus vaccination among adolescent males and females in the United
States? Papillomavirus Research, 2, 46–51.
https://doi.org/10.1016/j.pvr.2016.02.001
Churilla, T., Egleston, B., Dong, Y., Shaikh, T., Murphy, C., Mantia-Smaldone, G., …

166
Anderson, P. (2016). Disparities in the management and outcome of cervical
cancer in the United States according to health insurance status. Gynecologic
Oncology, 141(3), 516–523. https://doi.org/10.1016/j.ygyno.2016.03.025
City of Chicago. (2015, July 31). CDPH Announces Record Jump In Chicago Teens
Receiving HPV Vaccine [Press release]. Retrieved from
http://www.cityofchicago.org/city/en/depts/mayor/press_room/press_releases/201
5/july/cdph-announces-record-jump-in-chicago-teens-receiving-hpv-vaccin.html
Clouston, S. A. P., Rubin, M. S., Phelan, J. C., & Link, B. G. (2016). A Social History of
Disease: Contextualizing the Rise and Fall of Social Inequalities in CauseSpecific Mortality. Demography, 53(5), 1631–1656.
https://doi.org/10.1007/s13524-016-0495-5
Colby, S. L., & Ortman, J. M. (2015). Projections of the Size and Composition of the U.S.
Population: 2014 to 2060 (Current Population Reports No. P25-1143).
Washington, D.C.: U.S. Census Bureau. Retrieved from
https://pdfs.semanticscholar.org/09c9/ad858a60f9be2d6966ebd0bc267af5a76321.
pdf
Colgrove, J., Abiola, S., & Mello, M. M. (2010). HPV Vaccination Mandates —
Lawmaking amid Political and Scientific Controversy. New England Journal of
Medicine, 363(8), 785–791. https://doi.org/10.1056/NEJMsr1003547
Collins, Y., Holcomb, K., Chapman-Davis, E., Khabele, D., & Farley, J. H. (2014).
Gynecologic cancer disparities: A report from the Health Disparities Taskforce of
the Society of Gynecologic Oncology. Gynecologic Oncology, 133(2), 353–361.

167
https://doi.org/10.1016/j.ygyno.2013.12.039
Community Preventive Services Task Force. (2015). Increasing Appropriate
Vaccination: Community-Based Interventions Implemented in Combination [Task
Force Finding and Rationale Statement, updated 2015]. Retrieved from the
Community Guide website:
https://www.thecommunityguide.org/sites/default/files/assets/VaccinationCommunity-Based-in-Combination.pdf
Creswell, J. (2009). Research design: Qualitative, quantitative, and mixed methods
approaches (Laureate Education, Inc., custom ed.). Thousand Oaks, CA: Sage
Publications.
Cutler, D., Lleras-Muney, A., & Vogl, T. (2008). Socioeconomic Status and Health:
Dimensions and Mechanisms (No. w14333). Cambridge, MA: National Bureau of
Economic Research. Retrieved from http://www.nber.org/papers/w14333.pdf
Dale, A. (2004). Secondary Analysis of Quantitative Data. In M. Lewis-Beck, A.
Bryman, & T. Liao (Eds.), The SAGE Encyclopedia of Social Science Research
Methods. 2455 Teller Road, Thousand Oaks California 91320 United States of
America: Sage Publications, Inc. Retrieved from
http://methods.sagepub.com/reference/the-sage-encyclopedia-of-social-scienceresearch-methods/n896.xml
Daniel-Ulloa, J., Gilbert, P. A., & Parker, E. A. (2016). Human Papillomavirus
Vaccination in the United States: Uneven Uptake by Gender, Race/Ethnicity, and
Sexual Orientation. American Journal of Public Health, 106(4), 746–747.

168
https://doi.org/10.2105/AJPH.2015.303039
Darden, P. M., & Jacobson, R. M. (2014). Impact of a physician recommendation.
Human Vaccines & Immunotherapeutics, 10(9), 2632–2635.
https://doi.org/10.4161/hv.29020
Davids, B.-O., Hutchins, S. S., Jones, C. P., & Hood, J. R. (2014). Disparities in Life
Expectancy Across US Counties Linked to County Social Factors, 2009
Community Health Status Indicators (CHSI). Journal of Racial and Ethnic Health
Disparities, 1(1), 2–11. https://doi.org/10.1007/s40615-013-0001-3
de Vaus, D. (2006). Retrospective Study. In V. Jupp (Ed.), The SAGE Dictionary of
Social Research Methods. 1 Oliver’s Yard, 55 City Road, London England EC1Y
1SP United Kingdom: SAGE Publications, Ltd. Retrieved from
http://methods.sagepub.com/reference/the-sage-dictionary-of-social-researchmethods/n181.xml
Dempsey, A. F., Gebremariam, A., Koutsky, L. A., & Manhart, L. (2008). Using risk
factors to predict human papillomavirus infection: Implications for targeted
vaccination strategies in young adult women. Vaccine, 26(8), 1111–1117.
https://doi.org/10.1016/j.vaccine.2007.11.088
Dempsey, A. F., Pyrzanowski, J., Brewer, S., Barnard, J., Sevick, C., & O’Leary, S. T.
(2015). Acceptability of using standing orders to deliver human papillomavirus
vaccines in the outpatient obstetrician/gynecologist setting. Vaccine, 33(15),
1773–1779. https://doi.org/10.1016/j.vaccine.2015.02.044
DeNavas-Walt, C., Proctor, B. D., & Lee, C. H. (2006). Income, Poverty, and Health

169
Insurance Coverage in the United States: 2005 (No. P60-231). U.S. Census
Bureau. Retrieved from https://www.census.gov/prod/2006pubs/p60-231.pdf
DeSantis, C. E., Siegel, R. L., Sauer, A. G., Miller, K. D., Fedewa, S. A., Alcaraz, K. I.,
& Jemal, A. (2016). Cancer statistics for African Americans, 2016: Progress and
opportunities in reducing racial disparities: Cancer Statistics for African
Americans, 2016. CA: A Cancer Journal for Clinicians, 66(4), 290–308.
https://doi.org/10.3322/caac.21340
Descourouez, J. L., & Hayney, M. S. (2013). Vaccination exemptions: Implications of
decline in vaccination rates. Journal of the American Pharmacists Association,
53(3), 324–326. https://doi.org/10.1331/JAPhA.2013.13516
Diemer, M. A., Mistry, R. S., Wadsworth, M. E., López, I., & Reimers, F. (2013). Best
Practices in Conceptualizing and Measuring Social Class in Psychological
Research: Social Class Measurement. Analyses of Social Issues and Public Policy,
13(1), 77–113. https://doi.org/10.1111/asap.12001
Dizon, D. S., Krilov, L., Cohen, E., Gangadhar, T., Ganz, P. A., Hensing, T. A., …
Masters, G. (2016). Clinical Cancer Advances 2016: Annual Report on Progress
Against Cancer From the American Society of Clinical Oncology. Journal of
Clinical Oncology, 34(9), 987–1011. https://doi.org/10.1200/JCO.2015.65.8427
Dorell, C. G., Jain, N., & Yankey, D. (2011). Validity of Parent-Reported Vaccination
Status for Adolescents Aged 13–17 Years: National Immunization Survey-Teen,
2008. Public Health Reports, 126(2_suppl), 60–69.
https://doi.org/10.1177/00333549111260S208

170
Dovidio, J. F., & Fiske, S. T. (2012). Under the Radar: How Unexamined Biases in
Decision-Making Processes in Clinical Interactions Can Contribute to Health
Care Disparities. American Journal of Public Health, 102(5), 945–952.
https://doi.org/10.2105/AJPH.2011.300601
Du, X. L., Lin, C. C., Johnson, N. J., & Altekruse, S. (2011). Effects of individual-level
socioeconomic factors on racial disparities in cancer treatment and survival:
Findings from the National Longitudinal Mortality Study, 1979-2003. Cancer,
117(14), 3242–3251. https://doi.org/10.1002/cncr.25854
Durham, D. P., Ndeffo-Mbah, M. L., Skrip, L. A., Jones, F. K., Bauch, C. T., & Galvani,
A. P. (2016). National- and state-level impact and cost-effectiveness of
nonavalent HPV vaccination in the United States. Proceedings of the National
Academy of Sciences, 113(18), 5107–5112.
https://doi.org/10.1073/pnas.1515528113
Dwyer-Lindgren, L., Bertozzi-Villa, A., Stubbs, R. W., Morozoff, C., Mackenbach, J. P.,
van Lenthe, F. J., … Murray, C. J. L. (2017). Inequalities in Life Expectancy
Among US Counties, 1980 to 2014: Temporal Trends and Key Drivers. JAMA
Internal Medicine, 177(7), 1003.
https://doi.org/10.1001/jamainternmed.2017.0918
Egen, O., Beatty, K., Blackley, D. J., Brown, K., & Wykoff, R. (2017). Health and Social
Conditions of the Poorest Versus Wealthiest Counties in the United States.
American Journal of Public Health, 107(1), 130–135.
https://doi.org/10.2105/AJPH.2016.303515

171
Elam-Evans, L. D., Yankey, D., Jeyarajah, J., Singleton, J. A., Curtis, R. C., MacNeil, J.,
… Centers for Disease Control and Prevention (CDC). (2014). National, regional,
state, and selected local area vaccination coverage among adolescents aged 13-17
years--United States, 2013. MMWR. Morbidity and Mortality Weekly Report,
63(29), 625–633.
Emanuel, E. J., Ubel, P. A., Kessler, J. B., Meyer, G., Muller, R. W., Navathe, A. S., …
Volpp, K. G. (2016). Using Behavioral Economics to Design Physician Incentives
That Deliver High-Value Care. Annals of Internal Medicine, 164(2), 114.
https://doi.org/10.7326/M15-1330
Embrett, M. G., & Randall, G. E. (2014). Social determinants of health and health equity
policy research: Exploring the use, misuse, and nonuse of policy analysis theory.
Social Science & Medicine, 108, 147–155.
https://doi.org/10.1016/j.socscimed.2014.03.004
Epstein, R. A. (2016). Innovation and Inequality: The Separability Thesis. Harvard
Journal of Law and Public Policy, 39(1). Retrieved from
http://chicagounbound.uchicago.edu/cgi/viewcontent.cgi?article=12316&context=
journal_articles
Fairley, C. K., Zou, H., Zhang, L., & Chow, E. P. F. (2017). Human papillomavirus
vaccination in men who have sex with men – what will be required by 2020 for
the same dramatic changes seen in heterosexuals. Sexual Health, 14(1), 123.
https://doi.org/10.1071/SH16067
Farmer, M. M., & Ferraro, K. F. (2005). Are racial disparities in health conditional on

172
socioeconomic status? Social Science & Medicine, 60(1), 191–204.
https://doi.org/10.1016/j.socscimed.2004.04.026
Ferguson, C. J. (2009). An effect size primer: A guide for clinicians and researchers.
Professional Psychology: Research and Practice, 40(5), 532–538.
https://doi.org/10.1037/a0015808
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., … Bray, F.
(2015). Cancer incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012: Globocan 2012. International Journal of Cancer,
136(5), E359–E386. https://doi.org/10.1002/ijc.29210
Ferrer, H., Audrey, S., Trotter, C., & Hickman, M. (2015). An appraisal of theoretical
approaches to examining behaviours in relation to Human Papillomavirus (HPV)
vaccination of young women. Preventive Medicine, 81, 122–131.
https://doi.org/10.1016/j.ypmed.2015.08.004
Flanagan, B. E., Gregory, E. W., Hallisey, E. J., Heitgerd, J. L., & Lewis, B. (2011). A
Social Vulnerability Index for Disaster Management. Journal of Homeland
Security and Emergency Management, 8(1). https://doi.org/10.2202/15477355.1792
Food and Drug Administration. (2016). Approved Products - Human Papillomavirus
Vaccine [WebContent]. Retrieved May 5, 2017, from
https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm172
678.htm
Ford, C. A., Cheek, C., Culhane, J., Fishman, J., Mathew, L., Salek, E. C., … Jaccard, J.

173
(2016). Parent and Adolescent Interest in Receiving Adolescent Health
Communication Information From Primary Care Clinicians. Journal of
Adolescent Health, 59(2), 154–161.
https://doi.org/10.1016/j.jadohealth.2016.03.001
Forman, D., de Martel, C., Lacey, C. J., Soerjomataram, I., Lortet-Tieulent, J., Bruni, L.,
… Franceschi, S. (2012). Global Burden of Human Papillomavirus and Related
Diseases. Vaccine, 30, F12–F23. https://doi.org/10.1016/j.vaccine.2012.07.055
Franco, E. L., Shinder, G. A., Tota, J. E., & Isidean, S. D. (2015). Sobering realizations in
cancer prevention and screening and their lessons. Preventive Medicine, 76, 129–
131. https://doi.org/10.1016/j.ypmed.2015.04.014
Frank, R. G. (2004). Behavioral Economics and Health Economics (NBER Working
Paper No. 10881). Retrieved from the National Bureau of Economic Research
website: http://www.nber.org/papers/w10881
Froment, M.-A., Gomez, S. L., Roux, A., DeRouen, M. C., & Kidd, E. A. (2014). Impact
of socioeconomic status and ethnic enclave on cervical cancer incidence among
Hispanics and Asians in California. Gynecologic Oncology, 133(3), 409–415.
https://doi.org/10.1016/j.ygyno.2014.03.559
Fuzzell, L., Fedesco, H. N., Alexander, S. C., Fortenberry, J. D., & Shields, C. G. (2016).
“I just think that doctors need to ask more questions”: Sexual minority and
majority adolescents’ experiences talking about sexuality with healthcare
providers. Patient Education and Counseling, 99(9), 1467–1472.
https://doi.org/10.1016/j.pec.2016.06.004

174
Galbraith, K. V., Lechuga, J., Jenerette, C. M., Moore, L. A. D., Palmer, M. H., &
Hamilton, J. B. (2016). Parental acceptance and uptake of the HPV vaccine
among African-Americans and Latinos in the United States: A literature review.
Social Science & Medicine, 159, 116–126.
https://doi.org/10.1016/j.socscimed.2016.04.028
Gallagher, J. E., Wilkie, A. A., Cordner, A., Hudgens, E. E., Ghio, A. J., Birch, R. J., &
Wade, T. J. (2016). Factors associated with self-reported health: implications for
screening level community-based health and environmental studies. BMC Public
Health, 16(1). https://doi.org/10.1186/s12889-016-3321-5
Garland, S. M., Kjaer, S. K., Muñoz, N., Block, S. L., Brown, D. R., DiNubile, M. J., …
Velicer, C. (2016). Impact and Effectiveness of the Quadrivalent Human
Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world
Experience. Clinical Infectious Diseases, 63(4), 519–527.
https://doi.org/10.1093/cid/ciw354
Gay, J. L., Robb, S. W., Benson, K. M., & White, A. (2016). Can the Social Vulnerability
Index Be Used for More than Emergency Preparedness? An Examination Using
Youth Physical Fitness Data. Journal of Physical Activity and Health, 13(2), 121–
130. https://doi.org/10.1123/jpah.2015-0042
Gelman, A., Miller, E., Schwarz, E. B., Akers, A. Y., Jeong, K., & Borrero, S. (2013).
Racial Disparities in Human Papillomavirus Vaccination: Does Access Matter?
Journal of Adolescent Health, 53(6), 756–762.
https://doi.org/10.1016/j.jadohealth.2013.07.002

175
Gennetian, L. A., Darling, M., & Aber, J. L. (2016). Behavioral Economics and
Developmental Theory: Implications for Early Childhood Interventions [White
paper]. Retrieved from https://behavioralpolicy.org/wpcontent/uploads/2016/05/BE-and-Early-Childhood-2016_working-paper-1.pdf
Gesser-Edelsburg, A., Walter, N., Shir-Raz, Y., & Green, M. S. (2015). Voluntary or
Mandatory? The Valence Framing Effect of Attitudes Regarding HPV
Vaccination. Journal of Health Communication, 20(11), 1287–1293.
https://doi.org/10.1080/10810730.2015.1018642
Getzen, T. E. (2013). Health economics and financing (5th ed.). Hoboken, NJ: John
Wiley and Sons.
Gilkey, M. B., Calo, W. A., Moss, J. L., Shah, P. D., Marciniak, M. W., & Brewer, N. T.
(2016). Provider communication and HPV vaccination: The impact of
recommendation quality. Vaccine, 34(9), 1187–1192.
https://doi.org/10.1016/j.vaccine.2016.01.023
Gilkey, M. B., Malo, T. L., Shah, P. D., Hall, M. E., & Brewer, N. T. (2015). Quality of
Physician Communication about Human Papillomavirus Vaccine: Findings from a
National Survey. Cancer Epidemiology Biomarkers & Prevention, 24(11), 1673–
1679. https://doi.org/10.1158/1055-9965.EPI-15-0326
Gilkey, M. B., & McRee, A.-L. (2016). Provider communication about HPV vaccination:
A systematic review. Human Vaccines & Immunotherapeutics, 12(6), 1454–1468.
https://doi.org/10.1080/21645515.2015.1129090
Gillison, M. L. (2016). Human Papillomavirus and Oropharyngeal Cancer Stage. Journal

176
of Clinical Oncology, 34(16), 1833–1835.
https://doi.org/10.1200/JCO.2016.66.6081
Glantz, S. A. (2005). The Special Case of Two Groups: The t Test. In Primer of
Biostatistics (6th ed., pp. 73-125). New York, NY: McGraw-Hill Professional.
Glanz, K., Rimer, B. K., & Viswanath, K. (Eds.). (2015). Health behavior: theory,
research, and practice (5. edition). San Francisco, Calif: Jossey-Bass.
Glenn, B., Tsui, J., D. Coronado, G., E. Fernandez, M., S. Savas, L., M. Taylor, V., &
Bastani, R. (2015). Understanding HPV Vaccination Among Latino Adolescent
Girls in Three U.S. Regions. Journal of Immigrant and Minority Health, 17(1),
96–103. https://doi.org/10.1007/s10903-014-9996-8
Goldberg, D. S. (2014). The Implications of Fundamental Cause Theory for Priority
Setting. American Journal of Public Health, 104(10), 1839–1843.
https://doi.org/10.2105/AJPH.2014.302058
Golden, S. D., McLeroy, K. R., Green, L. W., Earp, J. A. L., & Lieberman, L. D. (2015).
Upending the Social Ecological Model to Guide Health Promotion Efforts
Toward Policy and Environmental Change. Health Education & Behavior,
42(1_suppl), 8S–14S. https://doi.org/10.1177/1090198115575098
Grabovschi, C., Loignon, C., & Fortin, M. (2013). Mapping the concept of vulnerability
related to health care disparities: a scoping review. BMC Health Services
Research, 13(1). https://doi.org/10.1186/1472-6963-13-94
Handler, M. Z., Handler, N. S., Majewski, S., & Schwartz, R. A. (2015). Human
papillomavirus vaccine trials and tribulations. Journal of the American Academy

177
of Dermatology, 73(5), 743–756. https://doi.org/10.1016/j.jaad.2015.05.040
Hansen, B. T., Kjær, S. K., Arnheim-Dahlström, L., Liaw, K.-L., Jensen, K. E., Thomsen,
L. T., … Nygård, M. (2014). Human papillomavirus (HPV) vaccination and
subsequent sexual behaviour: Evidence from a large survey of Nordic women.
Vaccine, 32(39), 4945–4953. https://doi.org/10.1016/j.vaccine.2014.07.025
Hansen, P. G., Skov, L. R., & Skov, K. L. (2016). Making Healthy Choices Easier:
Regulation versus Nudging. Annual Review of Public Health, 37(1), 237–251.
https://doi.org/10.1146/annurev-publhealth-032315-021537
Hawkes, S., Kismödi, E., Larson, H., & Buse, K. (2014). Vaccines to promote and protect
sexual health: Policy challenges and opportunities. Vaccine, 32(14), 1610–1615.
https://doi.org/10.1016/j.vaccine.2013.09.039
Healthypeople.gov. (2017). Social Determinants of Health. Retrieved from the Healthy
People 2020 website: https://www.healthypeople.gov/2020/topicsobjectives/topic/social-determinants-of-health
Healy, C. M., Montesinos, D. P., & Middleman, A. B. (2014). Parent and provider
perspectives on immunization: Are providers overestimating parental concerns?
Vaccine, 32(5), 579–584. https://doi.org/10.1016/j.vaccine.2013.11.076
Henry, K. A., Stroup, A. M., Warner, E. L., & Kepka, D. (2016). Geographic Factors and
Human Papillomavirus (HPV) Vaccination Initiation among Adolescent Girls in
the United States. Cancer Epidemiology Biomarkers & Prevention, 25(2), 309–
317. https://doi.org/10.1158/1055-9965.EPI-15-0658
Henry, K. A., Swiecki-Sikora, A. L., Stroup, A. M., Warner, E. L., & Kepka, D. (2017).

178
Area-based socioeconomic factors and Human Papillomavirus (HPV) vaccination
among teen boys in the United States. BMC Public Health, 18(1).
https://doi.org/10.1186/s12889-017-4567-2
Hoff, K., & Stiglitz, J. E. (2016). Striving for balance in economics: Towards a theory of
the social determination of behavior. Journal of Economic Behavior &
Organization, 126, 25–57. https://doi.org/10.1016/j.jebo.2016.01.005
Horn, L., Howard, C., Waller, J., & Ferris, D. G. (2010). Opinions of Parents About
School-Entry Mandates for the Human Papillomavirus Vaccine: Journal of Lower
Genital Tract Disease, 14(1), 43–48.
https://doi.org/10.1097/LGT.0b013e3181b0fad4
Howlader, N., et al. (Eds). (2017). SEER Cancer Statistics Review, 1975-2014 [based on
November 2016 SEER data submission, updated April 2017]. Retrieved from the
National Cancer Institute website: https://seer.cancer.gov/csr/1975_2014/
Hswen, Y., Gilkey, M. B., Rimer, B. K., & Brewer, N. T. (2017). Improving Physician
Recommendations for Human Papillomavirus Vaccination: The Role of
Professional Organizations. Sexually Transmitted Diseases, 44(1), 43–48.
https://doi.org/10.1097/OLQ.0000000000000543
Hunt, B. R., Tran, G., & Whitman, S. (2015). Life Expectancy Varies in Local
Communities in Chicago: Racial and Spatial Disparities and Correlates. Journal
of Racial and Ethnic Health Disparities, 2(4), 425–433.
https://doi.org/10.1007/s40615-015-0089-8
Hutter, J. N., & Decker, C. F. (2016). Human papillomavirus infection. Disease-a-Month,

179
62(8), 294–300. https://doi.org/10.1016/j.disamonth.2016.03.014
IBM Knowledge Center. (n.d.). A Likelihood Ratio Test.
https://www.ibm.com/support/knowledgecenter/en/SSLVMB_sub/spss/tutorials/
mixed_diet_intro_04.html
IBM Support. (2016, September 7). Differences between using a variable as a WEIGHT
variable in SPSS and using it as a WLS or regression weight (REGWGT) in
REGRESSION [IBM Support forum]. http://www01.ibm.com/support/docview.wss?uid=swg21477175
IBM Support. (n.d.). Complex Samples Option [SPSS Help forum].
http://127.0.0.1:52320/help/nav/3_5
Institute of Medicine, & National Research Council (Eds.). (2011). Improving access to
oral health care for vulnerable and underserved populations. Washington, D.C:
National Academies Press.
International Papillomavirus Society. (2016). IPVS Policy statement on safety of HPV
vaccines. Papillomavirus Research, 2, 9–10.
https://doi.org/10.1016/j.pvr.2015.11.001
Jain, N., Singleton, J. A., Montgomery, M., & Skalland, B. (2009). Determining Accurate
Vaccination Coverage Rates for Adolescents: The National Immunization SurveyTeen 2006. Public Health Reports, 124(5), 642–651.
https://doi.org/10.1177/003335490912400506
Jemal, A., Simard, E. P., Dorell, C., Noone, A.-M., Markowitz, L. E., Kohler, B., …
Edwards, B. K. (2013). Annual Report to the Nation on the Status of Cancer,

180
1975-2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)Associated Cancers and HPV Vaccination Coverage Levels. JNCI Journal of the
National Cancer Institute, 105(3), 175–201. https://doi.org/10.1093/jnci/djs491
Jeudin, P., Liveright, E., del Carmen, M. G., & Perkins, R. B. (2014). Race, Ethnicity,
and Income Factors Impacting Human Papillomavirus Vaccination rates. Clinical
Therapeutics, 36(1), 24–37. https://doi.org/10.1016/j.clinthera.2013.11.001
Jokinen-Gordon, H. (2014). The Influence of Family Socioeconomic Status on Health
Care Professional Recommendations of the HPV Vaccine. In S. L. Blair & J. H.
McCormick (Eds.), Contemporary Perspectives in Family Research (Vol. 8, pp.
27–43). Emerald Group Publishing Limited. Retrieved from
http://www.emeraldinsight.com/doi/10.1108/S1530-35352014000008B010
Joseph, N. P., Bernstein, J., Pelton, S., Belizaire, M., Goff, G., Horanieh, N., & Freund,
K. M. (2016). Brief Client-Centered Motivational and Behavioral Intervention to
Promote HPV Vaccination in a Hard-to-Reach Population: A Pilot Randomized
Controlled Trial. Clinical Pediatrics, 55(9), 851–859.
https://doi.org/10.1177/0009922815616244
Joshua, P., Zwi, K., Moran, P., & White, L. (2015). Prioritizing vulnerable children: why
should we address inequity?: Prioritizing vulnerable children: Why should we
address inequity? Child: Care, Health and Development, 41(6), 818–826.
https://doi.org/10.1111/cch.12264
Juster, R.-P., Seeman, T., McEwen, B. S., Picard, M., Mahar, I., Mechawar, N., …
Lupien, S. J. (2016). Social Inequalities and the Road to Allostatic Load: From

181
Vulnerability to Resilience. In D. Cicchetti (Ed.), Developmental
Psychopathology (pp. 1–54). Hoboken, NJ, USA: John Wiley & Sons, Inc.
Retrieved from http://doi.wiley.com/10.1002/9781119125556.devpsy408
Kahneman, D., & Tversky, A. (1979). Prospect Theory: An Analysis of Decision under
Risk. Econometrica, 47(2), 263. https://doi.org/10.2307/1914185
Kao, A. C. (2015). Driven to Care: Aligning External Motivators with Intrinsic
Motivation. Health Services Research, 50, 2216–2222.
https://doi.org/10.1111/1475-6773.12422
Kasting, M. L., Shapiro, G. K., Rosberger, Z., Kahn, J. A., & Zimet, G. D. (2016).
Tempest in a teapot: A systematic review of HPV vaccination and risk
compensation research. Human Vaccines & Immunotherapeutics, 12(6), 1435–
1450. https://doi.org/10.1080/21645515.2016.1141158
Katzel, J. A., Merchant, M., Chaturvedi, A. K., & Silverberg, M. J. (2015). Contribution
of Demographic and Behavioral Factors on the Changing Incidence Rates of
Oropharyngeal and Oral Cavity Cancers in Northern California. Cancer
Epidemiology Biomarkers & Prevention, 24(6), 978–984.
https://doi.org/10.1158/1055-9965.EPI-14-1416
Kepka, D., Balch, A., Warner, E., & Spigarelli, M. (2015). Statewide Vaccine Registry
Data Indicate High Number of Missed Opportunities for the HPV Vaccine
Among Eligible Girls. Cancer Epidemiology Biomarkers & Prevention, 24(4),
762–763. https://doi.org/10.1158/1055-9965.EPI-15-0110
Kepka, D., Berkowitz, Z., Yabroff, K. R., Roland, K., & Saraiya, M. (2012). Human

182
papillomavirus vaccine practices in the USA: do primary care providers use
sexual history and cervical cancer screening results to make HPV vaccine
recommendations?: Table 1. Sexually Transmitted Infections, 88(6), 433–435.
https://doi.org/10.1136/sextrans-2011-050437
Khan, H. M. R., Gabbidon, K., Saxena, A., Abdool-Ghany, F., Dodge, J. M., &
Lenzmeier, T. (2016). Disparities in Cervical Cancer Characteristics and Survival
Between White Hispanics and White Non-Hispanic Women. Journal of Women’s
Health, 25(10), 1052–1058. https://doi.org/10.1089/jwh.2015.5585
Kim, D. K., Riley, L. E., Harriman, K. H., Hunter, P., & Bridges, C. B. (2017). Advisory
Committee on Immunization Practices Recommended Immunization Schedule for
Adults Aged 19 Years or Older - United States, 2017. American Journal of
Transplantation, 17(4), 1132–1135. https://doi.org/10.1111/ajt.14244
Kish, J. K., Yu, M., Percy-Laurry, A., & Altekruse, S. F. (2014). Racial and Ethnic
Disparities in Cancer Survival by Neighborhood Socioeconomic Status in
Surveillance, Epidemiology, and End Results (SEER) Registries. JNCI
Monographs, 2014(49), 236–243. https://doi.org/10.1093/jncimonographs/lgu020
Knight, E. K., Benjamin, G. D., & Yanich, D. (2016). Framing social determinants of
health within the professional public health community: research translation and
implications for policy change. Journal of Applied Communication Research,
44(3), 256–274. https://doi.org/10.1080/00909882.2016.1192291
Kreuter, M. W., McQueen, A., Boyum, S., & Fu, Q. (2016). Unmet basic needs and
health intervention effectiveness in low-income populations. Preventive Medicine,

183
91, 70–75. https://doi.org/10.1016/j.ypmed.2016.08.006
Krieger, N., Chen, J. T., Waterman, P. D., Rehkopf, D. H., & Subramanian, S. V. (2005).
Painting a Truer Picture of US Socioeconomic and Racial/Ethnic Health
Inequalities: The Public Health Disparities Geocoding Project. American Journal
of Public Health, 95(2), 312–323. https://doi.org/10.2105/AJPH.2003.032482
Kulczycki, A., Qu, H., & Shewchuk, R. (2016a). Primary Care Physicians’ Adherence to
Guidelines and Their Likelihood to Prescribe the Human Papillomavirus Vaccine
for 11- and 12-Year-Old Girls. Women’s Health Issues, 26(1), 34–39.
https://doi.org/10.1016/j.whi.2015.07.012
Kulczycki, A., Qu, H., & Shewchuk, R. (2016b). Recommend, but also Discuss:
Different Patterns of Physician-Perceived Barriers to Discussing HPV
Vaccination and Their Association with Vaccine Administration in 11–12 YearOld Girls. Maternal and Child Health Journal. https://doi.org/10.1007/s10995016-2079-9
Laerd Statistics (2015). Binomial logistic regression using SPSS Statistics. Statistical
tutorials and software guides. Retrieved from https://statistics.laerd.com/
Laerd Statistics (2016). Chi-square test for independence using SPSS
Statistics. Statistical tutorials and software guides. Retrieved from
https://statistics.laerd.com/
Laugesen, M. J., Mistry, R., Carameli, K. A., Ribisl, K. M., Needleman, J., & Bastani, R.
(2014). Early Policy Responses to the Human Papillomavirus Vaccine in the
United States, 2006–2010. Journal of Adolescent Health, 55(5), 659–664 6p.

184
https://doi.org/10.1016/j.jadohealth.2014.04.015
Lemons, J. F. (2016, February 19). Vaccine Controversies. CQ Researcher, 26(8), 171–
189.
Leonard, T., Hughes, A. E., & Pruitt, S. L. (2017). Understanding How Low–
Socioeconomic Status Households Cope with Health Shocks: An Analysis of
Multisector Linked Data. The ANNALS of the American Academy of Political and
Social Science, 669(1), 125–145. https://doi.org/10.1177/0002716216680989
Lillvis, D. F., Kirkland, A., & Frick, A. (2014). Power and Persuasion in the Vaccine
Debates: An Analysis of Political Efforts and Outcomes in the United States,
1998-2012: Power and Persuasion in the Vaccine Debates. Milbank Quarterly,
92(3), 475–508. https://doi.org/10.1111/1468-0009.12075
Lin, Y., Schootman, M., & Zhan, F. B. (2015). Racial/ethnic, area socioeconomic, and
geographic disparities of cervical cancer survival in Texas. Applied Geography,
56, 21–28. https://doi.org/10.1016/j.apgeog.2014.10.004
Link, B., & Phelan, J. (1995). Social Conditions As Fundamental Causes of Disease. In
M. L. Fennell (Ed.), Forty Years of Medical Sociology: The State of the Art and
Directions for the Future [Special issue]. Journal of Health and Social Behavior,
35, pp. 80-94. Retrieved from http://www.jstor.org/stable/2626958
Lu, P., Yankey, D., Jeyarajah, J., O’Halloran, A., Elam-Evans, L. D., Smith, P. J., …
Dunne, E. F. (2015). HPV Vaccination Coverage of Male Adolescents in the
United States. PEDIATRICS, 136(5), 839–849. https://doi.org/10.1542/peds.20151631

185
Mackenbach, J. P. (2017). Persistence of social inequalities in modern welfare states:
Explanation of a paradox. Scandinavian Journal of Public Health, 45(2), 113–
120. https://doi.org/10.1177/1403494816683878
MacLeod, W. B. (2016). Human capital: Linking behavior to rational choice via dual
process theory. Labour Economics, 41, 20–31.
https://doi.org/10.1016/j.labeco.2016.05.019
Madhivanan, P., Pierre-Victor, D., Mukherjee, S., Bhoite, P., Powell, B., Jean-Baptiste,
N., … Krupp, K. (2016). Human Papillomavirus Vaccination and Sexual
Disinhibition in Females. American Journal of Preventive Medicine, 51(3), 373–
383. https://doi.org/10.1016/j.amepre.2016.03.015
Malagón, T., Drolet, M., Boily, M.-C., Laprise, J.-F., & Brisson, M. (2015). Changing
Inequalities in Cervical Cancer: Modeling the Impact of Vaccine Uptake, Vaccine
Herd Effects, and Cervical Cancer Screening in the Post-Vaccination Era. Cancer
Epidemiology Biomarkers & Prevention, 24(1), 276–285.
https://doi.org/10.1158/1055-9965.EPI-14-1052
Mallen-St Clair, J., Alani, M., Wang, M. B., & Srivastan, E. S. (2016). Human
papillomavirus in oropharyngeal cancer: The changing face of a disease.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1866(2), 141–150.
https://doi.org/10.1016/j.bbcan.2016.07.005
Malo, T. L., Perkins, R. B., Lee, J.-H., & Vadaparampil, S. T. (2016a). Primary Care
Physiciansʼ Adherence to Expert Recommendations for Cervical Cancer
Screening and Prevention in the Context of Human Papillomavirus Vaccination:

186
Sexually Transmitted Diseases, 43(7), 438–444.
https://doi.org/10.1097/OLQ.0000000000000458
Malo, T. L., Ali, K. N., Sutton, S. K., Perkins, R. B., Giuliano, A. R., & Vadaparampil, S.
T. (2016b). The content and context of physicians’ communication with males
about human papillomavirus vaccination. Human Vaccines &
Immunotherapeutics, 12(6), 1511–1518.
http://doi.org/10.1080/21645515.2015.1132963
Maness, S. B., Reitzel, L. R., Watkins, K. L., & McNeill, L. H. (2016). HPV Awareness,
Knowledge and Vaccination Attitudes among Church-going African-American
Women. American Journal of Health Behavior, 40(6), 771–778.
https://doi.org/10.5993/AJHB.40.6.9
Mariner, W. K. (2014). Paternalism, Public Health, and Behavioral Economics: A
Problematic Combination. Connecticut Law Review, 46(5), 1817–1838.
Marur, S., D’Souza, G., Westra, W. H., & Forastiere, A. A. (2010). HPV-associated head
and neck cancer: a virus-related cancer epidemic. The Lancet Oncology, 11(8),
781–789. https://doi.org/10.1016/S1470-2045(10)70017-6
Maurer, J., Harris, K. M., & Uscher-Pines, L. (2014). Can Routine Offering of Influenza
Vaccination in Office-Based Settings Reduce Racial and Ethnic Disparities in
Adult Influenza Vaccination? Journal of General Internal Medicine, 29(12),
1624–1630. https://doi.org/10.1007/s11606-014-2965-z
McCarthy, A. M., Dumanovsky, T., Visvanathan, K., Kahn, A. R., & Schymura, M. J.
(2010). Racial/ethnic and socioeconomic disparities in mortality among women

187
diagnosed with cervical cancer in New York City, 1995–2006. Cancer Causes &
Control, 21(10), 1645–1655. https://doi.org/10.1007/s10552-010-9593-7
McCree, D. H., Purcell, D. W., Cleveland, J. C., & Brooks, J. T. (2017). Increasing
Availability of Prevention to Communities Disproportionately Affected by HIV.
American Journal of Public Health, 107(7), 1027-1028.
Mechanic, D., & Tanner, J. (2007). Vulnerable People, Groups, And Populations:
Societal View. Health Affairs, 26(5), 1220–1230.
https://doi.org/10.1377/hlthaff.26.5.1220
Mello, M. M., Wood, J., Burris, S., Wagenaar, A. C., Ibrahim, J. K., & Swanson, J. W.
(2013). Critical Opportunities for Public Health Law: A Call for Action.
American Journal of Public Health, 103(11), 1979–1988.
https://doi.org/10.2105/AJPH.2013.301281
Merzel, C. R., Vandevanter, N. L., Middlestadt, S., Bleakley, A., Ledsky, R., & Messeri,
P. A. (2004). Attitudinal and contextual factors associated with discussion of
sexual issues during adolescent health visits. Journal of Adolescent Health, 35(2),
108–115. https://doi.org/10.1016/j.jadohealth.2003.09.011
Moghtaderi, A., & Adams, S. (2016). The Role of Physician Recommendations and
Public Policy in Human Papillomavirus Vaccinations. Applied Health Economics
and Health Policy, 14(3), 349–359. https://doi.org/10.1007/s40258-016-0225-6
Mohammed, K. A., Geneus, C. J., Osazuwa-Peters, N., Adjei Boakye, E., Tobo, B. B., &
Burroughs, T. E. (2016). Disparities in Provider Recommendation of Human
Papillomavirus Vaccination for U.S. Adolescents. Journal of Adolescent Health.

188
59(5), 592-598. https://doi.org/10.1016/j.jadohealth.2016.06.005
Monnat, S. M., Rhubart, D. C., & Wallington, S. F. (2016). Differences in Human
Papillomavirus Vaccination Among Adolescent Girls in Metropolitan Versus
Non-metropolitan Areas: Considering the Moderating Roles of Maternal
Socioeconomic Status and Health Care Access. Maternal and Child Health
Journal, 20(2), 315-325. https://doi.org/10.1007/s10995-015-1831-x
Montez, J. K., Zajacova, A., & Hayward, M. D. (2017). Contextualizing the Social
Determinants of Health: Disparities in Disability by Educational Attainment
Across US States. American Journal of Public Health, 107(7), 1101-1108.
Moreland-Russell, S., Barbero, C., Andersen, S., Geary, N., Dodson, E. A., & Brownson,
R. C. (2015). “Hearing from all sides” How legislative testimony influences state
level policy-makers in the United States. International Journal of Health Policy
and Management, 4(2), 91–98. https://doi.org/10.15171/ijhpm.2015.13
Moss, J. L., Gilkey, M. B., Rimer, B. K., & Brewer, N. T. (2016). Disparities in
collaborative patient-provider communication about human papillomavirus (HPV)
vaccination. Human Vaccines & Immunotherapeutics, 12(6), 1476–1483.
https://doi.org/10.1080/21645515.2015.1128601
Moss, J. L., Reiter, P. L., Rimer, B. K., & Brewer, N. T. (2016). Collaborative patientprovider communication and uptake of adolescent vaccines. Social Science &
Medicine, 159, 100–107. https://doi.org/10.1016/j.socscimed.2016.04.030
Mullins, T. L. K., Zimet, G. D., Rosenthal, S. L., Morrow, C., Ding, L., Huang, B., &
Kahn, J. A. (2016). Human papillomavirus vaccine-related risk perceptions and

189
subsequent sexual behaviors and sexually transmitted infections among
vaccinated adolescent women. Vaccine, 34(34), 4040–4045.
https://doi.org/10.1016/j.vaccine.2016.06.026
Murphy, J. G., & Dennhardt, A. A. (2016). The behavioral economics of young adult
substance abuse. Preventive Medicine, 92, 24–30.
https://doi.org/10.1016/j.ypmed.2016.04.022
National Center for Health Statistics. (2016). Health, United States, 2015: With Special
Feature on Racial and Ethnic Health Disparities. (2016-1232). Hyattsville, MD.
Retrieved from https://www.cdc.gov/nchs/data/hus/hus15.pdf
National Comprehensive Cancer Network. (2017). About NCCN. Retrieved from
https://www.nccn.org/about/default.aspx
National Conference of State Legislatures. (2017). HPV Vaccine: State Legislation and
Statutes. Retrieved May 5, 2017, from http://www.ncsl.org/research/health/hpvvaccine-state-legislation-and-statutes.aspx
National Program of Cancer Registries. (2015). State Cancer Profiles [data from the
November 2015 data submission to the Cancer Surveillance System and SEER
November 2015 submission]. Retrieved from
https://statecancerprofiles.cancer.gov/index.html
Oliver, K., Frawley, A., & Garland, E. (2016). HPV vaccination: Population approaches
for improving rates. Human Vaccines & Immunotherapeutics, 12(6), 1589–1593.
https://doi.org/10.1080/21645515.2016.1139253
Olson, J., Abendroth, T., Castellani, W., Donaldson, K., & Hollenbeak, C. (2015).

190
Default settings of computerized physician order entry system order sets drive
ordering habits. Journal of Pathology Informatics, 6(1), 16.
https://doi.org/10.4103/2153-3539.153916
Omer, S. B., Richards, J. L., Ward, M., & Bednarczyk, R. A. (2012). Vaccination
Policies and Rates of Exemption from Immunization, 2005–2011. New England
Journal of Medicine, 367(12), 1170–1171.
https://doi.org/10.1056/NEJMc1209037
Ondercin, H. L. (2004). External Validity. In M. Lewis-Beck, A. Bryman, & T. Futing
Liao (Eds.), The SAGE Encyclopedia of Social Science Research Methods. 2455
Teller Road, Thousand Oaks California 91320 United States of America: Sage
Publications, Inc. Retrieved from http://methods.sagepub.com/reference/the-sageencyclopedia-of-social-science-research-methods/n318.xml
Onon, T. S. (2011). History of human papillomavirus, warts and cancer: What do we
know today? Best Practice & Research Clinical Obstetrics & Gynaecology,
25(5), 565–574. https://doi.org/10.1016/j.bpobgyn.2011.05.001
Osazuwa-Peters, N. (2013). Human papillomavirus (HPV), HPV-associated
oropharyngeal cancer, and HPV vaccine in the United States—Do we need a
broader vaccine policy? Vaccine, 31(47), 5500–5505.
https://doi.org/10.1016/j.vaccine.2013.09.031
Osazuwa-Peters, N., López, J., Rice, S., Tutlam, N., Tokarz, S., & Varvares, M. A.
(2015). No change in physician discussions with patients about the human
papillomavirus vaccine between 2007 and 2013. Journal of Cancer Policy, 5, 18–

191
22. https://doi.org/10.1016/j.jcpo.2015.06.001
Osazuwa-Peters, N., Boakye, E. A., Mohammed, K. A., Tobo, B. B., Geneus, C. J., &
Schootman, M. (2017). Not just a woman's business! Understanding men and
women's knowledge of HPV, the HPV vaccine, and HPV-associated
cancers. Preventive Medicine, 99, 299-304.
https://doi.org/10.1016/j.ypmed.2017.03.014
Øversveen, E., Rydland, H. T., Bambra, C., & Eikemo, T. A. (2017). Rethinking the
relationship between socio-economic status and health: Making the case for
sociological theory in health inequality research. Scandinavian Journal of Public
Health, 45(2), 103–112. https://doi.org/10.1177/1403494816686711
Palmer, J., Carrico, C., & Costanzo, C. (2015). Identifying and Overcoming Perceived
Barriers of Providers towards HPV Vaccination: A Literature Review. Journal of
Vaccines, 2015, 1–7. https://doi.org/10.1155/2015/869468
Parrella, A., Braunack-Mayer, A., Collins, J., Clarke, M., Tooher, R., Ratcliffe, J., &
Marshall, H. (2016). Prioritizing government funding of adolescent vaccinations:
recommendations from young people on a citizens’ jury. Vaccine, 34(31), 3592–
3597. https://doi.org/10.1016/j.vaccine.2016.05.019
Patel, M. S., Volpp, K. G., Small, D. S., Wynn, C., Zhu, J., Yang, L., … Day, S. C.
(2016). Using active choice within the electronic health record to increase
physician ordering and patient completion of high-value cancer screening tests.
Healthcare. https://doi.org/10.1016/j.hjdsi.2016.04.005
Perkins, R. B. (2016). HPV vaccination: Clinical potential, implementation challenges,

192
and future directions. Human Vaccines & Immunotherapeutics, 12(6), 1327–1331.
https://doi.org/10.1080/21645515.2016.1177680
Perkins, R. B., Brogly, S. B., Adams, W. G., & Freund, K. M. (2012). Correlates of
Human Papillomavirus Vaccination Rates in Low-Income, Minority Adolescents:
A Multicenter Study. Journal of Women’s Health, 21(8), 813–820.
https://doi.org/10.1089/jwh.2011.3364
Perkins, R. B., Lin, M., Wallington, S. F., & Hanchate, A. D. (2016). Impact of schoolentry and education mandates by states on HPV vaccination coverage: Analysis of
the 2009–2013 National Immunization Survey-Teen. Human Vaccines &
Immunotherapeutics, 12(6), 1615–1622.
https://doi.org/10.1080/21645515.2016.1150394
Phelan, J. C., Link, B. G., & Tehranifar, P. (2010). Social Conditions as Fundamental
Causes of Health Inequalities: Theory, Evidence, and Policy Implications. Journal
of Health and Social Behavior, 51(1 Suppl), S28–S40.
https://doi.org/10.1177/0022146510383498
Polonijo, A. N., & Carpiano, R. M. (2013). Social inequalities in adolescent human
papillomavirus (HPV) vaccination: A test of fundamental cause theory. Social
Science & Medicine, 82, 115–125.
https://doi.org/10.1016/j.socscimed.2012.12.020
Polonijo, A. N., Carpiano, R. M., Reiter, P. L., & Brewer, N. T. (2016). Socioeconomic
and Racial-ethnic Disparities in Prosocial Health Attitudes: The Case of Human
Papillomavirus (HPV) Vaccination for Adolescent Males. Journal of Health and

193
Social Behavior, 57(3), 390–406. https://doi.org/10.1177/0022146516660344
Proctor, B. D., Semega, J. L., & Kollar, M. A. (2016). Income and Poverty in the United
States: 2015 (No. P60–256(RV)). U.S. Census Bureau. Retrieved from
https://www.census.gov/content/dam/Census/library/publications/2016/demo/p60256.pdf
Pruitt, S. L., & Schootman, M. (2010). Geographic disparity, area poverty, and human
papillomavirus vaccination. American Journal of Preventive Medicine, 38(5),
525-533. https://doi.org/10.1016/j.amepre.2010.01.018
Quiroga, S. S., Medina, D. M., & Glick, J. (2014). In the Belly of the Beast: Effects of
Anti-Immigration Policy on Latino Community Members. American Behavioral
Scientist, 58(13), 1723–1742. https://doi.org/10.1177/0002764214537270
Rahman, M., Hirth, J. M., & Berenson, A. B. (2017). Adherence to ACIP
Recommendation for Human Papillomavirus Vaccine Among US Adolescent
Girls. Journal of Community Health, 42(2), 385–389.
https://doi.org/10.1007/s10900-016-0267-6
Rahman, M., Islam, M., & Berenson, A. B. (2015). Differences in HPV Immunization
Levels Among Young Adults in Various Regions of the United States. Journal of
Community Health, 40(3), 404–408. https://doi.org/10.1007/s10900-015-9995-2
Rahman, M., Laz, T. H., McGrath, C. J., & Berenson, A. B. (2015). Provider
Recommendation Mediates the Relationship Between Parental Human
Papillomavirus (HPV) Vaccine Awareness and HPV Vaccine Initiation and
Completion Among 13- to 17-Year-Old US Adolescent Children. Clinical

194
Pediatrics, 54(4), 371–375. https://doi.org/10.1177/0009922814551135
Ramer, I., Varier, I., Zhang, D., Demicco, E. G., Posner, M. R., Misiukiewicz, K., …
Sikora, A. G. (2016). Racial disparities in incidence of human papillomavirusassociated oropharyngeal cancer in an urban population. Cancer Epidemiology,
44, 91–95. https://doi.org/10.1016/j.canep.2016.07.004
Ratnapradipa, D., McDaniel, J. T., & Barger, A. (2017). Social Vulnerability and Lyme
Disease Incidence: A Regional Analysis of the United States, 2000-2014.
Epidemiology, Biostatistics and Public Health. https://doi.org/10.2427/12158
Reagan-Steiner, S., Yankey, D., Jeyarajah, J., Elam-Evans, L. D., Curtis, C. R., MacNeil,
J., … Singleton, J. A. (2016). National, Regional, State, and Selected Local Area
Vaccination Coverage Among Adolescents Aged 13–17 Years — United States,
2015. MMWR. Morbidity and Mortality Weekly Report, 65(33), 850–858.
https://doi.org/10.15585/mmwr.mm6533a4
Reagan-Steiner, S., Yankey, D., Jeyarajah, J., Elam-Evans, L. D., Singleton, J. A., Curtis,
C. R., … Stokley, S. (2015). National, Regional, State, and Selected Local Area
Vaccination Coverage Among Adolescents Aged 13–17 Years — United States,
2014. Morbidity and Mortality Weekly Report, 64(29), 784–792.
Reiter, P. L., Gupta, K., Brewer, N. T., Gilkey, M. B., Katz, M. L., Paskett, E. D., &
Smith, J. S. (2014). Provider-Verified HPV Vaccine Coverage among a National
Sample of Hispanic Adolescent Females. Cancer Epidemiology Biomarkers &
Prevention, 23(5), 742–754. https://doi.org/10.1158/1055-9965.EPI-13-0979
Reiter, P. L., Katz, M. L., Ruffin, M. T., Hade, E. M., DeGraffenreid, C. R., Patel, D. A.,

195
… Unger, E. R. (2013). HPV Prevalence among Women from Appalachia:
Results from the CARE Project. PLoS ONE, 8(8), e74276.
https://doi.org/10.1371/journal.pone.0074276
Richards, M. J., Peters, M., & Sheeder, J. (2016). Human papillomavirus vaccine:
Continuation, completion, and missed opportunities. Journal of Pediatric and
Adolescent Gynecology, 29(2), 117-121.
https://doi.org/10.1016/j.jpag.2015.08.003
Robitz, R., Gottlieb, S. L., De Rosa, C. J., Guerry, S. L., Liddon, N., Zaidi, A., …
Markowitz, L. E. (2011). Parent Attitudes about School Requirements for Human
Papillomavirus Vaccine in High-Risk Communities of Los Angeles, California.
Cancer Epidemiology Biomarkers & Prevention, 20(7), 1421–1429.
https://doi.org/10.1158/1055-9965.EPI-10-1236
Roland, K. B., Benard, V. B., Greek, A., Hawkins, N. A., & Saraiya, M. (2014). Primary
care providers human papillomavirus vaccine recommendations for the medically
underserved: A pilot study in U.S. Federally Qualified Health Centers. Vaccine,
32(42), 5432–5435. https://doi.org/10.1016/j.vaccine.2014.07.098
Romaguera, J., Caballero-Varona, D., Tortolero-Luna, G., Marrero, E., Suárez, E., Pérez,
C. M., … Ortiz, A. P. (2016). Factors Associated with HPV Vaccine Awareness
in a Population-Based Sample of Hispanic Women in Puerto Rico. Journal of
Racial and Ethnic Health Disparities, 3(2), 281–290.
https://doi.org/10.1007/s40615-015-0144-5
Rous, P., & Beard, J. W. (1935). The progression to carcinoma of virus-induced rabbit

196
papillomas (Shope). Journal of Experimental Medicine, 62(4), 523–548.
https://doi.org/10.1084/jem.62.4.523
Rutten, L. J., Wilson, P. M., Jacobson, D. J., Agunwamba, A. A., Radecki Breitkopf, C.,
Jacobson, R. M., & St. Sauver, J. L. (2017). A Population-Based Study of
Sociodemographic and Geographic Variation in HPV Vaccination. Cancer
Epidemiology Biomarkers & Prevention, 26(4), 533–540.
https://doi.org/10.1158/1055-9965.EPI-16-0877
Saini, V., Garcia-Armesto, S., Klemperer, D., Paris, V., Elshaug, A. G., Brownlee, S., …
Fisher, E. S. (2017). Drivers of poor medical care. The Lancet.
https://doi.org/10.1016/S0140-6736(16)30947-3
Saposnik, G., Redelmeier, D., Ruff, C. C., & Tobler, P. N. (2016). Cognitive biases
associated with medical decisions: a systematic review. BMC Medical Informatics
and Decision Making, 16(1). https://doi.org/10.1186/s12911-016-0377-1
Saraiya, M., Unger, E. R., Thompson, T. D., Lynch, C. F., Hernandez, B. Y., Lyu, C. W.,
… HPV Typing of Cancers Workgroup. (2015). US Assessment of HPV Types in
Cancers: Implications for Current and 9-Valent HPV Vaccines. JNCI Journal of
the National Cancer Institute, 107(6), djv086-djv086.
https://doi.org/10.1093/jnci/djv086
Saslow, D., Andrews, K. S., Manassaram-Baptiste, D., Loomer, L., Lam, K. E., FisherBorne, M., … on behalf of the American Cancer Society Guideline Development
Group. (2016). Human papillomavirus vaccination guideline update: American
Cancer Society guideline endorsement: HPV Vaccination Guideline Update. CA:

197
A Cancer Journal for Clinicians, 66(5), 375–385.
https://doi.org/10.3322/caac.21355
S.B. 132. S. Reg. Sess. 2017-2018. (N.Y. 2017) Retrieved from
https://www.nysenate.gov/legislation/bills/2017/S132
Scherr, C. L., Augusto, B., Ali, K., Malo, T. L., & Vadaparampil, S. T. (2016). Providerreported acceptance and use of the Centers for Disease Control and Prevention
messages and materials to support HPV vaccine recommendation for adolescent
males. Vaccine, 34(35), 4229–4234. https://doi.org/10.1016/j.vaccine.2016.06.037
Schmeler, K. M., & Sturgis, E. M. (2016). Expanding the benefits of HPV vaccination to
boys and men. The Lancet, 387(10030), 1798–1799.
https://doi.org/10.1016/S0140-6736(16)30314-2
Shay, L. A., Street, R. L., Baldwin, A. S., Marks, E. G., Lee, S. C., Higashi, R. T., …
Tiro, J. A. (2016). Characterizing safety-net providers’ HPV vaccine
recommendations to undecided parents: A pilot study. Patient Education and
Counseling, 99(9), 1452–1460. https://doi.org/10.1016/j.pec.2016.06.027
Shin, H., Molinari, N., & Wolter, K. (2008, May.) A dual-frame design for the national
immunization survey. Paper presented at the 63rd annual conference of the
American Association for Public Opinion Research, New Orleans, LA. Retrieved
from
http://ww2.amstat.org/sections/srms/Proceedings/y2008/Files/shinheechoon.pdf
Shuval, K., Leonard, T., Drope, J., Katz, D. L., Patel, A. V., Maitin-Shepard, M., …
Grinstein, A. (2017). Physical activity counseling in primary care: Insights from

198
public health and behavioral economics: Physical Activity &amp; Primary Care.
CA: A Cancer Journal for Clinicians, 67(3), 233–244.
https://doi.org/10.3322/caac.21394
Siegler, J. E., Kable, J. W., & Chatterjee, A. (2016). Resident Decision Making: Opioids
in the Outpatient Setting. Journal of Graduate Medical Education, 8(2), 138–141.
https://doi.org/10.4300/JGME-D-15-00186.1
Small, S. L., Sampselle, C. M., Martyn, K. K., & Dempsey, A. F. (2014). Modifiable
influences on female HPV vaccine uptake at the clinic encounter level: A
literature review: Modifiable influences on female HPV vaccine uptake. Journal
of the American Association of Nurse Practitioners, 26(9), 519–525.
https://doi.org/10.1002/2327-6924.12057
Smith, L. M., Kaufman, J. S., Strumpf, E. C., & Levesque, L. E. (2015). Effect of human
papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour
among adolescent girls: the Ontario Grade 8 HPV Vaccine Cohort Study.
Canadian Medical Association Journal, 187(2), E74–E81.
https://doi.org/10.1503/cmaj.140900
Speybroeck, N., Harper, S., de Savigny, D., & Victora, C. (2012). Inequalities of health
indicators for policy makers: six hints. International Journal of Public Health,
57(5), 855–858. https://doi.org/10.1007/s00038-012-0386-5
Sundaram, N., Schaetti, C., Merten, S., Schindler, C., Ali, S. M., Nyambedha, E. O., …
Weiss, M. G. (2015). Sociocultural determinants of anticipated oral cholera
vaccine acceptance in three African settings: a meta-analytic approach. BMC

199
Public Health, 16(1). https://doi.org/10.1186/s12889-016-2710-0
Syrjänen, S., & Syrjänen, K. (2008). The history of papillomavirus research. Central
European Journal of Public Health, 16 Suppl, S7-13.
Syverton, J. T., Dascomb, H. E., Koomen, J., Wells, E. B., & Berry, G. P. (1950). The
virus-induced papilloma-to-carcinoma sequence; the growth pattern in natural and
experimental infections. Cancer Research, 10(6), 379–384.
Tehranifar, P., Neugut, A. I., Phelan, J. C., Link, B. G., Liao, Y., Desai, M., & Terry, M.
B. (2009). Medical Advances and Racial/Ethnic Disparities in Cancer Survival.
Cancer Epidemiology Biomarkers & Prevention. https://doi.org/10.1158/10559965.EPI-09-0305
Teplow-Phipps, R. L., Papadouka, V., Benkel, D. H., Holleran, S., Ramakrishnan, R.,
Rosenthal, S. L., … Stockwell, M. S. (2016). Influence of Gender and GenderSpecific Recommendations on Adolescent Human Papillomavirus Vaccination.
American Journal of Preventive Medicine, 51(2), 161–169.
https://doi.org/10.1016/j.amepre.2016.01.030
The Socio-economic Inequalities and HIV Working Group. (2017). Inequalities by
educational level in response to combination antiretroviral treatment and survival
in HIV-positive men and women in Europe: AIDS, 31(2), 253–262.
https://doi.org/10.1097/QAD.0000000000001270
Tversky, A., & Kahneman, D. (1975). Judgment under Uncertainty: Heuristics and Biases.
In D. Wendt & C. Vlek (Eds.), Utility, Probability, and Human Decision Making
(pp.

141–162).

Dordrecht:

Springer

Netherlands.

Retrieved

from

200
http://www.springerlink.com/index/10.1007/978-94-010-1834-0_8
U.S. Cancer Statistics Working Group. (2016). United States Cancer Statistics: 1999–
2013 Incidence and Mortality Web-based Report. Retrieved from the CDC website:
https://nccd.cdc.gov/uscs/cancersbyraceandethnicity.aspx
U.S. Const., amend. X
Vadaparampil, S. T., Kahn, J. A., Salmon, D., Lee, J.-H., Quinn, G. P., Roetzheim, R., …
Giuliano, A. R. (2011). Missed clinical opportunities: Provider recommendations
for HPV vaccination for 11–12 year old girls are limited. Vaccine, 29(47), 8634–
8641. https://doi.org/10.1016/j.vaccine.2011.09.006
Vadaparampil, S. T., Malo, T. L., Kahn, J. A., Salmon, D. A., Lee, J.-H., Quinn, G. P., …
Giuliano,

A.

R.

(2014).

Physicians’

Human

Papillomavirus

Vaccine

Recommendations, 2009 and 2011. American Journal of Preventive Medicine,
46(1), 80–84. https://doi.org/10.1016/j.amepre.2013.07.009
Vadaparampil, S. T., Malo, T. L., Sutton, S. K., Ali, K. N., Kahn, J. A., Casler, A., …
Giuliano, A. R. (2016). Missing the Target for Routine Human Papillomavirus
Vaccination: Consistent and Strong Physician Recommendations are Lacking for
11-12 Year Old Males. Cancer Epidemiology Biomarkers & Prevention.
https://doi.org/10.1158/1055-9965.EPI-15-1294
Vanderpool, R. C., Crosby, R. A., & Stradtman, L. R. (2014). Protecting a new generation
against HPV: Are we willing to be bold? Human Vaccines & Immunotherapeutics,
10(9), 2559–2561. https://doi.org/10.4161/21645515.2014.970068
Viens, L. J., Henley, S. J., Watson, M., Markowitz, L. E., Thomas, C. C., Thompson, T.

201
D., … Saraiya, Mona. (2016). Human Papillomavirus–Associated Cancers —
United States, 2008–2012. Morbidity and Mortality Weekly Report, 65(26), 661–
666. https://doi.org/10.15585/mmwr.mm6526a1
Volpp, K., Loewenstain, G., & Asch, D. (2015). Behavioral Economics and Health. In K.
Glanz, B. K. Rimer, & K. Viswanath (Eds.), Health Behavior: Theory, Research,
and Practice (5th ed., pp. 377–396). San Francisco: Jossey-Bass.
Waldrop, A. R., Moss, J. L., Liu, B., & Zhu, L. (2017). Ranking States on Coverage of
Cancer-Preventing Vaccines Among Adolescents: The Influence of Imprecision.
Public Health Reports, 132(6), 627-636.
http://dx.doi.org/10.1177/0033354917727274
Walker, T. Y., Elam-Evans, L. D., Singleton, J. A., Yankey, D., Markowitz, L. E.,
Fredua, B., … & Stokley, S. (2017). National, Regional, State, and Selected Local
Area Vaccination Coverage Among Adolescents Aged 13–17 Years—United
States, 2016. Morbidity and Mortality Weekly Report, 66(33), 874-882.
http://dx.doi.org/10.15585/mmwr.mm6633a2
Whittemore, D., Ding, L., Widdice, L. E., Brown, D. A., Bernstein, D. I., Franco, E. L.,
& Kahn, J. A. (2016). Distribution of Vaccine-Type Human Papillomavirus Does
Not Differ by Race or Ethnicity Among Unvaccinated Young Women. Journal of
Women’s Health, 25(11), 1153–1158. https://doi.org/10.1089/jwh.2015.5674
Williams, D. R., Priest, N., & Anderson, N. B. (2016). Understanding associations among
race, socioeconomic status, and health: Patterns and prospects. Health
Psychology, 35(4), 407–411. https://doi.org/10.1037/hea0000242

202
Willis, I., & Fitton, J. (2016). A review of multivariate social vulnerability
methodologies: a case study of the River Parrett catchment, UK. Natural Hazards
and Earth System Sciences, 16(6), 1387–1399. https://doi.org/10.5194/nhess-161387-2016
Wilson, A. R., Hashibe, M., Bodson, J., Gren, L. H., Taylor, B. A., Greenwood, J., …
Kepka, D. (2016). Factors related to HPV vaccine uptake and 3-dose completion
among women in a low vaccination region of the USA: an observational study.
BMC Women’s Health, 16(1). https://doi.org/10.1186/s12905-016-0323-5
World Health Organization. (2016, June). Human papillomavirus (HPV) and cervical
cancer. Retrieved May 5, 2017, from
http://www.who.int/mediacentre/factsheets/fs380/en/
Yanez, B., McGinty, H. L., Buitrago, D., Ramirez, A. G., & Penedo, F. J. (2016). Cancer
outcomes in Hispanics/Latinos in the United States: An integrative review and
conceptual model of determinants of health. Journal of Latina/O Psychology,
4(2), 114–129. https://doi.org/10.1037/lat0000055
Ylitalo, K. R., Lee, H., & Mehta, N. K. (2013). Health Care Provider Recommendation,
Human Papillomavirus Vaccination, and Race/Ethnicity in the US National
Immunization Survey. American Journal of Public Health, 103(1), 164–169.
https://doi.org/10.2105/AJPH.2011.300600
Zimet, G. D. (2015). “A Day Late and a Dollar Short”: Physicians and HPV Vaccination.
Cancer Epidemiology Biomarkers & Prevention, 24(11), 1643–1644.
https://doi.org/10.1158/1055-9965.EPI-15-0879

203
Zimet, G. D., Rosberger, Z., Fisher, W. A., Perez, S., & Stupiansky, N. W. (2013).
Beliefs, behaviors and HPV vaccine: Correcting the myths and the
misinformation. Preventive Medicine, 57(5), 414–418 5p.
https://doi.org/10.1016/j.ypmed.2013.05.013
zur Hausen, H. (2009). Papillomaviruses in the causation of human cancers — a brief
historical account. Virology, 384(2), 260–265.
https://doi.org/10.1016/j.virol.2008.11.046

204
Appendix A: Complex Samples Results
Research Question One
In RQ1, I examined whether there is a relationship between initiation of the HPV
vaccine series and socioeconomic and demographic variables in the 2015 select local area
dataset, controlling for known confounders (Table A1). Model 1 included gender, race
and ethnicity, poverty status, mother’s education level, and select local areas of interest;
Model 2 added clinical parameters: well-check visits, number of visits in the past 12
months, type of health insurance, and if the teen was ever uninsured since age 11. Model
3 added control factors: age of teen, relationship of respondent to teen, number of
children in house under 18, mother’s marital status, and age of the teen’s mother.
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Table A1
Relationships between HPV vaccine initiation and socioeconomic and demographic
variables, Select Local Area, 2015

Gender
Male
Female
Race/ethnicity
Non-Hispanic White
Hispanic
Non-Hispanic Black
Poverty status
Above (> $75,000)
Above (≤ $75,000)
Below
Mother’s education level
Less than high school
High school graduate
Some college
College graduate
Select local area
New York City
Washington, D.C.
Philadelphia
Chicago
El Paso
Houston
Bexar County
Hidalgo County

Model 1
(OR, 95% CI)

Model 2
(OR, 95% CI)

Model 3
(OR, 95% CI)

1.18 [0.81-1.71]
-

-

-

1.10 [0.63-1.93]
0.95 [0.52-1.75]

-

-

1.49 [0.87-2.54]
1.35 [0.72-2.54]

-

-

1.74 [0.90-3.35]
1.06 [0.57-1.96]
1.31 [0.77-2.24]
-

-

-

1.08 [0.61-1.91]
1.00 [0.57-1.75]
0.95 [0.55-1.65]
0.59 [0.33-1.06]
0.43 [0.23-0.83]*
0.75 [0.42-1.34]
0.45 [0.25-0.82]**

1.05 [0.60-1.84]
0.89 [0.52-1.51]
0.90 [0.53-1.55]
0.68 [0.41-1.13]
0.41 [0.22-0.77]**
0.79 [0.46-1.36]
0.52 [0.31-0.88]*

1.07 [0.60-1.88]
0.93 [0.53-1.62]
0.89 [0.50-1.57]
0.63 [0.37-1.07]
0.42 [0.22-0.82]**
0.79 [0.46-1.37]
0.55 [0.32-0.94]*

Note. CI, Confidence Interval. OR, odds ratio.
* p < .05
** p < .01
Overall, for RQ1 I rejected the null hypothesis, showing instead that there was a
relationship between initiation of the HPV vaccine series and at least one socioeconomic
or demographic variable in select local areas in unadjusted and adjusted models. Teens
were significantly less likely to initiate the vaccine if they lived in Houston (58% less
likely) or Hidalgo County (45%) than teens who lived in Chicago.
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Research Question Two
In RQ2, I examined whether there is a relationship between completion of the
HPV vaccine series and socioeconomic and demographic variables in the 2015 select
local area dataset, controlling for known confounders (Table A2).
Table A2
Relationships between HPV vaccine completion and socioeconomic and demographic
variables, Select Local Area, 2015

Gender
Male
Female
Race/ethnicity
Non-Hispanic White
Hispanic
Non-Hispanic Black
Poverty status
Above (> $75,000)
Above (≤ $75,000)
Below
Mother’s education level
Less than high school
High school graduate
Some college
College graduate
Select local area
New York City
Washington, D.C.
Philadelphia
Chicago
El Paso
Houston
Bexar County
Hidalgo County

Model 1
(OR, 95% CI)

Model 2
(OR, 95% CI)

0.65 [0.45-0.93]*
-

0.68 [0.48-0.95]*
-

1.28 [0.76-2.14]
1.12 [0.64-1.94]

-

-

1.07 [0.65-1.75]
1.15 [0.67-1.98]

-

-

0.55 [0.30-1.04]
0.82 [0.47-1.44]
0.57 [0.34-0.94]
-

-

-

0.95 [0.53-1.70]
1.41 [0.81-2.45]
2.00 [1.14-3.51]
1.24 [0.71-2.17]
1.46 [0.78-2.72]
1.09 [0.61-1.93]
1.18 [0.66-2.11]

-

-

Note. CI, Confidence Interval. OR, odds ratio.
* p < .05
** p < .01

Model 3
(OR, 95% CI)
0.65 [0.46-0.92]*
-
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Overall, for RQ2 I rejected the null hypothesis, showing instead that there was a
relationship between completion of the HPV vaccine series and at least one
socioeconomic or demographic variable in select local areas in unadjusted and adjusted
models. In the select local area sample, only gender was significantly associated. Males
were significantly less likely to initiate the vaccine (35%) than females.
Research Question Three
In RQ3, I examined whether there is a relationship between initiation of the HPV
vaccine series and social vulnerability by select local area county, using logistic
regression and data from the 2014 NIS-Teen and the 2014 Social Vulnerability Index
(Table A3).
Table A3
Relationship between HPV vaccine initiation and overall county social vulnerability
ranking, 2014
Social Vulnerability
percentile ranking
Washington, D.C.
Philadelphia
El Paso County
Bexar County

.59 (Med-High)
.91 (High)
.95 (High)
.82 (High)

HPV Vaccine Initiation
OR
1.29
1.71
1.17
-

95% CI
.68 – 2.43
.94 – 3.12
.61 – 2.24
-

Note. Med-High indicates a medium-high vulnerability, or being in the third-highest
percentile of vulnerability. CI, Confidence Interval. OR, odds ratio.
Overall, for RQ3 I could not reject the null hypothesis, as the relationship
between HPV vaccine initiation and social vulnerability ranking did not meet statistical
significance.
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Research Question Four
In RQ4, I examined whether there is a relationship between physician
recommendation of the HPV vaccine series and social vulnerability by select local area
county, using logistic regression and data from the 2014 NIS-Teen and the 2014 Social
Vulnerability Index (Table A4).
Table A4
Relationship between physician recommendation of the HPV vaccine and overall county
social vulnerability ranking, 2014
Social Vulnerability
percentile ranking
Washington, D.C.
Philadelphia
El Paso County
Bexar County

.59 (Med-High)
.91 (High)
.95 (High)
.82 (High)

Physician Recommendation
OR
2.90
2.14
1.50
-

95% CI
1.54 – 5.46***
1.19 – 3.87*
.83 – 2.70
-

Note. Med-High indicates a medium-high vulnerability, or being in the third-highest
percentile of vulnerability. CI, Confidence Interval. OR, odds ratio.
* p < .05
*** p < .001
Overall, for RQ4 I rejected the null hypothesis, as the relationship between HPV
vaccine initiation and social vulnerability ranking was significantly different. Teens were
significantly more likely to receive a physician recommendation if they lived in
Washington, D.C. (190% more likely) and Philadelphia (114%) than teens living in
Chicago.
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Appendix B: Multicollinearity Tests
Table B1
Multicollinearity Model Summaries

HPV Initiation
HPV Completion
No Shots

R

R2

Adjusted R2

SEM

.31
.40
.61

.09
.16
.37

.08
.15
.37

.44
.43
.39

Note. SEM, Standard Error of the Mean.
Table B2
Multicollinearity Tolerance and Variance Inflation Factors

Physician recommendation
Gender
Race and ethnicity
Poverty level
Mother’s education level
Select local area
Number of visits
Type of health insurance
Ever uninsured
Well-check visit
Relationship to teen
Children under 18 in household
Mother’s marital status
Mother’s age
Teen’s age

HPV Vaccine Initiation
VIF (Tolerance)
1.04 (.96)
1.06 (.94)
1.27 (.79)
2.21 (.45)
1.60 (.62)
1.04 (.96)
1.04 (.96)
1.68 (.59)
1.05 (.95)
1.02 (.98)
1.08 (.93)
1.13 (.89)
1.24 (.81)
1.26 (.80)
1.08 (.93)

Note. VIF, Variance Inflation Factor. A VIF between 1 and 10 and a tolerance value
closer to 1.0 (versus closer to 0) indicate no multicollinearity.
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Appendix C: Physician Recommendation
Table 12
Relationships between physician recommendation and socioeconomic and demographic
variables, Select Local Area

Gender
Race/ethnicity
Poverty status
Mother’s education level
Select local area
Number of visits in 12 months
Type of health insurance
Ever uninsured since age 11
Well-check visit
Respondent relationship to
teen
Number of children under 18
Mother’s marital status
Mother’s age
Teen’s age
HPV vaccine initiation
HPV vaccine completion
No shots received

2014
χ2 (df)
37.90 (1)***
4.29 (2)
6.88 (2)*
14.05 (3)**
21.23 (3)***
18.23 (4)***
.29 (1)
.16 (1)
31.92 (1)***

2015
χ2 (df)
15.29 (1)***
1.58 (2)
14.45 (2)***
11.32 (3)**
17.74 (7)**
10.96 (4)*
.04 (1)
.48 (1)
3.22 (1)

3.27 (3)

27.25 (3)***

1.32 (2)
1.18 (1)
7.19 (2)*
12.59 (4)**
30.03 (1)***
95.57 (1)***
209.23 (1)***

15.58 (2)***
.58 (1)
26.23 (2)***
10.61 (4)*
100.92 (1)***
220.64 (1)***
567.31 (1)***

Note. χ2, chi-square statistic. df, degrees of freedom.
* p < .05
** p < .01
*** p < .001
Table 13
Relationships between physician recommendation and vaccination, Select Local Area

HPV vaccine initiation
HPV vaccine completion
No shots received

2014
OR [95% CI]
3.08 [2.03-4.66]
8.20 [5.12-12.13]
.08 [.06-.12]

Note. CI, Confidence Interval. OR, odds ratio

2015
OR (95% CI)
5.21 [3.68-7.37]
35.64 [17.53-72.46]
.04 [.03-.05]
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Appendix D: HPV Vaccination and States
Table 14
HPV vaccine initiation, completion, and physician recommendation by U.S. state, 2015

Alabama
Arizona
Arkansas
California
Florida
Iowa
Louisiana
Maine
Massachusetts
Mississippi
Missouri
New Hampshire
New Mexico
Ohio
Oklahoma
Pennsylvania
Rhode Island
Tennessee
Texas

Initiation
OR [95% CI]

Completion
OR [95% CI]

.60 [.35-1.00]*
.60 [.38-.95]*
.52 [.28-.98]*
.45 [.26-.79]**
.55 [.32-.93]*
.46 [.23-.94]*
.50 [.31-.82]**
.49 [.29-.80]**
.46 [26-.80]**
.58 [.37-.92]*

1.82 [1.09-3.05]*
1.70 [1.07-2.72]*
1.90 [1.05-3.41]*
2.17 [1.06-4.46]*
1.68 [1.00-2.84]*
2.18 [1.09-4.37]*
2.03 [1.14-3.64]*
1.80 [1.10-2.96]*
2.67 [1.24-5.78]*
-

Physician
recommendation
OR [95% CI]
.46 [.26-.82]**
.55 [.30-1.00]*
.37 [.20-.68]***
.53 [.31-.90]*
3.89 [1.20-12.57]*
.47 [.27-.82]**
.55 [.33-.89]*

Note. CI, Confidence Interval. OR, odds ratio. Only states with a statistically significant
relationship are included in the table. Data from 2015 U.S. NIS-Teen sample; all
dependent variables were controlled for significant sociodemographic variables.
* p < .05
** p < .01
*** p < .001
Of note, teens who lived in three states were both less likely to initiate and more
likely to complete the HPV vaccine than teens who lived in Chicago: Arizona, Iowa, and
Pennsylvania. In addition, teens living in three states who were less likely to initiate the
HPV vaccine series were also less likely to receive a physician recommendation:
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Missouri, Tennessee, and Texas. Teens who lived in Rhode Island were more likely to
complete the HPV vaccine series as well as receive a physician recommendation.
However, teens who lived in Alabama, Arkansas, and Mississippi were less likely to
receive a physician recommendation, but the relationships between these states in
initiating or completing the HPV vaccine were not significant compared with teens living
in Chicago.

